false 0001498148 0001498148 2026-03-01 2026-05-31 0001498148 dei:BusinessContactMember 2026-03-01 2026-05-31 0001498148 2026-02-28 0001498148 2025-02-28 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2025-02-28 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesGPreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesGPreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesEPreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesFPreferredStockMember 2025-02-28 0001498148 2026-05-31 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2026-05-31 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesGPreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember 2026-05-31 0001498148 us-gaap:SubsequentEventMember 2026-07-15 0001498148 2025-03-01 2026-02-28 0001498148 2024-03-01 2025-02-28 0001498148 AITX:CostOfGoodsSoldMember 2025-03-01 2026-02-28 0001498148 AITX:CostOfGoodsSoldMember 2024-03-01 2025-02-28 0001498148 AITX:DepreciationAndAmortizationMember 2025-03-01 2026-02-28 0001498148 AITX:DepreciationAndAmortizationMember 2024-03-01 2025-02-28 0001498148 AITX:LossOnDisposalOfRevenueEarningDevicesMember 2025-03-01 2026-02-28 0001498148 AITX:LossOnDisposalOfRevenueEarningDevicesMember 2024-03-01 2025-02-28 0001498148 2025-03-01 2025-05-31 0001498148 AITX:CostOfGoodsSoldMember 2026-03-01 2026-05-31 0001498148 AITX:CostOfGoodsSoldMember 2025-03-01 2025-05-31 0001498148 AITX:DepreciationAndAmortizationMember 2026-03-01 2026-05-31 0001498148 AITX:DepreciationAndAmortizationMember 2025-03-01 2025-05-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-02-29 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-02-29 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-02-29 0001498148 us-gaap:CommonStockMember 2024-02-29 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-02-29 0001498148 us-gaap:RetainedEarningsMember 2024-02-29 0001498148 2024-02-29 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-02-28 0001498148 us-gaap:CommonStockMember 2025-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-02-28 0001498148 us-gaap:RetainedEarningsMember 2025-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-02-28 0001498148 us-gaap:CommonStockMember 2026-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-02-28 0001498148 us-gaap:RetainedEarningsMember 2026-02-28 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-03-01 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:CommonStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-03-01 2025-02-28 0001498148 us-gaap:RetainedEarningsMember 2024-03-01 2025-02-28 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-03-01 2026-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:CommonStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-03-01 2026-02-28 0001498148 us-gaap:RetainedEarningsMember 2025-03-01 2026-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:CommonStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-03-01 2025-05-31 0001498148 us-gaap:RetainedEarningsMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:CommonStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-03-01 2026-05-31 0001498148 us-gaap:RetainedEarningsMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2026-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-05-31 0001498148 us-gaap:CommonStockMember 2025-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-05-31 0001498148 us-gaap:RetainedEarningsMember 2025-05-31 0001498148 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-05-31 0001498148 us-gaap:CommonStockMember 2026-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-05-31 0001498148 us-gaap:RetainedEarningsMember 2026-05-31 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2017-07-25 0001498148 AITX:RoboticAssistanceDevicesLLCMember us-gaap:SeriesEPreferredStockMember 2017-08-27 2017-08-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember us-gaap:SeriesFPreferredStockMember 2017-08-27 2017-08-28 0001498148 us-gaap:CommonStockMember AITX:EquityFinancingAgreementMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-31 0001498148 srt:ControllerMember 2025-03-01 2026-02-28 0001498148 srt:ControllerMember 2026-02-28 0001498148 srt:ControllerMember 2025-02-28 2025-02-28 0001498148 srt:ControllerMember 2025-02-28 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:TwoCustomerMember 2025-03-01 2026-02-28 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:OneCustomerMember 2024-03-01 2025-02-28 0001498148 AITX:TwoCustomerMember 2026-02-28 0001498148 AITX:OneCustomerMember 2025-02-28 0001498148 AITX:IncentiveCompensationPlanMember 2025-03-01 2026-02-28 0001498148 AITX:IncentiveCompensationPlanMember 2024-03-01 2025-02-28 0001498148 srt:ControllerMember 2026-03-01 2026-05-31 0001498148 srt:ControllerMember 2026-05-31 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:TwoCustomerMember 2026-03-01 2026-05-31 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:ThreeCustomerMember 2024-03-01 2025-02-28 0001498148 AITX:TwoCustomerMember 2026-05-31 0001498148 AITX:OneCustomerMember 2025-05-31 0001498148 AITX:IncentiveCompensationPlanMember 2026-03-01 2026-05-31 0001498148 AITX:IncentiveCompensationPlanMember 2025-03-01 2025-05-31 0001498148 us-gaap:ComputerEquipmentMember 2026-02-28 0001498148 us-gaap:FurnitureAndFixturesMember 2026-02-28 0001498148 us-gaap:OfficeEquipmentMember 2026-02-28 0001498148 AITX:WarehouseEquipmentMember 2026-02-28 0001498148 AITX:DemoDevicesMember 2026-02-28 0001498148 us-gaap:VehiclesMember 2026-02-28 0001498148 us-gaap:LeaseholdImprovementsMember 2026-02-28 0001498148 us-gaap:ComputerEquipmentMember srt:MinimumMember 2026-05-31 0001498148 us-gaap:ComputerEquipmentMember srt:MaximumMember 2026-05-31 0001498148 us-gaap:OfficeEquipmentMember 2026-05-31 0001498148 AITX:ManufacturingEquipmentMember 2026-05-31 0001498148 AITX:WarehouseEquipmentMember 2026-05-31 0001498148 us-gaap:ToolsDiesAndMoldsMember 2026-05-31 0001498148 AITX:DemoDevicesMember 2026-05-31 0001498148 us-gaap:VehiclesMember 2026-05-31 0001498148 us-gaap:LeaseholdImprovementsMember 2026-05-31 0001498148 us-gaap:FairValueInputsLevel1Member 2026-02-28 0001498148 us-gaap:FairValueInputsLevel2Member 2026-02-28 0001498148 us-gaap:FairValueInputsLevel3Member 2026-02-28 0001498148 us-gaap:FairValueInputsLevel1Member 2025-02-28 0001498148 us-gaap:FairValueInputsLevel2Member 2025-02-28 0001498148 us-gaap:FairValueInputsLevel3Member 2025-02-28 0001498148 us-gaap:FairValueInputsLevel1Member 2026-05-31 0001498148 us-gaap:FairValueInputsLevel2Member 2026-05-31 0001498148 us-gaap:FairValueInputsLevel3Member 2026-05-31 0001498148 AITX:SimpleAgreementForFutureEquityMember 2022-12-23 0001498148 2024-06-03 2024-06-03 0001498148 us-gaap:SeriesAPreferredStockMember 2025-01-03 2025-01-03 0001498148 us-gaap:CommonStockMember 2025-01-03 2025-01-03 0001498148 us-gaap:WarrantMember 2025-01-03 2025-01-03 0001498148 us-gaap:SeriesAPreferredStockMember 2025-02-28 0001498148 us-gaap:WarrantMember 2025-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2024-03-01 2025-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-02-28 0001498148 us-gaap:AutomobilesMember 2026-02-28 0001498148 us-gaap:AutomobilesMember 2025-02-28 0001498148 AITX:DemoDevicesMember 2025-02-28 0001498148 us-gaap:ToolsDiesAndMoldsMember 2026-02-28 0001498148 us-gaap:ToolsDiesAndMoldsMember 2025-02-28 0001498148 us-gaap:MachineryAndEquipmentMember 2026-02-28 0001498148 us-gaap:MachineryAndEquipmentMember 2025-02-28 0001498148 us-gaap:ComputerEquipmentMember 2025-02-28 0001498148 us-gaap:OfficeEquipmentMember 2025-02-28 0001498148 us-gaap:FurnitureAndFixturesMember 2025-02-28 0001498148 AITX:WarehouseEquipmentMember 2025-02-28 0001498148 us-gaap:LeaseholdImprovementsMember 2025-02-28 0001498148 us-gaap:AutomobilesMember 2026-05-31 0001498148 us-gaap:MachineryAndEquipmentMember 2026-05-31 0001498148 us-gaap:ComputerEquipmentMember 2026-05-31 0001498148 us-gaap:FurnitureAndFixturesMember 2026-05-31 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-03-01 2026-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2026-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2026-03-01 2026-05-31 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-03-01 2025-05-31 0001498148 AITX:FixedAssetsMember 2025-03-01 2026-02-28 0001498148 AITX:FixedAssetsMember 2024-03-01 2025-02-28 0001498148 AITX:RevenueEarningDevicesMember 2025-03-01 2026-02-28 0001498148 AITX:RevenueEarningDevicesMember 2024-03-01 2025-02-28 0001498148 AITX:FixedAssetsMember 2026-03-01 2026-05-31 0001498148 AITX:FixedAssetsMember 2025-03-01 2025-05-31 0001498148 AITX:RevenueEarningDevicesMember 2026-03-01 2026-05-31 0001498148 AITX:RevenueEarningDevicesMember 2025-03-01 2025-05-31 0001498148 us-gaap:InvestorMember 2019-02-01 2019-02-01 0001498148 us-gaap:InvestorMember 2020-02-29 2020-02-29 0001498148 AITX:InvestorOneMember 2019-05-09 2019-05-09 0001498148 AITX:InvestorOneMember 2020-02-29 2020-02-29 0001498148 AITX:InvestorTwoMember 2019-05-09 2019-05-09 0001498148 AITX:InvestorTwoMember 2020-02-29 2020-02-29 0001498148 us-gaap:InvestorMember 2025-03-01 2026-02-28 0001498148 AITX:InvestorOneMember 2019-11-18 0001498148 AITX:InvestorOneMember 2019-11-18 2019-11-18 0001498148 us-gaap:InvestorMember 2020-02-29 0001498148 AITX:InvestorOneMember 2020-05-31 0001498148 AITX:InvestorTwoMember 2019-12-30 0001498148 AITX:InvestorTwoMember 2019-12-30 2019-12-30 0001498148 AITX:InvestorTwoMember 2020-02-29 0001498148 us-gaap:InvestorMember 2020-04-22 0001498148 us-gaap:InvestorMember 2020-04-22 2020-04-22 0001498148 us-gaap:InvestorMember 2020-07-01 2020-07-01 0001498148 us-gaap:InvestorMember AITX:SimilarAgreementMember 2020-07-01 2020-07-01 0001498148 us-gaap:InvestorMember AITX:AgreementOneMember 2019-02-01 0001498148 us-gaap:InvestorMember AITX:AgreementTwoMember 2019-11-18 0001498148 us-gaap:InvestorMember AITX:AgreementThreeMember 2020-07-01 0001498148 us-gaap:InvestorMember 2020-08-27 0001498148 us-gaap:InvestorMember 2020-08-31 2020-08-31 0001498148 us-gaap:InvestorMember AITX:AgreementMember 2020-08-27 2020-08-27 0001498148 2021-03-01 0001498148 us-gaap:InvestorMember srt:MaximumMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember srt:MinimumMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-05-31 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 2021-05-31 0001498148 us-gaap:InvestorMember 2026-02-28 0001498148 us-gaap:InvestorMember 2025-02-28 0001498148 us-gaap:InvestorMember 2026-03-01 2026-05-31 0001498148 us-gaap:InvestorMember 2020-08-27 2020-08-27 0001498148 us-gaap:InvestorMember 2026-05-31 0001498148 us-gaap:RelatedPartyMember 2026-02-28 0001498148 us-gaap:RelatedPartyMember 2025-02-28 0001498148 us-gaap:RelatedPartyMember 2025-03-01 2026-02-28 0001498148 us-gaap:RelatedPartyMember 2024-03-01 2025-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2026-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2025-03-01 2026-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2025-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2024-03-01 2025-02-28 0001498148 2023-12-01 2023-12-31 0001498148 us-gaap:SeriesGPreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:SeriesGPreferredStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:RelatedPartyMember 2026-05-31 0001498148 us-gaap:RelatedPartyMember 2026-03-01 2026-05-31 0001498148 srt:ChiefExecutiveOfficerMember 2026-03-01 2026-05-31 0001498148 srt:ChiefExecutiveOfficerMember 2023-12-01 2023-12-31 0001498148 srt:ChiefExecutiveOfficerMember 2025-03-01 2025-05-31 0001498148 srt:ChiefExecutiveOfficerMember us-gaap:SeriesGPreferredStockMember 2026-05-31 0001498148 AITX:PromissoryNotePayableOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFiveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableSixMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableSixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableSevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableSevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableNineMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFifteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFifteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableSixteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableSeventeenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableSeventeenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableEighteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableEighteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableNineteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableNineteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentySixMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentySixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtySixMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtySixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyFiveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortySixMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortySixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortySevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortySevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFiveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableNineMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableElevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableElevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwelveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwelveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFourteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFourteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFifteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFifteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSixteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSixteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSeventeenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSeventeenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableEighteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableEighteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableNineteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableNineteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2026-05-31 0001498148 AITX:PurchaseAgreementMember 2026-03-01 2026-05-31 0001498148 AITX:PurchaseAgreementMember 2026-05-31 0001498148 AITX:PurchaseAgreementOneMember 2026-03-01 2026-05-31 0001498148 AITX:PurchaseAgreementOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementMember 2026-03-01 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2026-05-31 0001498148 AITX:BusinessLoanMember 2026-03-01 2026-05-31 0001498148 AITX:BusinessLoanMember 2026-05-31 0001498148 AITX:ConvertibleNoteMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2026-05-31 0001498148 AITX:ConvertibleNoteOneMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyOneMember 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-03-01 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-05-31 0001498148 AITX:ConvertibleNoteFiveMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteFiveMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2026-05-31 0001498148 AITX:ConvertibleNoteSevenMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSevenMember 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-05-05 2026-05-05 0001498148 AITX:PromissoryNotePayableTwoMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableTwoMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThreeMember 2023-03-01 2024-02-29 0001498148 AITX:PromissoryNotePayableThreeMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableThreeMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThreeMember 2026-02-08 0001498148 AITX:PromissoryNotePayableThreeMember 2026-02-08 2026-02-08 0001498148 AITX:PromissoryNotePayableSixMember 2024-03-01 0001498148 AITX:PromissoryNotePayableSevenMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableSevenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineMember 2024-03-01 0001498148 AITX:PromissoryNotePayableNineMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableNineMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineMember 2025-02-11 2025-02-11 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-05 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-05 2025-03-05 0001498148 AITX:PromissoryNotePayableTenMember 2022-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableElevenMember 2022-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableElevenMember 2025-03-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2022-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-11-24 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-11-24 2025-11-24 0001498148 AITX:PromissoryNotePayableThirteenMember us-gaap:SeriesFPreferredStockMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirteenMember srt:DirectorMember us-gaap:SeriesFPreferredStockMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-03-01 2025-08-31 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-04-25 2025-04-25 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-04-25 0001498148 AITX:PromissoryNotePayableFourteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableFifteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableFifteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableSeventeenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableSeventeenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEighteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableEighteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableNineteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:LenderMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:LenderMember us-gaap:SeriesFPreferredStockMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-10-26 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2023-10-31 0001498148 AITX:PromissoryNotePayableTwentyMember 2025-11-24 0001498148 AITX:PromissoryNotePayableTwentyMember 2024-02-29 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember AITX:SeriesFPreferredshareWarrantsMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2022-11-09 0001498148 AITX:PromissoryNotePayableTwentyTwoMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-09 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2022-11-10 0001498148 AITX:PromissoryNotePayableTwentyThreeMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-10 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2022-11-15 0001498148 AITX:PromissoryNotePayableTwentyFourMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-15 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2023-01-11 0001498148 AITX:PromissoryNotePayableTwentyFiveMember AITX:SeriesFPreferredshareWarrantsMember 2023-01-11 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentySixMember 2023-02-06 0001498148 AITX:PromissoryNotePayableTwentySixMember AITX:SeriesFPreferredshareWarrantsMember 2023-02-06 0001498148 AITX:PromissoryNotePayableTwentySixMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2023-04-05 0001498148 AITX:PromissoryNotePayableTwentySevenMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-05 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2023-04-20 0001498148 AITX:PromissoryNotePayableTwentyNineMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-20 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2023-05-11 0001498148 AITX:PromissoryNotePayableTwentyNineMember AITX:SeriesFPreferredshareWarrantsMember 2023-05-11 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2024-03-01 0001498148 AITX:PromissoryNotePayableThirtyMember 2023-10-27 0001498148 AITX:PromissoryNotePayableThirtyMember AITX:SeriesFPreferredshareWarrantsMember 2023-10-27 0001498148 AITX:PromissoryNotePayableThirtyMember 2024-03-01 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2023-11-30 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2023-11-30 2023-11-30 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2024-07-01 2024-07-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2024-07-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThirtyTwoMember AITX:LenderMember 2024-03-08 0001498148 AITX:PromissoryNotePayableThirtyTwoMember AITX:LenderMember 2024-03-08 2024-03-08 0001498148 AITX:PromissoryNotePayableThirtySixMember 2025-08-25 2025-08-25 0001498148 AITX:PromissoryNotePayableFourtyMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyTwoMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableFourtyTwoMember srt:MinimumMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableFourtyTwoMember srt:MaximumMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableFourtyTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyFiveMember 2025-06-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtySixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtySixMember 2025-06-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtySevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtySevenMember 2025-06-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyNineMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyNineMember 2025-06-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwoMember 2025-12-10 0001498148 AITX:PromissoryNotePayableThreeMember 2025-11-24 0001498148 AITX:PromissoryNotePayableFiveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableFiveMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableFiveMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableSixMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEightMember 2024-03-01 0001498148 AITX:PromissoryNotePayableEightMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEightMember 2025-02-11 2025-02-11 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-05 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-05 2025-03-05 0001498148 AITX:PromissoryNotePayableTenMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableTenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEighteenMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:SeriesFPreferredshareWarrantsMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyMember 2024-03-01 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-11-09 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-09 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteOneMember 2022-11-10 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteOneMember 2024-03-01 0001498148 AITX:PromissoryNoteOneMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteOneMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteTwoMember 2022-11-15 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteTwoMember 2024-03-01 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteTwoMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteTwoMember 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteThreeMember 2023-01-11 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteThreeMember 2024-03-01 0001498148 AITX:PromissoryNoteThreeMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteThreeMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:PromissoryNoteFourMember AITX:SeriesFPreferredshareWarrantsMember 2023-02-06 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteFourMember 2024-03-01 0001498148 AITX:PromissoryNoteFourMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteFourMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:PromissoryNoteFiveMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-05 0001498148 AITX:PromissoryNoteFiveMember AITX:SeriesFPreferredshareWarrantsMember 2024-03-01 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteFiveMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteFiveMember 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSixMember 2023-04-20 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSixMember 2024-03-01 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSixMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSixMember 2026-05-31 0001498148 AITX:PromissoryNoteSevenMember AITX:SeriesFPreferredshareWarrantsMember 2023-05-11 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSevenMember 2024-03-01 0001498148 AITX:PromissoryNoteSevenMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteSevenMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:PromissoryNoteEightMember AITX:SeriesFPreferredshareWarrantsMember 2023-10-27 0001498148 AITX:PromissoryNoteEightMember AITX:SeriesFPreferredshareWarrantsMember 2024-03-01 0001498148 AITX:PromissoryNoteEightMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteEightMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2023-11-30 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2023-11-30 2023-11-30 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2024-07-01 2024-07-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2024-07-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2024-03-08 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2024-03-08 2024-03-08 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2023-11-30 2023-11-30 0001498148 AITX:PromissoryNotePayableTwentySixMember 2025-08-25 2025-08-25 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2025-12-17 0001498148 AITX:ConvertibleNoteTwoMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember srt:MaximumMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-04-13 2026-04-13 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2025-12-17 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2025-12-17 2025-12-17 0001498148 AITX:ConvertibleNoteFiveMember 2025-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2025-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember srt:MaximumMember 2026-05-31 0001498148 us-gaap:PreferredStockMember 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesBConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesBConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesBConvertibleRedeemablePreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember 2024-03-01 2025-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesFConvertiblePreferredStockMember 2026-02-28 0001498148 us-gaap:PreferredStockMember us-gaap:SeriesGPreferredStockMember 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 2025-02-10 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-03-01 2026-02-28 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-09 2025-08-09 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-01 2025-08-31 0001498148 2025-08-01 2025-08-31 0001498148 2025-09-01 2025-09-30 0001498148 2025-12-01 2025-12-31 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-12-01 2025-12-31 0001498148 2026-01-01 2026-01-30 0001498148 AITX:AmendedEquityFinancingAgreementMember 2026-03-19 2026-03-19 0001498148 AITX:SeriesFConvertiblePreferredStockMember 2024-04-30 0001498148 AITX:SeriesFConvertiblePreferredStockMember 2026-02-28 0001498148 AITX:SeriesFConvertiblePreferredStockMember 2025-02-28 0001498148 AITX:UnissuedSeriesFPreferredStockMember 2025-03-01 2026-02-28 0001498148 AITX:UnissuedSeriesFPreferredStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:CommonStockMember 2022-07-07 0001498148 us-gaap:CommonStockMember 2022-07-08 0001498148 us-gaap:CommonStockMember 2023-03-18 0001498148 us-gaap:CommonStockMember 2023-03-19 0001498148 us-gaap:CommonStockMember 2023-08-29 0001498148 us-gaap:CommonStockMember 2023-08-30 0001498148 us-gaap:CommonStockMember 2024-03-21 0001498148 us-gaap:CommonStockMember 2024-03-22 0001498148 us-gaap:CommonStockMember 2024-10-03 0001498148 us-gaap:CommonStockMember 2024-10-04 0001498148 us-gaap:CommonStockMember 2025-02-20 0001498148 us-gaap:CommonStockMember 2025-02-21 0001498148 us-gaap:CommonStockMember 2025-07-24 0001498148 us-gaap:CommonStockMember 2025-07-25 0001498148 us-gaap:CommonStockMember 2025-10-14 0001498148 us-gaap:CommonStockMember 2025-10-15 0001498148 2026-03-18 0001498148 2026-03-19 0001498148 AITX:CommonStockActivityMember 2025-03-01 2026-02-28 0001498148 AITX:CommonStockActivityMember 2026-02-28 0001498148 AITX:CommonStockActivityMember us-gaap:SeriesCPreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:WarrantMember 2025-03-01 2026-02-28 0001498148 us-gaap:WarrantMember 2024-03-01 2025-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2026-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2024-03-01 2025-02-28 0001498148 AITX:TwentyTwentyOnePlanMember 2022-08-10 2022-08-11 0001498148 AITX:TwentyTwentyOnePlanMember 2021-04-14 0001498148 AITX:TwentyTwentyOnePlanMember us-gaap:OptionMember 2025-03-01 2026-02-28 0001498148 us-gaap:OptionMember AITX:TwentyTwentyThreePlanMember 2025-03-01 2026-02-28 0001498148 AITX:TwentyTwentyOnePlanMember us-gaap:OptionMember 2024-03-01 2025-02-28 0001498148 us-gaap:OptionMember AITX:TwentyTwentyThreePlanMember 2024-03-01 2025-02-28 0001498148 2025-02-10 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-05-10 2025-05-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-08-09 0001498148 AITX:SeriesCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-25 2025-08-25 0001498148 2025-08-25 2025-08-25 0001498148 2025-09-30 2025-09-30 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 2025-12-31 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001498148 2026-01-01 2026-01-31 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-01-01 2026-01-31 0001498148 AITX:SeriesCRedeemablePreferredStockMember srt:MaximumMember 2025-09-01 2025-09-30 0001498148 AITX:SeriesCRedeemablePreferredStockMember srt:MinimumMember 2025-09-01 2025-09-30 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-02-01 2026-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-03-19 2026-03-19 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-05-06 2026-05-06 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-05-12 2026-05-12 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-05-12 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-05-31 0001498148 2026-02-05 2026-02-05 0001498148 AITX:CommonStockActivityMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockActivityOneMember 2026-03-01 2026-05-31 0001498148 2026-03-25 0001498148 2026-03-25 2026-03-25 0001498148 2026-04-20 0001498148 2026-04-20 2026-04-20 0001498148 2026-05-04 0001498148 2026-05-04 2026-05-04 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2025-03-01 2025-05-31 0001498148 AITX:SeriesFPreferredWarrantsMember 2025-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2024-03-01 2025-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2025-03-01 2026-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-05-31 0001498148 2023-02-28 0001498148 2023-03-01 2024-02-28 0001498148 2023-03-01 2024-02-29 0001498148 us-gaap:EmployeeStockOptionMember 2024-02-29 0001498148 us-gaap:EmployeeStockOptionMember 2023-03-01 2024-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2025-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2026-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2026-03-01 2026-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2026-05-31 0001498148 2025-06-01 2025-06-30 0001498148 2025-08-01 2025-08-01 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-09 2021-03-10 0001498148 AITX:FerndaleMichiganMember AITX:TenYearsLeaseAgreementMember 2021-03-09 2021-03-10 0001498148 AITX:FerndaleMichiganMember AITX:TenYearsLeaseAgreementMember 2021-03-10 0001498148 AITX:ThreeYearsLeaseAgreementMember 2024-02-05 2024-02-05 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-10 2025-03-11 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-11 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-10 2021-03-10 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-10 0001498148 AITX:ThreeYearsLeaseAgreementMember 2024-02-04 2024-02-05 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-11 2025-03-11 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2025-03-01 2026-02-28 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2024-03-01 2025-02-28 0001498148 AITX:ConvertibleSeriesCPreferredSharesMember 2025-03-01 2026-02-28 0001498148 AITX:ConvertibleSeriesCPreferredSharesMember 2024-03-01 2025-02-28 0001498148 AITX:ConvertibleAndExchangeableDebtMember 2025-03-01 2026-02-28 0001498148 AITX:ConvertibleAndExchangeableDebtMember 2024-03-01 2025-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2026-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2024-03-01 2025-02-28 0001498148 AITX:ConvertibleExchangeableDebtMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleExchangeableDebtMember 2025-03-01 2025-05-31 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesCPreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2026-03-01 2026-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2025-05-31 0001498148 us-gaap:SubsequentEventMember AITX:SharePurchaseAgreementMember 2026-03-01 2026-03-01 0001498148 us-gaap:SubsequentEventMember AITX:ExchangeAgreementsMember 2026-03-01 2026-03-01 0001498148 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2026-03-01 2026-03-01 0001498148 us-gaap:CommonStockMember us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2026-03-01 2026-03-01 0001498148 us-gaap:SubsequentEventMember AITX:AmendedEquityFinancingAgreementMember 2026-05-04 2026-05-04 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-12 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-12 2026-03-12 0001498148 us-gaap:SubsequentEventMember us-gaap:SeriesCPreferredStockMember 2026-03-19 2026-03-19 0001498148 us-gaap:SubsequentEventMember us-gaap:SeriesCPreferredStockMember 2026-03-19 0001498148 us-gaap:SubsequentEventMember us-gaap:SeriesCPreferredStockMember us-gaap:CommonStockMember 2026-03-19 2026-03-19 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-25 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-25 2026-03-25 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-03-25 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-25 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-05 2026-05-05 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-04-20 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-04-20 2026-04-20 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-04-20 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-04-20 2026-04-20 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-04-20 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-04-20 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-01 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-01 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-05-01 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-05-01 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-04 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-04 2026-05-04 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-29 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-29 2026-05-29 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-03 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-03 0001498148 us-gaap:SubsequentEventMember us-gaap:CommonStockMember AITX:SharePurchaseAgreementMember 2026-06-01 2026-07-14 0001498148 us-gaap:SubsequentEventMember AITX:SharePurchaseAgreementMember 2026-06-01 2026-07-14 0001498148 us-gaap:SubsequentEventMember AITX:ExchangeAgreementsMember 2026-06-01 2026-07-14 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 2026-06-09 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 2026-06-09 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-15 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember 2026-06-15 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2027-06-15 2027-06-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-12-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-12-15 2026-12-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2027-07-15 2027-07-15 0001498148 us-gaap:SubsequentEventMember AITX:AmendedEquityFinancingAgreementMember 2026-06-23 2026-06-23 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-26 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-26 2026-06-26 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-26 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-26 0001498148 AITX:LenderMember AITX:PromissoryNotePayableMember us-gaap:SubsequentEventMember 2026-07-09 0001498148 AITX:LenderMember AITX:PromissoryNotePayableMember us-gaap:SubsequentEventMember 2026-07-09 2026-07-09 0001498148 us-gaap:CommonStockMember AITX:EquityFinancingAgreementMember us-gaap:SubsequentEventMember 2026-06-23 2026-06-23 0001498148 AITX:CommonStockWarrantMember 2026-02-28 0001498148 AITX:CommonStockWarrantMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2026-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure AITX:Integer

 

As filed with the Securities and Exchange Commission on July 16, 2026

 

Registration No. 333-[_________]

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM S-1

 

REGISTRATION STATEMENT

 

UNDER

 

THE SECURITIES ACT OF 1933

 

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

 

Nevada   3714  

27-2343603

(State or other jurisdiction of incorporation or organization)   (Primary Standard Industrial Classification Code Number)   (I.R.S. Employer Identification Number)

 

10800 Galaxie Avenue, Ferndale, Michigan 48220

(877) 787-6268

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Steve Reinharz, Chief Executive Officer 

Artificial Intelligence Technology Solutions Inc.

10800 Galaxie Avenue, Ferndale, Michigan 48220

(877) 787-6268

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

 

Frederick M. Lehrer, P. A.

2108 Emil Jahna Road

Clermont, Florida 34117

(561) 706-7646

flehrer@securitiesattorney1.com

 

Approximate date of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company Emerging growth company

 

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.

 

 

 

 

 

 

The information in this prospectus is not complete and may be changed. The Selling Stockholder may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

SUBJECT TO COMPLETION, DATED JULY 16, 2026

 

PROSPECTUS

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

1,555,000,000 Shares of Common Stock

5,000,000 Commitment Shares

1,550,000,000 Maximum of Put Shares

 

This prospectus relates to the resale, from time to time, by Trillium Partners LP (the “Selling Stockholder” or “Trillium”) of up to 1,555,000,000 shares of our common stock, par value $0.0001 per share, consisting of (i) 5,000,000 shares issuable to Trillium as commitment shares (the “Commitment Shares”) under the Equity Purchase Agreement described in this prospectus, issuable in two equal tranches of 2,500,000 shares, and (ii) up to 1,550,000,000 shares (the “Put Shares”) that we may elect to issue and sell to Trillium from time to time under the Equity Purchase Agreement dated June 23, 2026 (the “Purchase Agreement”) between us and Trillium.

 

The Purchase Agreement establishes an “equity line of credit” or “ELOC.” Under the Purchase Agreement, we have the right, but not the obligation, to require Trillium to purchase up to $10,000,000 of our common stock over a 36-month commitment period, subject to the conditions and limitations described in this prospectus. We may direct purchases through either of two mechanisms that we elect in each put notice:

 

a “Regular Put,” for which the purchase price equals 85% of the average of the three (3) lowest daily closing bid prices of our common stock during the ten (10) consecutive trading days immediately preceding the put date (a “lookback” price with next-trading-day settlement, no floor price and no post-closing adjustment); and
   
an “Accelerated Put,” for which the purchase price equals 85% of the average of the three (3) lowest daily closing bid prices during a forward ten (10) trading day valuation period beginning the trading day after the put date, subject to a Floor Price and the knock-out mechanics described in this prospectus, and for which we deliver estimated shares equal to 125% of the applicable investment amount at the time of the put, followed by a true-up at the end of the valuation period.

 

We will not receive any proceeds from the resale of shares by the Selling Stockholder. We will, however, receive proceeds from our sale of Put Shares to Trillium under the Purchase Agreement. See “Use of Proceeds.”

 

Trillium is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”), in connection with the resale of our common stock under the Purchase Agreement. No other underwriter or person has been engaged to facilitate the sale of shares of our common stock in this offering.

 

Our common stock is quoted on the OTC Markets under the symbol “AITX.” On July 15, 2026, the last reported sale price of our common stock was $0.0086 per share.

 

INVESTING IN OUR COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD CAREFULLY REVIEW THE RISKS AND UNCERTAINTIES DESCRIBED UNDER THE HEADING “RISK FACTORS” BEGINNING ON PAGE 5 OF THIS PROSPECTUS.

 

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

The date of this prospectus is July 16, 2026.

 

 

 

 

TABLE OF CONTENTS

 

Prospectus Summary 1
The Offering 2
About This Offering 3
Risk Factors 5
Cautionary Note Regarding Forward-Looking Statements 8
Use of Proceeds 8
Dilution 13
Selling Stockholder 14
Plan of Distribution 14
Description of the Equity Purchase Agreement and Registration Rights Agreement 15
Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
Business 22
Directors, Executive Officers, and Corporate Governance 30
Executive Compensation 31
Security Ownership of Certain Beneficial Owners and Management 32
Certain Relationships and Related Transactions 33
Description of Securities 34
Legal Matters 36
Experts 36
Where You Can Find More Information 36
Index to Financial Statements F-1

 

i

 

 

PROSPECTUS SUMMARY

 

This summary highlights information contained elsewhere in this prospectus. This summary does not contain all of the information you should consider before investing in our common stock. You should read this entire prospectus carefully, including the “Risk Factors” section and our consolidated financial statements and the related notes included elsewhere in this prospectus, before making an investment decision. Unless the context otherwise requires, references to “AITX,” the “Company,” “we,” “us,” and “our” refer to Artificial Intelligence Technology Solutions Inc. and its subsidiaries. All dollar amounts are in U.S. dollars unless otherwise indicated.

 

Our Company

 

Artificial Intelligence Technology Solutions Inc. is a developer and operator of artificial intelligence-driven security and productivity solutions for enterprise clients. Through its family of companies—including Robotic Assistance Devices, Inc. (“RAD-I”), Robotic Assistance Devices Mobile (“RAD-M”), Robotic Assistance Devices Group (“RAD-G”), Robotic Assistance Devices Residential (“RAD-R”), and Robotic Assistance Devices Lanka (Private) Limited (“RAD Lanka”), the Company develops and delivers a range of AI-driven technologies and services designed to transform security, automation, and operational workflows across multiple industries.

 

Through its primary subsidiary, RAD-I, the Company markets an AI-driven “Solutions-as-a-Service” model to the security and guarding services industry, which the Company estimates to be an approximately $50 billion market in the United States. The Company’s solutions are designed to deliver cost savings of between 35% and 80% compared with traditional manned security and monitoring, using a suite of stationary and mobile devices together with the Company’s software and monitoring platforms.

 

The Company describes its operations across three principal pillars: (i) stationary security devices (RAD-I); (ii) mobile autonomous platforms (RAD-M), including the ROAMEO mobile security unit, early commercial deployment of which began in May 2026; and (iii) the Company’s SARA agentic artificial intelligence platform (RAD-G). RAD Lanka, a wholly owned subsidiary located in Sri Lanka and operating under Port City Colombo status, supports software development, artificial intelligence initiatives, and technical operations across the Company’s subsidiaries. Internally, the Company refers to the long-term outcome of this strategy as “RAD Town,” an integrated autonomous-security deployment across a campus, community, or jurisdiction.

 

Recent Financial Results

 

For the fiscal year ended February 28, 2026, we reported revenue of $7,745,336, an increase of $1,614,450, or 26%, over the prior fiscal year. Gross profit increased 48% to $5,533,700 and gross margin expanded to approximately 71% from approximately 61%. Operating expenses were essentially flat at approximately $17,477,097, and our loss from operations improved by approximately $2.0 million to $(11,943,397). We reported a net loss of approximately $14.5 million for the fiscal year ended February 28, 2026 and had an accumulated deficit of approximately $171 million as of that date.

 

Our independent registered public accounting firm has included an explanatory paragraph in its report on our consolidated financial statements expressing substantial doubt about our ability to continue as a going concern. For the year ended February 28, 2026, the Company had negative cash flow from operating activities of $9,344,534. As of February 28, 2026 the Company has an accumulated deficit of $171,121,742 and negative working capital of $17,017,745. Management does not anticipate having positive cash flow from operations in the near future. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

 

We have funded our operations principally through the issuance of equity and debt securities, including variable-priced instruments, and we expect to continue to rely on external financing, including the equity line established by the Purchase Agreement described in this prospectus. See “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

Corporate Information

 

We are a Nevada corporation. Our principal executive offices are located at 10800 Galaxie Avenue, Ferndale, Michigan 48220, and our telephone number is. Our common stock is quoted on the OTC Markets under the symbol “AITX.” Our website address is www.aitx.ai. Information contained on, or accessible through, our website is not incorporated by reference into, and does not constitute a part of, this prospectus.

 

1

 

 

THE OFFERING

 

Common stock offered by the Selling Stockholder   Up to 1,555,000,000 common stock shares, consisting of 5,000,000 Commitment Shares and up to 1,550,000,000 Put Shares issuable under the Purchase Agreement.
     
Common stock outstanding before this offering   419,371,776 shares as of July 15, 2026.
     
Common stock to be outstanding after this offering   Up to 1,974,371,776 shares, assuming issuance of all Commitment Shares and all Put Shares registered hereby. This number will change as Put Shares are issued at then-current prices.
     
Commitment period   36 months, commencing on the Effective Date of the registration statement of which this prospectus forms a part.
     
Use of proceeds   We will not receive any proceeds from the resale of shares by the Selling Stockholder. We may receive up to $10,000,000 in aggregate gross proceeds from sales of Put Shares to Trillium under the Purchase Agreement, which we intend to use for working capital and general corporate purposes. See “Use of Proceeds.”
     
Beneficial ownership limitation   We may not issue shares to the extent that, after giving effect to the issuance, Trillium together with its affiliates would beneficially own more than 4.99% of our outstanding common stock. See “Description of the Equity Purchase Agreement and Registration Rights Agreement.”
     
Risk factors   An investment in our common stock involves a high degree of risk. See “Risk Factors” beginning on page 5.
     
OTC Markets symbol   AITX

 

2

 

 

ABOUT THIS OFFERING

 

On June 23, 2026, we entered into an Equity Purchase Agreement (the “Purchase Agreement”) and a related Registration Rights Agreement (the “Registration Rights Agreement”) with Trillium Partners LP. This offering relates to the resale by Trillium of the Commitment Shares and the Put Shares. The following is a summary of the material terms of the equity line established by the Purchase Agreement and is qualified in its entirety by reference to the full text of the Purchase Agreement and the Registration Rights Agreement, which are filed as exhibits to the registration statement of which this prospectus forms a part. For a description of our registration obligations to Trillium and the liquidated damages that may become payable if we fail to satisfy specified registration deadlines, see “Risk Factors” and “Description of the Equity Purchase Agreement and Registration Rights Agreement.” In addition, because our common stock is quoted on the OTC Markets and Trillium is an underwriter with respect to the resale of the shares, Trillium must resell the Commitment Shares and the Put Shares registered in this offering at a fixed price for the duration of the offering rather than at prevailing market prices; see “Plan of Distribution.”

 

The Equity Line; Put Right

 

Under the Purchase Agreement, we have the right, but not the obligation, to require Trillium to purchase up to $10,000,000 of our common stock during the 36-month commitment period, subject to the satisfaction of the conditions described below and in the Purchase Agreement. To exercise a put, we deliver a written put notice to Trillium specifying the dollar amount we elect to draw (the “Investment Amount”) and electing the applicable put type. If no put type is specified, the put is deemed a Regular Put. At least five (5) trading days must elapse between put notices.

 

Regular Puts

 

For a Regular Put, the purchase price per share equals 85% of the average of the three (3) lowest daily closing bid prices of our common stock during the ten (10) consecutive trading days immediately preceding (but not including) the put date. The number of Put Shares equals the Investment Amount divided by that purchase price. A Regular Put is not subject to a valuation period, a floor price, or any post-closing adjustment, and no estimated shares are delivered. The closing of a Regular Put occurs no later than one (1) trading day following the put date.

 

Accelerated Puts

 

For an Accelerated Put, the purchase price per share equals 85% of the average of the three (3) lowest daily closing bid prices of our common stock during a forward valuation period of ten (10) consecutive trading days beginning on the first trading day after the put date, subject to the Floor Price described below. Concurrently with an Accelerated Put notice, we deliver to Trillium’s brokerage account, via DWAC, “Estimated Shares” equal to 125% of the Investment Amount divided by the closing bid price on the trading day immediately prior to the put notice date. At the end of the valuation period, the parties “true up”: if the Estimated Shares exceed the number of Put Shares actually issuable, Trillium returns the excess to us via DWAC; if the Estimated Shares are fewer than the number issuable, we issue the shortfall to Trillium.

 

Floor Price and Knock-Out Mechanic (Accelerated Puts Only)

 

Each Accelerated Put is subject to a minimum price (the “Floor Price”) equal to the greater of (i) 75% of the closing bid price of our common stock on the put date or (ii) any higher minimum price we specify in the applicable Accelerated Put notice. If, on any trading day during the valuation period, the closing bid price is less than the Floor Price (a “Low Price Day”), then for each such Low Price Day neither party has the right or obligation to sell or purchase one-tenth (1/10th) of the Investment Amount, and the Investment Amount is reduced accordingly. If three (3) Low Price Days occur during a valuation period, the balance of the parties’ rights and obligations under that put terminate on the third Low Price Day, and the Investment Amount is adjusted to include only one-tenth (1/10th) of the initial Investment Amount for each trading day during the valuation period prior to termination on which the closing bid price equaled or exceeded the Floor Price.

 

3

 

 

Limitations on Puts

 

Our ability to require Trillium to purchase shares is subject to limitations, including that: (i) the aggregate of all Investment Amounts may not exceed $10,000,000; (ii) the Investment Amount for any single put may not exceed 250% of the average daily trading volume of our common stock for the ten (10) trading days preceding the put notice date, multiplied by the applicable purchase price; (iii) we may not deliver a put notice during an active valuation period for a prior put; (iv) at least five (5) trading days must have elapsed since the immediately preceding put notice; and (v) we may not deliver an Accelerated Put notice if, after giving effect to the issuance of the Estimated Shares, Trillium together with its affiliates would beneficially own more than 4.99% of our outstanding common stock (the “Beneficial Ownership Cap”). The 4.99% Beneficial Ownership Cap applies to all puts, whether Regular Puts or Accelerated Puts; on each closing date we may not issue, and Trillium is not required to purchase, Put Shares to the extent Trillium and its affiliates would beneficially own more than 4.99% of our outstanding common stock following the issuance.

 

Commitment Shares

 

As partial consideration for Trillium’s purchase commitment, we agreed to issue Trillium an aggregate of 5,000,000 Commitment Shares in two equal tranches: 2,500,000 shares upon the date the registration statement is declared effective by the SEC, and 2,500,000 shares on the date that is ninety (90) days following such effectiveness. The Commitment Shares are deemed fully earned upon execution of the Purchase Agreement. Both tranches are being registered for resale under this prospectus.

 

Conditions to Puts

 

Our right to deliver a put notice and Trillium’s obligation to purchase are subject to specified conditions, including that the registration statement of which this prospectus forms a part remains effective and available for the resale of the shares subject to the put, the accuracy of our representations and warranties, the absence of a material adverse effect, the continued quotation of our common stock without suspension or delisting, our continued DTC and DWAC eligibility, satisfaction of the Beneficial Ownership Cap, and delivery of a closing certificate. In addition, we may not issue Put Shares to the extent the issuance would exceed any applicable exchange cap or require stockholder approval under the rules of our principal market; because our common stock is quoted on the OTC Markets and is not listed on a national securities exchange, we do not currently expect these limitations to apply. There is no assurance that we will satisfy these conditions or be able to access the full amount available under the Purchase Agreement.

 

No Short Selling

 

Trillium has agreed that neither it nor its affiliates will engage in short sales of our common stock during the term of the Purchase Agreement, subject to customary exceptions, including sales after delivery of a put notice of a number of shares not exceeding the number reasonably expected to be issued under that put notice, sales of shares already held in Trillium’s brokerage account (including Estimated Shares previously delivered), and certain hedging transactions that do not involve the direct sale or transfer of our common stock.

 

4

 

 

RISK FACTORS

 

An investment in our common stock involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information contained in this prospectus, before deciding to invest in our common stock. If any of the following risks actually occurs, our business, financial condition, results of operations, and prospects could be materially and adversely affected, the trading price of our common stock could decline, and you could lose all or part of your investment. The risks described below are not the only risks we face.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Form S-1 contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact contained in this report — including statements regarding our future results of operations and financial condition, revenue and gross margin expectations, business strategy, product development and commercialization plans, planned international expansion, characterizations of our markets and industry, and the plans and objectives of management for future operations — are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “could,” or “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these identifying words.

 

Forward-looking statements are based on our current expectations, estimates, and assumptions regarding our business, the economy, and other future conditions, and reflect management’s beliefs only as of the date of this report. Because forward-looking statements relate to matters that have not yet occurred, they are inherently subject to risks, uncertainties, and changes in circumstances that are difficult to predict and many of which are outside our control. Our actual results, performance, and financial condition may differ materially from those expressed or implied by these statements. Factors that could cause actual results to differ materially include, among others, those described under “Risk Factors” in this Item 1A and elsewhere in this report. Accordingly, you should not place undue reliance on any forward-looking statement.

 

The forward-looking statements include, but are not limited to, statements concerning the matters described in the categories set forth below. These categories and the examples within them are illustrative only and do not constitute an exhaustive list of the forward-looking statements contained in this report, and the cautionary statements and risk factors set forth herein qualify all forward-looking statements wherever they appear. Except as required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

 

FORWARD LOOKING STATEMENTS

 

1. Revenue and Financial Projections.

 

Statements that RAD-I’s recurring revenue and gross margin could, on a standalone basis, support positive cash flow operations and management’s characterization that RAD-I has “achieved a point” at which it could support positive cash flow operations today; that RAD-M will surpass RAD-I’s monthly recurring revenue contribution at some future point; that subscription gross margin will exceed 75% and outright-sale gross margin will exceed 50% based on average bill of materials costs and pricing that the market “has appeared to accept,” each of which is a forward-looking characterization dependent on assumptions about continued pricing acceptance, stable input costs, and manufacturing scale that may not be realized; that RAD-G will generate substantial revenue from SARA platform licensing; that RAD-M represents a higher revenue ceiling than stationary solutions; and that penetration of any covered industry would produce sufficient revenue to support profitability.

 

2. Product Development and Commercialization.

 

Statements regarding the planned introduction of additional stationary solutions during fiscal year 2027; the establishment of RAD Europe during fiscal 2027 and the anticipated benefits thereof; all statements regarding ROAMEO’s commercial viability, autonomous operation without on-site human pilots, production ramp, and revenue trajectory following commencement of commercial billing in May 2026; statements regarding planned RAD-I product introductions, including their timing, features, and market acceptance; and statements regarding expansion of the authorized dealer network and anticipated contributions from the dealer channel.

 

3. Market and Industry Characterizations.

 

All characterizations of the physical security industry as undergoing a structural transition analogous to Industry 4.0; assertions that the human-guard labor model is experiencing unsustainable cost pressures; characterizations of the total addressable market for AI-driven and autonomous security solutions; any implication that competitive dynamics will favor the Company; and the “RAD Town” concept in its entirety, which is a conceptual design target and strategic roadmap, not a contracted project, existing deployment, or assured business outcome.

 

4. SARA Platform and Agentic AI.

 

All characterizations of SARA as an agentic AI platform enabling autonomous real-time action without continuous human intervention, including the Item 1 description that SARA enables devices to “perceive, decide, communicate, and act autonomously in real time, without continuous human intervention,” which states this as a present operational characteristic rather than design intent and should be read in light of the actual performance qualifications in this Item 1A; statements regarding SARA licensing and commercialization with third-party hardware manufacturers and monitoring platforms (including the Immix integration); anticipated expansion of the dealer network and platform ecosystem; statements regarding SARA’s performance in detection, escalation, and response workflows; the characterization in Item 1 that the firearm detection analytic “identifies visible handguns and long guns in real time,” which omits the design-intent and environmental-conditions qualifications that investors should consider when evaluating this statement; and all characterizations of RAD-G’s sales funnel as “substantial” or of management’s expectations for RAD-G revenue as “high.” Industry award recognitions do not constitute validation of product safety, efficacy, or commercial viability.

 

5

 

 

5. Management Estimates and Unaudited Financial Characterizations.

 

The approximate $20 million cumulative ROAMEO development figure is a management estimate not audited or reviewed by the Company’s independent registered public accounting firm. Segment-level profitability and cash flow characterizations for RAD-I—including management’s characterization in Item 1 that RAD-I “has achieved a point” at which its recurring revenue and gross margin could support positive cash flow operations today—are based on internal analysis for which no separately audited financial statements are published. This characterization excludes all expenses not directly attributable to the stationary solutions business, including shared corporate overhead, interest expense, and investment in RAD-M and RAD-G, and does not indicate that the Company as a whole operates at or near positive cash flow. No financial characterization of any individual subsidiary should be treated as audited data. Characterizations of gross margin expectations are based on average bill of materials costs and market pricing over limited historical periods, as well as pricing that the market “has appeared to accept,” and may not be representative of future results.

 

6. International Expansion.

 

Statements regarding the anticipated establishment of RAD Europe during fiscal 2027; expected benefits of RAD Lanka’s Port City Colombo status, including cost efficiency and tax benefits; and anticipated GDPR-compliant service capabilities to be provided through RAD Europe. All such forward-looking statements are subject to regulatory, legal, and operational risks inherent in international expansion.

 

RISK FACTORS

 

In addition to the forward-looking statement categories described above, investors should carefully consider the following material risk factors. Each could cause actual results, financial condition, or business performance to differ materially from those described in this Form S-1. This list is not exhaustive, and additional risks not currently anticipated by management may emerge.

 

I. FINANCIAL AND GOING CONCERN RISKS

 

Substantial Doubt About the Company’s Ability to Continue as a Going Concern.

 

The Company’s independent registered public accounting firm has included an explanatory paragraph in its audit reports expressing substantial doubt about the Company’s ability to continue as a going concern. The Company has incurred recurring net losses, has a history of negative operating cash flows, and carries an accumulated deficit that, as of recent reporting periods, has exceeded $176 million. The Company’s total liabilities substantially exceed its total assets, and it maintains negative stockholders’ equity. These conditions raise material uncertainty as to whether the Company will be able to meet its obligations as they come due. The Company’s financial statements do not include any adjustments to reflect the possible effects on the classification or carrying value of assets and liabilities that might result from the outcome of this uncertainty. There can be no assurance that the Company will be able to generate sufficient revenue, raise adequate capital, or otherwise secure the resources necessary to continue operations beyond the near term.

 

The Company Requires Continued External Financing and May Be Unable to Obtain It on Acceptable Terms or at All.

 

The Company’s operations are not yet self-funding. The Company has relied, and expects to continue to rely, on external debt and equity financing to fund operations, capital expenditures, product development, and the planned production ramp of ROAMEO and other new products. A significant portion of the Company’s debt has historically been owed to entities controlled by a single individual, creating concentrated lender risk and potential conflicts of interest. The Company has also utilized equity financing arrangements, including agreements providing for the issuance of common shares at variable prices, to access capital. If the Company is unable to obtain financing on acceptable terms—or if existing financing arrangements are not renewed or are terminated—the Company may be required to curtail or cease operations, defer planned capital expenditures (including the ROAMEO production ramp and RAD Europe establishment), reduce headcount, or otherwise alter its operating plans in ways that could materially harm its business and prospects.

 

The Company’s Common Stock Is Subject to Substantial Dilution Risk.

 

The Company has issued, and may continue to issue, substantial numbers of shares of common stock in connection with financing transactions, employee and director compensation, debt conversions, and other purposes. As of February 28, 2026, total common shares outstanding exceeded 267 million (post-reverse-split). In March 2026, FINRA processed a 100-for-1 reverse stock split; however, the authorized share count remains at approximately 12 billion shares, preserving the structural capacity for future dilutive issuances. Variable-price equity financing arrangements and debt conversion rights may result in issuances at prices below the then-current market price of the Company’s common stock, causing material dilution to existing shareholders. The reverse stock split does not alter the underlying financial condition of the Company or reduce the potential for future dilutive issuances. The Company does not provide assurance that future equity issuances will not substantially reduce the proportionate ownership or economic interest of existing stockholders.

 

The Company Has a History of Net Losses and Cannot Assure Future Profitability.

 

The Company has not achieved profitability in any fiscal year. Net losses for the three months ended May 31, 2026 and the fiscal year ended February 28, 2026 were approximately $5.7 million and $14.5 million, respectively. Operating expenses—including research and development, sales and marketing, and general and administrative costs—have consistently exceeded gross profit, and interest expense on the Company’s debt obligations represents an additional recurring charge. While gross margin on deployed subscription units has improved and the Company’s Solutions-as-a-Service model is designed to produce improving margins at scale, the Company’s operating cost structure, investment in ROAMEO commercialization, RAD-G platform development, and debt service obligations may prevent it from achieving profitability even as revenues increase. No assurance can be given as to whether or when the Company will achieve or sustain profitability.

 

Gross Margin Expectations May Not Be Achieved.

 

Item 1 of this Report states that subscription gross margin “will exceed” 75% and outright-sale gross margin “will exceed” 50% over deployment lifecycles, based on average bill of materials costs and pricing that the market “has appeared to accept”—language that reflects observed pricing acceptance rather than contracted or assured revenue, and that is itself a forward-looking characterization. These expectations assume continued pricing acceptance, no material input cost increases, manufacturing cost improvements associated with scale, and the absence of significant warranty, maintenance, or retrieval costs on churned units. To date, hardware gross margins have been achieved under small-batch production conditions. None of these assumptions are guaranteed, and actual gross margins may differ materially, particularly during the ROAMEO production ramp period when per-unit manufacturing costs may be higher than at scale.

 

6

 

 

II. OPERATIONAL AND PRODUCT RISKS

 

ROAMEO Commercial Deployment and Production Ramp Involve Significant Execution Risk.

 

The Company commenced commercial billing on ROAMEO units in May 2026 following what management estimates to be approximately $20 million in cumulative development investment. ROAMEO is a fully autonomous, outdoor mobile security vehicle operating without on-site human pilots, and its commercial viability depends on the continued reliable performance of its autonomous navigation stack, on-board sensor systems, cellular and 5G connectivity, and full integration with the SARA agentic AI platform in real-world field conditions. Initial commercial deployments are at a limited number of enterprise customer sites. Scaling ROAMEO to meet broader commercial demand will require significant expansion of the Company’s production capacity and manufacturing operations, neither of which has been demonstrated at commercial scale. Mechanical failures, software defects, connectivity disruptions, navigation errors, environmental limitations, or other operational issues experienced by deployed ROAMEO units could damage the Company’s reputation, result in contract terminations, expose the Company to liability, and materially impair the Company’s ability to achieve the revenue projections attributed to the RAD-M business. Management’s statements that RAD-M will surpass RAD-I’s revenue contribution are forward-looking and dependent on successful execution of each of these steps.

 

The Company’s Revenue Is Highly Concentrated and Dependent on Subscription Renewals.

 

Substantially all of the Company’s revenue is derived from recurring monthly subscription contracts, typically with initial terms of twelve months. Customer retention and subscription renewal are critical to the Company’s revenue stability and growth. A single customer has at times represented a disproportionate share of the Company’s revenue—one customer has previously accounted for approximately 47% of six-month revenue. The loss of one or more significant customers, a material reduction in subscription renewal rates, a failure to maintain service quality levels that support renewals, or disruption to services provided to the Fortune Top 10 enterprise customer or any large enterprise account could materially and adversely affect the Company’s revenue, cash flow, and operating results. The Company retains ownership of hardware deployed under subscription contracts; accordingly, subscriber churn results not only in revenue loss but also in costs associated with device retrieval, redeployment, or write-down.

 

The Company’s Hardware Manufacturing Operations Are Subject to Supply Chain, Capacity, and Quality Risks.

 

The Company performs final assembly, system integration, software loading, and quality assurance at its facility in Ferndale, Michigan, and sources sub-components—including machined metal and plastic components, printed circuit boards, and selected sub-assemblies—from domestic and international suppliers. The Company’s hardware gross margins to date have been produced under small-batch production conditions, and the ability to achieve projected margin improvements depends on production volume increases that have not yet been demonstrated. A disruption affecting one or more key suppliers, an inability to secure critical components at acceptable prices, quality defects, or a failure to scale manufacturing capacity to meet demand could delay product deployments, increase costs, reduce gross margins, and impair the Company’s ability to fulfill customer commitments. International supply chain disruptions, tariff changes, or export control regulations affecting components sourced from outside the United States could have a material adverse effect on component availability and cost. These risks are heightened during the ROAMEO production ramp, when any manufacturing bottleneck would directly constrain the Company’s ability to generate revenue from its highest-anticipated growth segment.

 

The RAD-R Residential Business Has Underperformed and Presents Ongoing Uncertainty.

 

The Company’s RAD-R subsidiary, which operates the RADCam residential security product, generated an immaterial amount of consolidated revenue during fiscal 2026, substantially below the Company’s expectations. The Company attributes this underperformance primarily to the structural differences between its B2B-oriented sales model and the consumer marketing investment required to compete in the B2C residential channel. The Company has no immediate plans to discontinue the RADCam product but has not committed to the additional consumer marketing spend management believes would be required to compete effectively. Although the Company has modified the residential software for deployment into small-and-medium business and enterprise markets through RAD-I, there can be no assurance that this repositioning will generate material revenue. The RAD-R segment may continue to generate losses, and the Company’s assessment of the segment’s strategic value may change in ways that result in impairment charges, operational restructuring, or reallocation of capital.

 

New Product Introductions and RAD Europe Establishment Are Subject to Execution Risk.

 

The Company has stated its intention to introduce additional stationary solutions during fiscal year 2027 and to establish RAD Europe during the same period. Both initiatives involve engineering, regulatory, operational, and commercial risks that could delay or prevent their realization. New product introductions may be delayed by supply chain constraints, manufacturing challenges, software development setbacks, or unfavorable customer reception. The establishment of RAD Europe will require legal entity formation, regulatory compliance infrastructure, staffing, and local market development in a new geography. There can be no assurance that either initiative will proceed on the stated timeline or will produce the anticipated revenue contribution.

 

III. TECHNOLOGY AND INTELLECTUAL PROPERTY RISKS

 

The Company’s AI and Autonomous Technology May Not Perform as Described or Expected.

 

The SARA platform and the Company’s suite of AI-driven security products rely on large language model architecture, machine learning models, computer vision analytics, autonomous decision-making systems, and voice interaction capabilities. AI systems of this nature are subject to known limitations, including errors in detection or classification, failure to perform reliably across varied environmental conditions, susceptibility to adversarial inputs, and performance degradation as the threat landscape or deployment environment changes. Item 1 of this Report states that SARA enables devices to “perceive, decide, communicate, and act autonomously in real time, without continuous human intervention” — describing this as a present operational characteristic. Investors should understand that this characterization reflects design intent under supported field conditions; deployed systems may require more human oversight than described in certain situations and may not consistently deliver the autonomous escalation, voice intervention, and first-responder coordination described in this Report. Item 1 also states that the Company’s firearm detection analytic “identifies visible handguns and long guns in real time”—an unqualified performance claim. Actual detection accuracy and response performance are subject to environmental conditions, image quality, and system configuration; the Company does not represent that the analytic will detect all firearms in all conditions, and the ASTORS award recognition does not constitute independent validation of detection accuracy rates or performance specifications. Failures of the Company’s AI systems to detect threats, correctly identify individuals or vehicles, or appropriately escalate or de-escalate situations could result in harm to persons or property, exposure to liability, and damage to the Company’s reputation and customer relationships. Industry award recognitions referenced in this Report do not constitute validation of the safety, accuracy, or commercial efficacy of any product.

 

7

 

 

The Company Relies on Trade Secrets and Confidentiality Protections Rather Than Patents and May Be Unable to Adequately Protect Its Intellectual Property.

 

The Company does not currently rely materially on patent protection for its hardware designs, software, firmware, AI models, the SARA platform, autonomous navigation stack, or related technology. Instead, the Company relies on trade secret protection, confidentiality and invention-assignment agreements with employees and contractors, copyrights, and trademark registrations. These protections may be insufficient to prevent misappropriation, reverse engineering, or independent development of competing technologies by third parties. Confidentiality agreements may be breached; trade secret protections may prove difficult to enforce, particularly across international jurisdictions; and employees or contractors with access to the Company’s proprietary systems, code, or AI models may depart and join competitors or establish competing businesses. The Company’s Sri Lanka operations at RAD Lanka introduce additional jurisdictional complexity with respect to IP enforcement. If the Company’s intellectual property is misappropriated or independently replicated, the Company may lose the technological differentiation that underpins its competitive positioning.

 

Cybersecurity Incidents Could Compromise the Company’s Products, Customer Data, and Operations.

 

The Company’s products are connected to the internet and to customer networks, and the SARA platform and related cloud services process and transmit data from deployed devices—including video, audio, and access-control information—across an expanding footprint of connected devices. Although the Company has achieved and maintained SOC 2 Type 2 status since February 2025, cybersecurity certifications do not guarantee the absence of vulnerabilities or the prevention of successful attacks. A breach of the Company’s systems, a compromise of deployed customer devices, or a successful attack on the SARA platform could result in unauthorized access to sensitive data, disruption of device functionality at customer sites, customer contract terminations, regulatory scrutiny, litigation, and significant reputational damage. The Company’s cybersecurity posture will require ongoing investment as threats evolve, as ROAMEO deployments expand the number of connected autonomous vehicles in the field, and as RAD Europe operations increase the Company’s exposure to GDPR and other international data protection regimes.

 

The SARA Platform May Not Achieve the Commercial Adoption Anticipated by RAD-G.

 

RAD-G’s business model depends substantially on expanding the SARA ecosystem through licensing and integration arrangements with third-party hardware manufacturers, monitoring platforms (including central station platforms such as Immix), dealers, and enterprise end users. The commercial success of RAD-G depends on third parties choosing to integrate SARA into their products, platforms, and workflows—decisions that are outside the Company’s control and that may not materialize on the timeline or at the scale management anticipates. The RAD-G sales funnel, characterized by management as substantial for an early-stage AI platform business, has not yet produced revenue commensurate with management’s expectations. Competition from large, well-funded AI technology companies with greater distribution and integration resources could impair RAD-G’s ability to establish SARA as a platform-of-choice in the physical security ecosystem.

 

IV. MARKET, COMPETITIVE, AND REGULATORY RISKS

 

The Company Operates in a Competitive Market and Faces Competition from Larger, Better-Capitalized Companies.

 

The Company competes across three distinct but related markets: traditional guard services and manned monitoring; legacy passive security hardware (cameras, access control devices, alarm systems); and an emerging set of AI-driven and autonomous security technology companies. Many of the Company’s actual and potential competitors have substantially greater financial resources, brand recognition, established distribution networks, and installed customer bases than the Company. Large security integrators and major technology companies may develop, license, or acquire AI and autonomous security capabilities that compete directly with the Company’s products and platform. The market characterizations, including statements that incumbent competitors are “structurally disadvantaged” or that legacy vendors “typically lack” agentic AI capability, reflect management’s view and are not statements of established fact. Competitive dynamics may develop in ways unfavorable to the Company, including through technological advances by competitors, price compression across the autonomous security category, or the market entry of well-capitalized technology companies.

 

Deployment of Autonomous Security Devices Is Subject to Evolving Legal, Regulatory, and Privacy Constraints.

 

The Company’s products deploy autonomous devices—including outdoor mobile robotic vehicles (ROAMEO), vehicle access management systems (AVA), visitor management systems (TOM), and AI-enabled cameras (ROSA, RIO, RAM, RADCam)—that collect audio, video, biometric, and identification data in commercial, residential, industrial, and potentially public-access environments. The legal framework governing the collection and processing of such data is complex, rapidly evolving, and varies significantly across jurisdictions. Applicable regulations include state biometric privacy statutes (such as the Illinois Biometric Information Privacy Act), the California Consumer Privacy Act, GDPR as applicable to the Company’s anticipated European operations through RAD Europe, and various other federal, state, and local privacy and data protection laws. Autonomous vehicles and robotic platforms operating in public or semi-public spaces may be subject to licensing, permitting, insurance, or operational requirements that vary by municipality, state, or country. The Company’s anticipated establishment of RAD Europe during fiscal 2027 will directly increase its exposure to GDPR compliance obligations. Failure to comply with applicable laws and regulations could result in regulatory enforcement actions, fines, litigation, mandatory product modifications, or constraints on the Company’s ability to operate or deploy products in affected markets.

 

Market Adoption of AI-Driven and Autonomous Security Solutions May Be Slower Than Management Anticipates.

 

The Company’s business plan assumes that customers in the physical security market will adopt AI-driven and autonomous solutions at a pace and scale consistent with management’s view of the industry’s structural transition. This assumption may not prove correct. Customers may be slower than expected to replace human guard labor or legacy surveillance systems with automated alternatives, whether due to risk aversion, labor union obligations, insurance requirements, regulatory constraints, concerns about AI reliability, or other factors. The “RAD Town” concept—in which the Company’s portfolio of stationary and mobile products operates as an integrated autonomous-security fabric across a campus or jurisdiction—is a long-term design target, not an existing deployment or contracted commercial arrangement. The analogies drawn in this Report to Industry 4.0 transitions in other sectors are management’s narrative framework and may not accurately predict the pace or trajectory of adoption in the physical security industry. Slower-than-anticipated adoption would adversely affect the Company’s ability to achieve its revenue projections and extend the period during which the Company requires external financing.

 

8

 

 

Government and Municipal Markets Present Additional Regulatory and Procurement Risks.

 

The Company’s end-user base includes government entities, and the Company has identified government as a target vertical market. Government procurement cycles are typically longer and more complex than commercial sales cycles, are subject to appropriations risk and political change, and may require certifications, clearances, or compliance with specific regulatory frameworks (including federal cybersecurity standards) that the Company may not currently hold or may be unable to obtain. Autonomous security devices deployed in public or government-managed spaces may attract heightened public and regulatory scrutiny regarding civil liberties, facial recognition, and autonomous decision-making in law enforcement-adjacent contexts. There can be no assurance that the Company will be able to successfully compete for or retain government contracts.

 

V. MANAGEMENT, PERSONNEL, AND KEY PERSON RISKS

 

The Company Is Dependent on Key Personnel, Particularly Its Chief Executive Officer and Chief Technology Officer.

 

The Company’s success is substantially dependent on the continued services of Steven Reinharz, who serves as both Chief Executive Officer and Chief Technology Officer and is the founder of RAD and its principal architect. Steven Reinharz is also the Company’s single largest equity holder and plays a central role in product strategy, customer relationships, investor relations, and industry positioning, including through his service on the Board of the Security Industry Association and chairmanship of its Autonomous Working Group. Item 1 of this Report states that Steven Reinharz has “written and spoken extensively” about the physical security industry’s structural transformation since the Company’s inception and is a “regular speaker” at events hosted by SIA and ASIS, the two leading industry organizations. This public profile, while reflecting genuine industry standing, further concentrates the Company’s market credibility and industry positioning in a single individual; any reputational, health, or availability issue affecting Steven Reinharz could have an outsized adverse effect on the Company’s relationships with customers, partners, dealers, and investors beyond the direct operational impact of his absence. The combined CEO and CTO role concentrates both business leadership and technical architecture in a single individual. The loss of Steven Reinharz, or any material reduction in his involvement in the Company’s business, could have a severe and potentially irreversible adverse effect on the Company. The Company does not currently represent that it has key-person insurance sufficient to compensate for this risk, and the ability to recruit a suitable replacement would be highly uncertain given the specialized combination of technical, operational, and strategic capabilities involved.

 

The Company’s Ability to Attract and Retain Qualified Technical, Sales, and Operational Personnel Is Critical.

 

The Company has approximately 135 employees across the United States, Canada, the United Kingdom, and Asia, including Sri Lanka, and its operations depend on specialized technical expertise in robotics engineering, AI development, autonomous systems, software architecture, and security operations. Competition for qualified engineers and AI talent is intense. The loss of other senior technical, sales, or operational personnel could disrupt operations and product development. The Company’s culture—centered on emotional intelligence, accountability, and multidisciplinary ownership—is described by management as a meaningful operational asset, but there can be no assurance that the Company can maintain this culture or retain key team members as it scales, particularly during periods of capital constraint, extended development timelines, or operational setbacks.

 

The Company’s International Operations Introduce Additional Risks.

 

The Company currently operates internationally through RAD Lanka, a Sri Lanka subsidiary operating within the Port City Colombo special economic zone, and has team members in the United Kingdom and Asia. The Company anticipates establishing RAD Europe during fiscal 2027 to support European market entry and GDPR-compliant service delivery. International operations expose the Company to risks including currency fluctuation, geopolitical instability, changes in local tax and regulatory regimes, difficulty enforcing contracts or intellectual property rights in foreign jurisdictions, and the operational complexity of managing distributed teams across multiple time zones and legal systems. The special economic zone status under which RAD Lanka operates may be subject to changes in Sri Lankan law or policy. The anticipated benefits of RAD Lanka’s Port City Colombo status, including cost efficiency and tax advantages, are not guaranteed to continue. There can be no assurance that the Company’s international expansion will proceed as planned or that the anticipated benefits of international operations will be realized.

 

VI. SECURITIES AND INVESTOR RISKS

 

The Company’s Common Stock Trades on the OTC Pink Market and Is Subject to Significant Volatility and Liquidity Constraints.

 

The Company’s common stock is quoted on the OTC Pink marketplace under the symbol “AITX,” which is not a registered national securities exchange. OTC Pink securities are generally subject to less rigorous disclosure and listing standards than exchange-listed securities, and the market for such securities may be less liquid, more volatile, and more susceptible to manipulation than exchange-listed markets. Shareholders may find it difficult to buy or sell shares at prices that reflect the Company’s intrinsic value, and bid-ask spreads may be wide. The Company’s stock price has been, and may continue to be, highly volatile in response to operating results, financing transactions, product announcements, press releases regarding ROAMEO deployments or RAD-G partnerships, and general market conditions. The March 2026 reverse stock split (100-for-1) does not guarantee any improvement in trading liquidity, price stability, or long-term shareholder value. Investors in OTC Pink securities should be aware that such investments carry a high degree of risk, and the Company’s shares should be considered highly speculative.

 

9

 

 

Insider and Related-Party Transactions Represent Potential Conflicts of Interest.

 

Approximately 96% of the Company’s total loans payable has, at recent reporting dates, been owed to entities controlled by a single individual. Related-party lending of this concentration creates potential conflicts of interest between the interests of that lender and the broader shareholder base, including with respect to the terms of any refinancing, conversion, restructuring, or settlement of such indebtedness. Transactions between the Company and related parties may not be negotiated at arm’s length, and the Company’s ability to obtain independent third-party financing to refinance related-party debt on terms favorable to all shareholders is uncertain. Steven Reinharz, as CEO, CTO, and the Company’s single largest equity holder, may have interests that diverge from those of other stockholders in certain circumstances. The Company’s governance framework may not fully mitigate these potential conflicts, and investors should be aware that the interests of related-party lenders and controlling stockholders may not always be aligned with those of the broader shareholder base.

 

The Company’s Prior and Ongoing Use of Variable-Price Equity Financing Creates Structural Dilution Risk.

 

The Company has historically utilized equity financing arrangements that provide for the issuance of common shares at variable prices, including at prices below the then-prevailing market price. These arrangements have contributed to the Company’s substantial share count (in excess of 267 million shares post-reverse-split) and have resulted in material dilution to existing shareholders. Although the Company completed a 100-for-1 reverse stock split in March 2026, the authorized share count of approximately 12 billion shares remains unchanged, preserving the structural capacity to issue additional shares. Continued reliance on these financing mechanisms, which may be required to fund ongoing operations, the ROAMEO production ramp, RAD-G platform development, or RAD Europe establishment, could result in further dilution and downward pressure on the trading price of the Company’s common stock.

 

VII RISKS RELATING TO OUR FINANCIAL CONDITION AND NEED FOR CAPITAL

 

Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern.

 

Our consolidated financial statements for the fiscal year ended February 28, 2026 were prepared assuming we will continue as a going concern. We have incurred recurring net losses, including a net loss of approximately $14.5 million for the fiscal year ended February 28, 2026, and had an accumulated deficit of approximately $171 million and a stockholders’ deficit as of that date. Our total liabilities substantially exceed our total assets. These conditions raise substantial doubt about our ability to continue as a going concern. If we are unable to obtain sufficient additional financing, we may be required to curtail, delay, or discontinue our operations.

 

We will require substantial additional capital, and our reliance on variable-priced equity financing, including the equity line with Trillium, may result in substantial dilution.

 

We have historically funded our operations through the issuance of equity and debt securities, including variable-priced instruments and convertible securities, and we expect to continue to require substantial additional capital. The equity line established by the Purchase Agreement is a variable-priced financing arrangement under which the number of shares we must issue increases as our stock price declines. Sales of Put Shares to Trillium, and Trillium’s resale of those shares, may cause substantial dilution to existing stockholders and may depress the market price of our common stock.

 

A substantial portion of our outstanding indebtedness is owed to related parties, which creates refinancing risk and potential conflicts of interest.

 

A significant portion of our loans payable is owed to entities controlled by a single individual affiliated with the Company. This concentration creates refinancing risk and potential conflicts of interest between that individual and our minority stockholders. Approximately 96% of the loans payable are owed to entities controlled by our CEO.

 

VIII RISKS RELATING TO THIS OFFERING AND OUR COMMON STOCK

 

Trillium will pay less than the prevailing market price for our common stock, which may cause our stock price to decline.

 

The Put Shares will be sold to Trillium at a discount of 15% to the applicable measure of market price (that is, at 85% of the average of the three lowest closing bid prices over the applicable pricing window). Trillium has a financial incentive to sell the shares it acquires promptly to realize the difference between the discounted purchase price and the market price. These sales, and the perception that these sales may occur, could cause the market price of our common stock to decline. As the price declines, we would be required to issue an increasing number of shares to raise the same amount of proceeds, resulting in further dilution and potential additional downward pressure on our stock price.

 

10

 

 

It is likely that the number of shares registered in this offering will be insufficient to allow us to draw the full commitment amount.

 

The number of Put Shares registered in this offering is based on assumptions about our stock price and trading volume. Because the number of shares issuable under the Purchase Agreement increases as our stock price declines, and because per-put and beneficial-ownership limitations restrict the size and timing of puts, it is likely that the number of shares registered will be insufficient to enable us to draw the full $10,000,000, and we may be required to register additional shares in one or more subsequent registration statements in order to do so.

 

The 4.99% beneficial ownership limitation and per-put volume limitation restrict our ability to access the equity line when we may most need capital.

 

We may not require Trillium to purchase shares to the extent Trillium and its affiliates would beneficially own more than 4.99% of our outstanding common stock following the purchase, and the size of each put is limited to 250% of the average daily trading volume over the preceding ten trading days multiplied by the purchase price. As a result, our ability to access the equity line depends in part on Trillium’s resale of previously purchased shares and on our trading volume, and the equity line may not be available in the amounts or at the times we need capital.

 

If an “Event” occurs under the Registration Rights Agreement, we will be required to pay liquidated damages.

 

Under the Registration Rights Agreement, if specified “Events” occur, including a failure to file or obtain effectiveness of the registration statement by the applicable deadlines, or a failure to maintain effectiveness beyond permitted blackout periods, we are required to pay Trillium liquidated damages equal to 1.5% of the aggregate Investment Amount paid as of the Event date, and an additional 1.5% for each subsequent 30-day period during which the Event continues, subject to an aggregate cap of 4% of the aggregate Investment Amount. These payments would increase our cash needs at a time when we may be unable to access the equity line.

 

Resales under this prospectus could be characterized as an indirect primary offering, which could limit the number of shares we may register or require a fixed offering price.

 

Rule 415 under the Securities Act permits the registration of securities for resale as a secondary offering that is not an offering “by or on behalf of” the issuer. If the SEC were to take the position that the resale of the shares by Trillium constitutes an indirect primary offering by us, the number of shares we are able to register in a single registration statement could be limited, the shares could be required to be sold at a fixed price, and the timing and cost of accessing the equity line could be adversely affected.

 

11

 

 

Our common stock is subject to the “penny stock” rules, which may make it more difficult for investors to resell their shares.

 

Our common stock is a “penny stock” as defined under the Exchange Act. The penny stock rules impose additional sales-practice requirements on broker-dealers that sell penny stocks to persons other than established customers and accredited investors. These requirements may reduce the level of trading activity in the secondary market for our common stock and may make it more difficult for investors to sell their shares.

 

The market price of our common stock has been and may continue to be volatile, and a large number of shares are or may become available for sale.

 

The market price of our common stock has been volatile and could fluctuate widely in response to various factors, many of which are beyond our control. In addition, we have a history of significant dilution and have effected reverse stock splits in the past. Sales of a substantial number of shares of our common stock in the public market, including under this prospectus, or the perception that such sales could occur, could adversely affect the market price of our common stock.

 

IX RISKS RELATING TO OUR BUSINESS AND INDUSTRY

 

We operate in a competitive and rapidly evolving market for AI-driven security and automation solutions, and we may be unable to compete effectively.
   
We depend on continued market adoption of our Solutions-as-a-Service model and on the successful commercial deployment of newer products, including ROAMEO mobile units and the SARA agentic AI platform.
   
We depend on key personnel, including our Chief Executive Officer, and on our ability to attract and retain qualified technical and operational personnel.
   
We identified that our disclosure controls and procedures were not effective as of February 28, 2026, and we may be unable to remediate material weaknesses in our internal control over financial reporting.
   
Our business depends on proprietary technology, and we may be unable to adequately protect our intellectual property.

 

12

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include statements regarding our plans, objectives, expectations, and intentions and other statements that are not historical facts, and may be identified by words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” and similar expressions. These statements are based on our current expectations and assumptions and are subject to risks and uncertainties, including those described under “Risk Factors,” that could cause actual results to differ materially from those expressed or implied. We undertake no obligation to update any forward-looking statement, except as required by law. The safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995 does not apply to the offering made by this prospectus.

 

USE OF PROCEEDS

 

This prospectus relates to the resale of shares of our common stock by the Selling Stockholder for its own account. We will not receive any proceeds from the resale of shares by the Selling Stockholder.

 

We may receive up to $10,000,000 in aggregate gross proceeds from sales of Put Shares to Trillium under the Purchase Agreement over the 36-month commitment period, assuming we exercise our put right in full and satisfy the conditions to each put. We cannot predict the actual amount of proceeds we will receive, which will depend on the number of shares we elect to sell, the market price of our common stock during the applicable pricing periods, and our ability to satisfy the conditions to each put. Based on historical trading volumes and the limitations in the Purchase Agreement, we do not expect to be able to draw the full commitment amount.

 

We intend to use the net proceeds we receive from sales of Put Shares for working capital and general corporate purposes, which may include research and development, sales and marketing, capital expenditures related to the deployment of our devices, repayment of indebtedness, and other general corporate purposes. We will pay Trillium’s counsel a fee of $15,000, payable upon the initial closing, and will bear the expenses of this registration. See “Plan of Distribution.”

 

DILUTION

 

Sales of Put Shares under the Purchase Agreement will have a dilutive effect on our existing stockholders. Because the purchase price of the Put Shares is determined by reference to the market price of our common stock during the applicable pricing period and reflects a 15% discount, the number of shares we must issue to raise a given amount of proceeds will increase as the market price of our common stock declines. In addition, the issuance of the 5,000,000 Commitment Shares will dilute existing stockholders. The following illustrates the potential dilutive effect of the equity line at assumed prices.

 

Sales of Put Shares under the Purchase Agreement will have a dilutive effect on our existing stockholders. Because the purchase price of the Put Shares is determined by reference to the market price of our common stock during the applicable pricing period and reflects a 15% discount, the number of shares we must issue to raise a given amount of proceeds will increase as the market price of our common stock declines. In addition, the issuance of the 5,000,000 Commitment Shares will dilute existing stockholders. The following table illustrates the potential dilutive effect of the equity line, assuming we sell $10,000,000 of Put Shares (the assumed aggregate proceeds), based on 387,232,589 shares of common stock outstanding as of July 1, 2026.

 

Assumed Market Price per Share  Purchase Price per Put Share (85% of Market Price)¹   Put Shares Issuable²   Commitment Shares   Total Shares Issued   Total Shares Outstanding After Issuance³   Shares Issued as % of Outstanding After Issuance⁴ 
$0.1000 (assumed recent price)  $0.0850    117,647,059    5,000,000    122,647,059    509,879,648    24.1%
$0.0750 (25% below recent price)  $0.0638    156,862,745    5,000,000    161,862,745    549,095,334    29.5%
$0.0500 (50% below recent price)  $0.0425    235,294,118    5,000,000    240,294,118    627,526,707    38.3%

 

  1. Reflects the 15% discount to the applicable market price provided under the Purchase Agreement.
  2. Represents the number of Put Shares required to generate $10,000,000 in gross proceeds at the applicable purchase price, rounded to the nearest whole share.
  3. Based on 387,232,589 shares of common stock outstanding as of June 1, 2026, plus the Put Shares and Commitment Shares set forth in the table.
  4. Represents the total shares issued under the equity line (Put Shares plus Commitment Shares) as a percentage of the total shares of common stock outstanding after giving effect to such issuance.

 

The foregoing is illustrative only. The actual number of shares issuable, and the resulting dilution, will depend on the market price of our common stock during the applicable pricing periods and the aggregate amount of Put Shares we elect to sell, and may differ materially from the amounts shown. The table does not give effect to any beneficial ownership limitation, exchange cap, or other issuance limitation that may apply under the Purchase Agreement or applicable listing rules.

 

13

 

 

SELLING STOCKHOLDER

 

The shares of common stock being offered by the Selling Stockholder are those issuable to the Selling Stockholder as Commitment Shares and those issuable upon our exercise of put rights under the Purchase Agreement. We are registering the shares in order to permit the Selling Stockholder to offer the shares for resale from time to time. The table below sets forth certain information regarding the beneficial ownership of our common stock by the Selling Stockholder as of the date of this prospectus and the number of shares being offered.

 

The Selling Stockholder is Trillium Partners LP, a Delaware limited partnership. Stephen Hicks holds voting and dispositive power over the shares held by the Selling Stockholder. Except for the transactions contemplated by the Purchase Agreement and the Registration Rights Agreement, and as otherwise described below, the Selling Stockholder has not held any position or office, or had any other material relationship, with us or any of our affiliates within the past three years. Trillium has represented to us that it is not a registered broker-dealer or an affiliate of a registered broker-dealer.

 

Trillium is an underwriter within the meaning of the Securities Act with respect to the resale of the shares offered by this prospectus.

 


SELLING SECURITY HOLDER

 

The following table details the name of each selling stockholder, the number of shares owned by Trillium Partners, LP (“Trillium”) the sole selling stockholder, and the number of shares that may be offered by Trillium. Trillium is not a broker-dealer. Trillium is deemed an underwriter in this offering. Trillium may sell up to 1,160,000,000 shares, which are issuable upon the exercise of our put right with Trillium. Trillium will not assign its obligations under the equity line of credit.

 

Name  Total
number of
shares owned
prior to offering
   Percentage of
shares owned
prior to
offering
   Number of
shares being
offered
  

Percentage of
shares owned

after the offering
assuming

all of the
shares are
sold in the
offering(1)

Trillium Partners, LP(2)   0    -    1,555,000,000   Less than 1%

 

(1) The number assumes the Selling Security Holder sells all of its shares being offered pursuant to this prospectus.
(2) Represents up to 5,000,000 Commitment Shares and up to 1,550,000,000 Put Shares registered for resale under the Purchase Agreement. Trillium Partners LP holds no shares of our common stock as of the date of this prospectus. Stephen Hicks, as manager of the general partner of Trillium Partners LP, has voting and dispositive power over the shares held by Trillium. Trillium’s beneficial ownership at any time is subject to the 4.99% Beneficial Ownership Cap described in this prospectus.

 

PLAN OF DISTRIBUTION

 

The common stock offered by this prospectus is being offered by the Selling Stockholder, Trillium Partners LP. The shares may be sold or distributed from time to time by the Selling Stockholder.

 

The Selling Stockholder may use any one or more of the following methods when selling shares, in each case at the fixed price described above: ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; privately negotiated transactions; and a combination of these methods. Broker-dealers engaged by the Selling Stockholder may arrange for other broker-dealers to participate in sales. In connection with the sale of the shares, the Selling Stockholder and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities Act, and any commissions received by such broker-dealers or agents and any profit on the resale of the shares may be deemed to be underwriting commissions or discounts under the Securities Act.

 

We have advised the Selling Stockholder that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the Selling Stockholder and its affiliates. The Selling Stockholder has agreed not to engage in short sales of our common stock during the term of the Purchase Agreement, subject to the exceptions described under “About This Offering—No Short Selling.” We have agreed to pay the expenses of registering the shares. We have agreed to indemnify the Selling Stockholder against certain liabilities, including liabilities under the Securities Act, in accordance with the Registration Rights Agreement and the indemnification provisions of the Purchase Agreement.

 

14

 

 

DESCRIPTION OF THE EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT

 

The following summarizes the material terms of the Purchase Agreement and the Registration Rights Agreement, each dated June 23, 2026, between us and Trillium. This summary is qualified in its entirety by reference to the full text of those agreements, which are filed as exhibits to the registration statement of which this prospectus forms a part.

 

Equity Purchase Agreement

 

Commitment; Puts. We have the right to require Trillium to purchase up to $10,000,000 of our common stock during a 36-month commitment period through Regular Puts and Accelerated Puts, as described under “About This Offering.” The purchase price for both put types is 85% of the applicable measure of the three lowest closing bid prices; Accelerated Puts are subject to a Floor Price (the greater of 75% of the put-date closing bid price or a higher price we specify) and a knock-out mechanic upon three Low Price Days. Accelerated Puts require delivery of Estimated Shares equal to 125% of the Investment Amount, subject to a true-up.

 

Commitment Shares. We agreed to issue 5,000,000 Commitment Shares in two equal tranches (upon effectiveness and 90 days thereafter), deemed fully earned on execution and registered for resale hereunder. Failure to timely issue either tranche constitutes an event of default under the Purchase Agreement.

 

Beneficial Ownership Cap. We may not issue shares to the extent Trillium and its affiliates would beneficially own more than 4.99% of our outstanding common stock following the issuance, calculated in accordance with Section 13(d) of the Exchange Act and Rule 13d-3.

 

Representations, Covenants and Conditions. The Purchase Agreement contains customary representations, warranties, and covenants, including covenants relating to reservation of shares, maintenance of DTC and DWAC eligibility, and a restriction (for the first 180 days of the commitment period) on entering into substantially comparable equity line arrangements with third parties without Trillium’s consent. Our right to deliver put notices is subject to the conditions described under “About This Offering—Conditions to Puts.”

 

Settlement; Defaults; Remedies. Regular Puts settle no later than one trading day after the put date; Accelerated Puts settle following the valuation period true-up. A failure by Trillium to fund, or by us to deliver Put Shares, constitutes an event of default. The Purchase Agreement provides for termination rights and remedies, and excludes specific performance against Trillium with respect to its funding obligations. Fees and expenses include a $15,000 reimbursement of Trillium’s counsel fees payable at the initial closing.

 

Governing Law. The Purchase Agreement is governed by Nevada law, and the parties submit to the exclusive jurisdiction of the federal and state courts located in Nevada and waive trial by jury.

 

Registration Rights Agreement

 

Under the Registration Rights Agreement, we agreed to file, as soon as practicable following the signing date, a registration statement on Form S-1 (or Form S-3, if available) covering the resale of all Registrable Securities (the Put Shares and the Commitment Shares), and to use reasonable best efforts to have it declared effective by the applicable Effectiveness Deadline (generally the 60th calendar day following the filing deadline, subject to acceleration if the SEC does not review the registration statement and subject to day-for-day extension for delays attributable to SEC review). We agreed to keep the registration statement continuously effective until the Registrable Securities cease to be Registrable Securities or have been sold.

 

Liquidated Damages. If an “Event” occurs (including a failure to file or achieve effectiveness by the applicable deadline, subject to specified SEC-review carve-outs, or a failure to maintain effectiveness beyond the permitted blackout period), we must pay Trillium liquidated damages equal to 1.5% of the aggregate Investment Amount paid as of the Event date, plus an additional 1.5% for each subsequent 30-day period during which the Event continues, subject to an aggregate cap of 4% of the aggregate Investment Amount.

 

Blackout Periods; Rule 415 Cutback. We may suspend use of the registration statement for no more than 20 consecutive trading days and no more than 45 trading days in any 12-month period. If the SEC determines that all Registrable Securities cannot be registered for resale on a single registration statement as a result of Rule 415, we agreed to reduce the number of shares registered in the order specified in the Registration Rights Agreement and to use reasonable best efforts to register omitted shares on subsequent registration statements. Indemnification under the Registration Rights Agreement is governed by the indemnification provisions of the Purchase Agreement.

 

15

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion together with our consolidated financial statements and the related notes included elsewhere in this prospectus. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those described under “Risk Factors.”

 

Results of Operations — Fiscal Year Ended February 28, 2026 Compared to Fiscal Year Ended February 28, 2025

 

Revenue. Revenue increased $1,614,450, or 26%, to $7,745,336 for the fiscal year ended February 28, 2026, from $6,130,886 for the prior fiscal year, reflecting continued customer adoption and expanding recurring revenue programs.

 

Gross Profit. Gross profit increased 48% to $5,533,700, and gross margin expanded to approximately 71% from approximately 61%, primarily due to lower cost of goods sold relative to revenue.

 

Operating Expenses; Loss from Operations. Operating expenses were essentially flat at approximately $17,477,097. As a result, our loss from operations improved by approximately $2.0 million to $(11,943,397).

 

Net Loss. We reported a net loss of approximately $14.5 million for the fiscal year ended February 28, 2026.

 

Liquidity and Capital Resources

 

As of February 28, 2026, our total liabilities substantially exceeded our total assets, and we had a stockholders’ deficit. We have funded our operations principally through the issuance of equity and debt securities, including variable-priced instruments and related-party loans. Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. We expect to continue to rely on external financing, including the equity line established by the Purchase Agreement, to fund our operations. There is no assurance that financing will be available to us on acceptable terms, or at all.

 

Cash Flows

 

As of February 28, 2026, we had cash and cash equivalents of $109,043, compared to $865,975 as of February 28, 2025, a decrease of $756,932. Our cash and cash equivalents consist of cash on deposit with high-quality U.S. financial institutions and money market instruments.

 

Net cash used in operating activities was $9,344,534 for the fiscal year ended February 28, 2026, compared to $12,196,388 for the fiscal year ended February 28, 2025. Cash used in operating activities in fiscal 2026 was primarily attributable to our net loss of $14,510,251, adjusted for non-cash items including depreciation and amortization of $2,122,730, stock-based compensation of $1,815,848, amortization of debt discounts of $536,078 and a gain on settlement of debt of $3,434,685, together with changes in operating assets and liabilities, including an increase in accrued interest payable of $3,847,474 and an investment in device parts inventory of $2,133,437.

 

Net cash used in investing activities was $12,861 for the fiscal year ended February 28, 2026, compared to $79,965 for the prior fiscal year, consisting primarily of purchases of fixed assets and trademarks.

 

Net cash provided by financing activities was $8,600,463 for the fiscal year ended February 28, 2026, compared to $13,036,402 for the prior fiscal year. Financing activities in fiscal 2026 consisted principally of net proceeds from the issuance of common stock of $5,219,853 and proceeds from loans payable of $4,808,171, partially offset by repayments of loans payable of $1,302,561 and redemptions of preferred stock of $125,000. As a result of the foregoing, cash decreased by $756,932 during the fiscal year ended February 28, 2026, compared to a net increase of $760,049 during the prior fiscal year.

 

Indebtedness

 

As of February 28, 2026, our total liabilities were $61,965,374, compared to total assets of $9,302,228. Our indebtedness consisted principally of loans payable with an aggregate face value of $33,672,294, of which $8,848,140 (net of unamortized discount of $635,774) was classified as current and $24,188,380 was classified as non-current. Substantially all of our long-term debt matures in the fiscal year ending February 29, 2028. Our loans payable bear interest at rates generally ranging up to 22% per annum, with the substantial majority bearing interest at 12% per annum, and certain notes were in default as of February 28, 2026. Accrued interest payable on our outstanding indebtedness totaled $11,393,658 as of February 28, 2026, of which $2,271,106 was classified as current and $9,122,552 was classified as non-current.

 

Certain of our outstanding notes are convertible into shares of our common stock, including a $495,000 convertible note and a $165,000 convertible note, each of which may be redeemed at a premium and bears interest at 12% per annum. During the fiscal year ended February 28, 2026, we exchanged $6,484,000 of loans payable and accrued interest for shares of our common stock.

 

A significant portion of our indebtedness is owed to related parties. As of February 28, 2026, $32,178,506, or approximately 96%, of our total loans payable was owed to companies controlled by a single individual, compared to $28,581,506, or approximately 87%, as of February 28, 2025. In addition, as of February 28, 2026, we had a loan payable to a related party of $461,633, which included $285,638 of deferred salary bearing interest at 12% per annum, together with accrued interest of $79,268. As of February 28, 2026, we also had deferred compensation payable to our Chief Executive Officer of $1,811,856 and an incentive compensation plan payable of $5,500,000, in respect of which we had accrued 1,500 shares of Series G Redeemable Preferred Stock, valued at $1,500,000, to be issued.

 

Preferred Stock

 

As of February 28, 2026, we had outstanding 417 shares of Series C Convertible, Redeemable Preferred Stock, with a carrying value of $547,941, which accrue dividends at 12% per annum and are redeemable at 109.5% of their $1,200 stated value; 3,350,000 shares of Series E Preferred Stock; and 2,513 shares of Series F Convertible Preferred Stock. No shares of our Series B Convertible, Redeemable Preferred Stock or Series G Redeemable Preferred Stock were issued and outstanding as of February 28, 2026. Our redeemable preferred stock is classified outside of permanent stockholders’ equity on our consolidated balance sheets.

 

Going Concern

 

We have incurred recurring net losses and negative cash flows from operations. For the fiscal year ended February 28, 2026, we incurred a net loss of $14,510,251 and had negative cash flow from operating activities of $9,344,534, and as of February 28, 2026, we had an accumulated deficit of $171,121,742, negative working capital of $17,017,745 and a total stockholders’ deficit of $53,211,087. These conditions raise substantial doubt about our ability to continue as a going concern for the twelve months following the date the consolidated financial statements were issued. Our consolidated financial statements do not include any adjustments to the recoverability and classification of asset carrying amounts, or to the amounts and classification of liabilities, that might result should we be unable to continue as a going concern. Management intends to address our liquidity requirements by growing revenues and raising additional capital through equity and debt financings, including the equity line described elsewhere in this prospectus, under which approximately $10 million remained available for issuance as of the date of this prospectus. There can be no assurance that such financing will be available on acceptable terms, or at all, or that our plans will be successful.

 

Critical Accounting Policies and Estimates

 

The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates. We consider the accounting policies described below to be those most important to the portrayal of our financial condition and results of operations and that require our most difficult, subjective or complex judgments. These policies should be read together with the summary of significant accounting policies set forth in Note 2 to our consolidated financial statements included elsewhere in this prospectus.

 

Use of Estimates

 

The most significant estimates reflected in our consolidated financial statements relate to the assumptions used to value equity instruments issued in connection with debt settlements, amendments and extensions; the classification and fair value measurement of liability-classified instruments and equity awards; the allowance for credit losses; inventory valuation reserves; the estimated useful lives and recoverability of long-lived assets; and the realizability of deferred tax assets. The ultimate resolution of the matters underlying these estimates could differ significantly from the amounts on which our financial statements are based.

 

16

 

 

Revenue Recognition

 

We recognize revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers, and, for the short-term rental of our devices, in accordance with ASC Topic 842, Leases. Under Topic 606, we recognize revenue when we transfer promised goods or services to a customer in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services, applying a five-step model that requires us to identify the performance obligations in each contract, estimate the amount of variable consideration to include in the transaction price, and allocate the transaction price to each separate performance obligation. The application of this model requires judgment, particularly in identifying distinct performance obligations and in estimating variable consideration. Our revenue is concentrated among a limited number of customers; for the fiscal year ended February 28, 2026, two customers accounted for approximately 55% of total revenue, and for the fiscal year ended February 28, 2025, one customer accounted for approximately 55% of total revenue.

 

Going Concern

 

In connection with the preparation of our consolidated financial statements, we evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. This evaluation requires management to make significant judgments about our projected cash flows, our available sources of financing, and our ability to execute our operating plans. As described in Note 1 to our consolidated financial statements, our recurring losses, negative working capital and negative cash flows from operations raise substantial doubt about our ability to continue as a going concern, and our consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Classification and Measurement of Financial Instruments; Derivative and Liability-Classified Instruments

 

We rely on the guidance in ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable or convertible instruments. We first determine whether a financial instrument should be classified as a liability, which is the case if the instrument is mandatorily redeemable or embodies a conditional obligation that we must or may settle by issuing a variable number of our equity shares. If an instrument is not classified as a liability, we then determine whether it should be presented as temporary equity, where redemption is outside our control, or as permanent equity. Instruments classified as liabilities are initially recorded at fair value, or cash received, and are remeasured to fair value at each subsequent reporting date, with changes in fair value recorded in other income (expense). Determining the appropriate classification of these instruments, and measuring their fair value, requires significant judgment and the use of estimates and assumptions that can materially affect our reported results.

 

Fair Value Measurements

 

We measure certain assets and liabilities at fair value on a recurring basis in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, which establishes a three-level hierarchy that prioritizes the inputs used to measure fair value, giving the highest priority to quoted prices in active markets (Level 1) and the lowest priority to unobservable inputs (Level 3). Our recurring fair value measurements are classified within Level 3 of the hierarchy because they rely on significant unobservable inputs. These measurements include our incentive compensation plan payable, which represents the revaluation of equity awards payable in Series G Preferred Shares and was recorded at $5,500,000 and $4,000,000 as of February 28, 2026 and February 28, 2025, respectively, and an investment for which the Level 3 portion of the fair value measurement is based on an independent third-party valuation. Because these measurements depend on unobservable inputs, including the redemption value of the Series G Preferred Shares, they are inherently uncertain, and changes in the underlying assumptions could have a material effect on our financial statements.

 

Share-Based Compensation and Incentive Compensation Plan

 

We recognize compensation expense in connection with an incentive compensation plan under which amounts are payable to our Chief Executive Officer in Series G Preferred Shares. The related liability is measured based on the redemption value of the Series G Preferred Shares, which are redeemable at $1,000 per share, and is remeasured at each reporting date. We recorded stock-based compensation of $1,500,000 for each of the fiscal years ended February 28, 2026 and February 28, 2025, with corresponding adjustments to the incentive compensation plan payable. In addition, we periodically issue warrants and other equity instruments in connection with financing transactions and debt settlements, the fair values of which we estimate using the Black-Scholes option-pricing model. That model requires us to make assumptions regarding the expected term, expected volatility, risk-free interest rate and the fair value of our common stock, and changes in these assumptions can significantly affect the estimated fair value of the instruments and the amounts we recognize.

 

Impairment of Long-Lived Assets

 

Our long-lived assets consist principally of revenue earning devices and fixed assets. Revenue earning devices are stated at cost and depreciated on a straight-line basis over an estimated useful life of 48 months, and our other fixed assets are depreciated over estimated useful lives ranging from three to five years. We continually evaluate whether events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable or that a revision to their estimated useful lives is warranted. In assessing recoverability, we use a combination of undiscounted cash flow and market approaches, and we measure any impairment loss as the amount by which the carrying amount of an asset exceeds its fair value. These assessments require significant judgment regarding future cash flows and asset utilization.

 

Inventory

 

Device parts inventory is stated at the lower of cost, determined using the weighted-average cost method, or net realizable value. We record a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification, and we recognize a charge to income when factors such as excess or obsolete inventory indicate that an increase in the reserve is required. Our inventory valuation reserve was $175,000 and $465,000 as of February 28, 2026 and February 28, 2025, respectively. Estimating net realizable value and the appropriate reserve requires judgment regarding future demand for, and usage of, our device parts.

 

Sales of Future Revenues

 

We have entered into transactions in which we received funding from investors in exchange for the right to receive payments based on a percentage of sales of certain revenue categories. We evaluate the facts and circumstances of each such arrangement to determine whether it should be accounted for as a sale of future revenues or, in substance, as debt, considering factors such as whether the arrangement purports to be a sale, whether we have continuing involvement in generating the underlying cash flows, whether the transaction is cancellable, whether the investor’s rate of return is implicitly limited by the terms of the agreement, and whether the investor has recourse. Where an arrangement is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of our financial statements, we have determined that all such arrangements constitute debt. This determination requires significant judgment and could materially affect the classification and timing of amounts reflected in our financial statements.

 

Income Taxes

 

We account for income taxes under the asset and liability method, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized, which requires significant judgment regarding the timing and amount of future taxable income.

 

17

 

 

 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

  

Forward-Looking Statements

 

The following discussion of our financial condition and results of operations for the three months ended May 31, 2026 and May 31, 2025 should be read in conjunction with our unaudited consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended February 28, 2026, as filed on June 9, 2026 with the SEC. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

 

Unless expressly indicated or the context requires otherwise, the terms “AITX”, the “Company”, “we”, “us”, and “our” refer to Artificial Intelligence Technology Solutions Inc.

 

Overview

 

AITX was incorporated in Florida on March 25, 2010. AITX reincorporated into Nevada on February 17, 2015. AITX’s fiscal year end is February 28 (February 29 during leap year). AITX is located at 10800 Galaxie Ave., Ferndale Michigan, 48220, and our telephone number is 877-767-6268.

 

AITX’s mission is to apply Artificial Intelligence (AI) technology to solve enterprise problems categorized as expensive, repetitive, difficult to staff, and outside of the core competencies of the client organization.

 

A short list of basic examples include:

 

  1. Typical security guard-related functions such as monitoring a parking lot during and after hours and responding appropriately. This scenario applies to perimeters, interior yard areas, and related similar environments.
     
  2. Integrated hardware/software with AI-driven responses, simulating and expanding on what legacy or manned solutions could perform.
     
  3. Automation of common access control functions through technology utilizing facial recognition and machine vision, leapfrogging most legacy solutions in use today.

 

RAD solutions are unique because they:

 

  1. Start with an AI-driven autonomous response utilizing cellular-optimized communications, while easily connecting to a human operator for a manned response, as needed.
     
  2. Use unique hardware purpose-built by RAD for delivery of these solutions. Various form factors have been customized to deliver this new functionality.
     
  3. Deliver services through RAD-developed software and cloud services, allowing enterprise IT groups to focus on core competencies instead of maintenance of complex video and security platforms.

 

We encourage everyone to ensure they have the most up to date news by visiting AITX at AITX News - AITX - Artificial Intelligence Technology Solutions.

 

18

 

 

Management Discussion and Analysis

 

Results of Operations for the Three Months Ended May 31, 2026 and 2025

 

The following table shows our results of operations for the three months ended May 31, 2026 and 2025. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

 

   Period     
   Three Months Ended   Three Months Ended   Change 
   May 31, 2026   May 31, 2025   Dollars   Percentage 
Revenues  $1,831,202   $1,854,837   $(23,635)   (1)%
Gross profit   1,183,824    1,233,501    (49,677)   (4)%
Operating expenses   3,893,188    4,412,170    (518,982)   (12)%
Loss from operations   (2,709,364)   (3,178,669)   469,305    15%
Other expense, net   (3,006,474)   (1,415,349)   (1,591,125)   (112)%
Net loss  $(5,715,838)  $(4,594,018)  $(1,121,820)   (24)%

 

Revenue

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

   Three Months Ended   Three Months Ended   Change 
   May 31, 2026   May 31, 2025   Dollars   Percentage 
Device rental activities  $1,613,095   $1,627,286   $(14,191)   (1)%
Direct sales of goods and services   218,107    227,551    (9,444)   (4)%
   $1,831,202   $1,854,837   $(23,635)   (1)%

 

Total revenue for the three-month period ended May 31, 2026 was $1,831,202which represented a decrease of $23,635 or 1% compared to total revenue of 1,854,837 for the three months ended May 31, 2025. The decrease in revenue was attributable to a significant drop in the sales for one major customer due to their internal cost cutting initiatives. This major customer previously represented about 48% of the Company’s revenues for the three months ended May 31, 2025 represented 21% of the Company’s revenues for the three months ended May 31, 2026. The Company managed to mitigate this reduction by gaining new customers and diversifying its customer base. For the three months ended May 31, 2026, two customers accounted for 36% of total revenue and for the three months ended May 31, 2025, two customers accounted for 65% of total revenue. The Company expects to see sales growth through new mobile products and software starting in the second quarter of this fiscal year. The mobile products will see a slow steady rollout over the fiscal year due to the capital intensive nature of these products.

 

Gross profit

 

Total gross profit for the three-month period ended May 31, 2026 was $1,183,824which represented a decrease of $49,677 compared to gross profit of $1,233,501 for the three months ended May 31, 2025. The decrease is consistent with the decrease in revenues as well as changes in product mix. The gross profit % of 65% for the three-month period ended May 31, 2026 compared with the gross profit % of 67% for the three month period ended May 31, 2025.

 

Operating Expenses

 

   Period   Change 
  

Three Months Ended

May 31, 2026

  

Three Months Ended

May 31, 2025

   Dollars   Percentage 
                 
Research and development  $885,593   $1,087,619   $(202,026)   (19)%
General and administrative   2,907,577    3,232,211    (324,634)   (10)%
Depreciation and amortization   32,646    34,121    (1,475)   (4)%
Operating lease cost and rent   67,372    58,219    9,153    16%
Operating expenses  $3,893,188   $4,412,170   $(518,982)   (12)%

 

19

 

 

Our operating expenses were comprised of general and administrative expenses, research and development, and depreciation. General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the three-month period ended May 31, 2026 and May 31, 2025, were $3,893,188 and $4,412,170, respectively. The overall decrease of $518,982 was primarily attributable to the following changes in operating expenses of:

 

  General and administrative expenses decreased by $324,634. In comparing the three months ended May 31, 2026 and May 31, 2025 this decrease was primarily due to the following decreases: wages and salaries by $227,585, professional fees by $45,167, stock based compensation by $19,847, production supplies by $45,525, RMC costs by $59,948, marketing by $53,486, freight and duty costs by $49,508 and dues and subscriptions by $27,858. These costs were partially offset by increases in subcontractor by $198,837 and with other net G& A account decreases.
     
  Research and development decreased by $202,026 due to a decrease in software development as the product is being released.
     
  Depreciation and amortization decreased by $1,475.
     
  Operating lease cost and rent increased by $9,153 due to one new lease in 2026.

 

Other Expense

 

Other expense during the three months ended May 31, 2026 and May 31, 2025, was $3,006,474 and $1,415,349, respectively. The $1,591,125 increase in other expense was primarily attributable to a $885,525 increase in interest expense due to an approximately $338,000 increase in debt discount amortization expense, an approximately $204,000 increase in interest on DVPO balance with the balance due to the switch to some notes (see Note 11) to compounding interest and interest on approximately $2.7 million increase in loans payable. The $707,600 loss on settlement was on the exchange of loans payable and accrued interest for the three months ended May 31, 2026

 

Net loss

 

We had a net loss of $5,715,838 for the three months ended May 31, 2026, compared to a net loss of $4,594,018 for the three months ended May 31, 2025. The increase in net loss of $1,121,820 is due to a number of factors: higher other expenses is reduced by lower operating expenses for the three months ended May 31, 2026.

 

Liquidity, Capital Resources and Cash Flows

 

Management believes that we will continue to incur losses for the immediate future. Therefore, we will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities, if ever. These conditions raise substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include and adjustments relating to the recovery of assets or the classification of liabilities that may be necessary should we be unable to continue as a going concern.

 

 

As of May 31, 2026, we had a cash balance of $94,643, accounts receivable (net) of $974,897, device parts inventory(net) of $1,378,950 and $44,890,383 in current liabilities. At the current cash consumption rate, we will need to consider additional funding sources going forward. We are taking proactive measures to reduce operating expenses and drive growth in revenue.

 

The successful outcome of future activities cannot be determined at this time and there is no assurance that, if achieved, we will have sufficient funds to execute our intended business plan or generate positive operating results.

 

Capital Resources

 

The following table summarizes total current assets, liabilities and working capital (deficit) for the periods indicated:

 

   May 31, 2026   February 28, 2026 
Current assets  $3,005,227   $2,935,003 
Current liabilities   44,890,383    19,952,748 
Working capital  $(41,885,156)  $(17,017,745)

 

As of May 31, 2026 and February 28, 2026, we had a cash balance of $94,643 and $109,043, respectively.

 

Summary of Cash Flows

 

   Three Months Ended
May 31, 2026
   Three Months Ended
May 31, 2025
 
Net cash used in operating activities  $(2,759,307)  $(3,321,185)
Net cash used in investing activities  $(16,438)  $(9,720)
Net cash provided by financing activities  $2,761,345   $2,789,777 

 

20

 

 

Net cash used in operating activities.

 

Net cash used in operating activities for the three months ended May 31, 2026 was $2,759,307 which included a net loss of $5,715,838, non-cash activity such as bad debts expense of $70,000, reduction of right of use asset of $38,013, accretion of lease liability $23,281, stock based compensation of $60,508, change in operating assets and liabilities of $1,255,482, amortization of debt discount of $385,493, decrease in related party accrued payroll and interest of $129,687 and depreciation and amortization of $545,841 to derive the uses of cash in operations.

 

Net cash used in investing activities.

 

Net cash used in investing activities for the three months ended May 31, 2026 was $16,438 which was the purchase of fixed assets of $15,600 and an acquisition of trademark of $838.

 

Net cash provided by financing activities.

 

Net cash provided by financing activities for the three months ended May 31, 2026 was $2,761,345. This consisted of share proceeds net of issuance costs of $823,480 , proceeds on the issuance of Series C Preferred Shares of $200,000, proceeds from loans payable of $2,714,028 reduced by repayments on loans payable of $976,163.

 

Off-Balance Sheet Arrangements

 

None.

  

Critical Accounting Policies and Estimates

 

Critical accounting policies and estimates are further discussed in our Annual Report on Form 10-K for the year ended February 28, 2026, as filed on June 9, 2026.

 

Related Party Transactions

 

For both the three months ended May 31, 2026, and May 31, 2025, the Company had repayments of net advances of $129,687 and $0, respectively. At May 31, 2026, the loan payable-related party was $331,946 and $461,633 at February 28, 2026. Included in the balance due to the related party at May 31, 2026, is $255,414 of deferred salary and interest, $157,513 of which bears interest at 12%. As of February 28, 2026, included in the balance due to the related party is $285,638 of deferred salary all of which bears interest at 12%. The accrued interest included in the loan at May 31, 2026, and February 28, 2026, was $84,956, and $79,268, respectively.

 

During the three months ended May 31, 2026, the Company paid out gross payments to the CEO of $71,105 offset by a bonus accrual of $250,000, which yields a net change of $178,895 relating to deferred compensation for CEO. This was all in accordance with a December 2023 board action allowing for $1 million of annual discretionary compensation as well as a February 28, 2026, board action which provided an additional $1.5 million in compensation. During the three months ended May 31, 2025, the Company paid out gross payments to the CEO of $1,496,687 offset by a bonus accrual of $250,000, which yielded a net change of $1,246,687 relating to deferred compensation for CEO. The balance of deferred compensation for CEO was $1,990,751 and $1,811,856 at May 31, 2026, and February 28, 2026, respectively

 

For the three months ended May 31, 2026, the Company accrued $0 (three months ended May 31, 2025-$0) of incentive compensation plan payable to the CEO. This will be payable in Series G Preferred Shares, which are redeemable at the Company’s option at $1,000 per share. On May 31, 2026, and February 28, 2026, there was $5,500,000 and $5,500,000 incentive compensation payable.

 

During the three months ended May 31, 2026, and 2025, the Company was charged $390,130 and $736,875, respectively for fees for research and development from a company partially owned by a principal shareholder. The principal shareholder received no compensation from this partially owned research and development company, and the fees were spent on core development projects. As at May 31, 2026, and February 28, 2026, the balance due to this company was $76,532 and $160,557, respectively.

 

21

 

 

BUSINESS

 

The following is a summary of our business. You should read this summary together with our more detailed disclosure and our consolidated financial statements and the related notes included elsewhere in this prospectus.

 

We are a developer and operator of AI-driven security and productivity solutions for enterprise clients. Through our family of companies—RAD-I, RAD-M, RAD-G, RAD-R, and RAD Lanka—we develop and deliver AI-driven technologies and services designed to transform security, automation, and operational workflows. Through RAD-I, we market a “Solutions-as-a-Service” model to the security and guarding services industry, which we estimate to be an approximately $50 billion market in the United States, and we design our solutions to deliver cost savings of between 35% and 80% compared with traditional manned security and monitoring. We describe our operations across three pillars: stationary security devices (RAD-I); mobile autonomous platforms (RAD-M), including the ROAMEO mobile security unit; and our SARA agentic AI platform (RAD-G). RAD Lanka, located in Sri Lanka under Port City Colombo status, supports software development and technical operations across our subsidiaries.

 

BUSINESS

 

Corporate History and Organization

 

Artificial Intelligence Technology Solutions Inc. (the “Company,” “AITX,” “we,” “our,” or “us”) was incorporated in the State of Florida on March 25, 2010, under the name On the Move Systems Corp., and reincorporated in the State of Nevada on February 17, 2015. On August 24, 2018, the Company changed its name to Artificial Intelligence Technology Solutions Inc.

 

In 2017, the Company acquired all of the ownership and equity interests in Robotic Assistance Devices, Inc. (“RAD”), a Nevada corporation founded by Steven Reinharz, the Company’s current Chief Executive Officer and Chief Technology Officer (the “Acquisition”). Prior to the Acquisition, the Company’s operations consisted of an early-stage transportation services business that was disposed of in connection with the Acquisition. As a result, the Acquisition was accounted for as a reverse recapitalization effected through a share exchange, with RAD treated as the accounting acquirer. No goodwill or other intangible assets were recorded in connection with the Acquisition, and the historical operations reflected in our consolidated financial statements are those of RAD.

 

Since the Acquisition, the Company has been engaged in the development, deployment, and commercialization of artificial intelligence and robotic solutions for security, monitoring, and operational applications. Mr. Reinharz was appointed Chief Executive Officer on March 2, 2021.

 

The Company conducts substantially all of its operations through five (5) wholly owned subsidiaries: Robotic Assistance Devices, Inc. (“RAD-I”); Robotic Assistance Devices Group, Inc. (“RAD-G”); Robotic Assistance Devices Mobile, Inc. (“RAD-M”); Robotic Assistance Devices Residential, Inc. (“RAD-R”); and Robotic Assistance Devices Lanka (PVT) Ltd. (“RAD Lanka”), a Sri Lanka entity holding Port City Colombo status that operates as a wholly owned subsidiary of RAD-G. The Company anticipates establishing an additional subsidiary, Robotic Assistance Devices Europe (“RAD Europe”), during fiscal 2027 to support growing business activity in the European Union and to serve as the Company’s cost center for Genera Data Protection Regulation (GDPR)-compliant services.

 

Business Overview

 

AITX is a vertically integrated developer and operator of artificial intelligence-driven security and operational automation solutions. The Company designs, manufactures, deploys, and supports a portfolio of stationary devices, mobile autonomous platforms, and software products powered by SARA™ (Speaking Autonomous Responsive Agent), our proprietary agentic AI platform. SARA enables our devices to perceive, decide, communicate, and act autonomously in real time, without continuous human intervention.

 

Substantially all of our revenue is generated through recurring monthly subscription contracts, typically with minimum twelve-month initial terms, under a Solutions-as-a-Service model in which the Company retains ownership of the deployed hardware. The Company also sells units outright to a limited number of legacy enterprise customers. We expect that, over the deployment life of a subscribed unit, gross margin will exceed 75%, and that gross margin on outright sales will exceed 50% based on average bill of materials costs over the past two years and related sales and dealer channel pricing that our market has appeared to accept.

 

Our customer base spans logistics, healthcare, commercial real estate, manufacturing, retail, education, government, and residential markets, and includes one Fortune Top 10 enterprise and several additional Fortune 500 enterprises. As of the date of this report, the Company has deployed approximately one thousand devices across the United States and Canada, and is in the early stages of European market entry.

 

22

 

 

Industry Context and Long-Term Vision

 

Management views the physical security industry as being in the early stages of the most significant structural transformation in its history. The founder, Steve Reinharz, has written and spoken extensively and is a regular speaker about this transformation since company inception at industry association events hosted by the two industry leading organizations, SIA (Security Industry Organization) and ASIS (American Society for Industry Security). The industry has historically depended on human guard labor, passive video surveillance, and manually monitored alarm systems—a model substantially unchanged in its fundamentals for more than fifty years. That model is, in our view, is undergoing change driven by a variety of factors including increasing challenges with labor and the advent of AI solutions. Guard labor costs continue to rise faster than commercial security budgets; qualified personnel are increasingly difficult to recruit and retain; manual monitoring workflows cannot scale to the volume of cameras and sensors now deployed; and the response-time performance of human-mediated systems is incompatible with the speed at which modern threats develop.

 

Other industries—logistics, manufacturing, financial services, agriculture—have already passed through the corresponding transition from mechanized labor (the Third Industrial Revolution) to autonomous, AI-orchestrated workflows (commonly described as the Fourth Industrial Revolution, or Industry 4.0). The physical security industry, in management’s view, is now in the first phase of that same transition. AITX is positioned to be a primary participant in this shift, and a substantial portion of the Company’s strategy, capital allocation, and product roadmap is oriented around accelerating it.

 

Internally, the Company refers to the long-term outcome of this transition as “RAD Town”—a vision in which AITX’s portfolio operates as an integrated autonomous-security fabric across a campus, community, or jurisdiction. In a fully realized RAD Town deployment, ROAMEO mobile units conduct outdoor patrol; AVA manages vehicle access at gates and perimeters; TOM handles credentialed pedestrian and visitor access at building entries; stationary ROSA, RIO, and RAM units provide fixed-position coverage of high-value zones; RADCam protects residential and small-business endpoints; and SARA orchestrates all of it as a single agentic layer, escalating to human responders only when necessary. RAD Town is not a single named site or development; it is the design target around which our product roadmap, software architecture, and partnership strategy are organized.

 

We believe that the companies that capture the largest share of the value created by this transition will be those that combine proprietary hardware, proprietary AI, a broad partner ecosystem, and operational discipline. The Company’s strategy is built on each of these elements.

 

Operating Structure and Sales Channels

 

The Company is organized around four operating subsidiaries focused on commercial product sales and one development and licensing subsidiary. For purposes of management reporting and strategic capital allocation, we view our commercial activity as proceeding along three principal sales avenues: (i) the stationary product portfolio operated through RAD-I; (ii) the mobile autonomous platform operated through RAD-M; and (iii) the agentic AI platform and ecosystem partnerships operated through RAD-G. RAD-R operates a residential product line that is currently a smaller component of consolidated revenue and is discussed separately below.

 

Management believes that RAD-I, on a standalone basis (based on direct and expenses for only stationary solutions and therefore stripped of any expense not related to stationary solutions and its development), has achieved a point at which its recurring revenue and gross margin could support positive cash flow operations     today. The Company has elected to continue investing materially in RAD-M and RAD-G because we believe those investments will produce substantially larger long-term revenue and enterprise value than would be achievable from RAD-I alone. The Company’s consolidated results therefore continue to reflect the costs of those investments, specifically in mobile, residential and agentic solutions. This positioning reflects management’s view based on internal segment-level analysis; the Company does not separately publish audited standalone financial statements for individual subsidiaries.

 

RAD-I: Stationary Solutions

 

Robotic Assistance Devices, Inc. (“RAD-I”) operates the Company’s stationary product portfolio. RAD-I is the largest revenue contributor within the consolidated group, and its product line represents the most mature, most deployed, and most operationally proven elements of our portfolio. RAD-I’s solutions are typically deployed at fixed locations—building entries, gates, perimeters, parking facilities, and interior chokepoints—and are delivered as recurring subscription services.

 

RAD-I’s current product portfolio includes the following solutions, each of which is integrated with the Company’s SARA agentic AI platform:

 

ROSA™ (Responsive Observation Security Agent)

 

ROSA is a compact, self-contained stationary security device combining visual analytics, two-way audio engagement, and AI-driven escalation. ROSA is the Company’s most widely deployed solution and serves as the foundation for several other products in the portfolio. ROSA is used for perimeter and entry-point monitoring, loitering and trespass deterrence, firearm detection, and a range of related applications, and replaces or substantially reduces the need for guard services at protected locations.

 

RIO™ (ROSA Independent Observatory)

 

RIO is a portable, solar-powered security tower comprising one or two ROSA devices mounted atop a solar trailer assembly. RIO is designed for rapid deployment in environments where permanent infrastructure is impractical, including construction sites, retail parking lots, healthcare campuses, distribution yards, public events, and temporary high-risk locations. Hundreds of RIO units are actively deployed across the United States.

 

23

 

 

AVA™ (Autonomous Verified Access)

 

AVA is a vehicle gate access management solution combining license plate recognition, two-way voice interaction, and cloud-based authorization. AVA is deployed at logistics hubs, gated communities, corporate and industrial campuses, and multi-tenant commercial properties. AVA is sold both as a standalone subscription and as a component of a broader access platform that includes the Homeowners Association Platform (“HOAP”), a digital pass and visitor management application used by residential communities.

 

TOM™ (The Office Manager)

 

TOM automates visitor management and front-desk functions at credentialed pedestrian access points. TOM is deployed across corporate campuses, multi-tenant commercial facilities, government buildings, and educational institutions. One of the world’s largest third-party logistics providers uses TOM to manage visitor intake across its North American distribution network.

 

ROSS™ and RAM™ (Camera Augmentation Software and Hardware)

 

ROSS is a software platform that adds AI-driven analytics, escalation workflows, and SARA-enabled response to existing third-party IP security cameras. RAM is a complementary hardware module that adds two-way audio, voice interaction, and ROSA-equivalent SARA functionality to third-party cameras. ROSS and RAM enable customers to modernize their existing camera infrastructure without full hardware replacement and provide a low-friction path to broader RAD ecosystem adoption.

 

Firearm Detection Analytic

 

The Company’s firearm detection analytic identifies visible handguns and long guns in real time and is available across RAD-I devices and through the ROSS platform. When integrated with SARA, the analytic produces autonomous escalation, voice intervention, administrator notification, and first-responder outreach within seconds of detection. The analytic received the American Security Today ASTORS award for Best Metal/Weapons Detection Solution.

 

Forthcoming Stationary Solutions

 

The Company expects to introduce additional stationary solutions during fiscal year 2027. These products are in active development and are intended to expand RAD-I’s coverage of indoor environments, specialized vertical markets, and high-volume credentialed-access workflows. The Company will provide additional disclosure regarding specific forthcoming products through press releases and subsequent periodic filings as they progress to commercial release.

 

RAD-M: Mobile Autonomous Solutions

 

Robotic Assistance Devices Mobile, Inc. (“RAD-M”) operates the Company’s mobile autonomous platform business. RAD-M is the second of the Company’s three primary sales avenues and is the principal area in which the Company has invested development capital over the past several fiscal years.

 

24

 

 

ROAMEO™ (Rugged Observation Assistance Mobile Electronic Officer)

 

ROAMEO is a fully autonomous, outdoor mobile security vehicle designed to conduct routine patrol operations across corporate campuses, distribution yards, parking facilities, educational and healthcare campuses, municipal parks, and similar large outdoor environments. ROAMEO operates without on-site human pilots, relying on the Company’s autonomous navigation stack, on-board sensor suite, cellular and 5G connectivity, and full integration with the SARA agentic AI platform. ROAMEO is designed to detect, assess, communicate, escalate, and report autonomously, and to replace or substantially reduce the cost of mobile guard patrols conducted in vehicles or on foot.

 

Development Investment and Deployment Status

 

Management estimates that the Company has spent approximately $20 million in the cumulative development of the ROAMEO platform across fiscal years preceding the fiscal year covered by this report. This estimate includes cash research and development expenditures, engineering costs, allocated executive and indirect labor, and other indirect costs reasonably attributable to the ROAMEO program. The Company does not separately report segment-level research and development on this basis in its audited consolidated financial statements; the $20 million figure reflects management’s internal allocation and view and is provided here to give investors a directionally accurate sense of the scale of investment that has been made.

 

Following the additional engineering, manufacturing, and integration work conducted during the fiscal year ended February 28, 2026, the Company commenced commercial deployment and recurring billing on two ROAMEO units in May 2026. Initial deployments are at two enterprise customer sites: a major logistics operator (previously disclosed by press release) and a healthcare group. The Company has additional pre-sold units in its order pipeline and is actively expanding its ROAMEO production capacity to meet demand.

 

RAD-M Financial Expectations

 

Management has significant expectations for the RAD-M business. Each ROAMEO deployment is structured as a recurring monthly subscription at a substantially higher monthly price point than the Company’s stationary products, and the addressable market for outdoor autonomous patrol is large relative to the Company’s current revenue base . Management expects that, based on the current sales pipeline and assuming successful execution of the ROAMEO production ramp, RAD-M will surpass RAD-I’s monthly recurring revenue contribution at some point as management believes the mobile business has a higher revenue ceiling than stationary solutions. This is a forward-looking statement; actual results may differ materially, and the timing and magnitude of RAD-M’s revenue contribution will depend on a range of factors including production capacity, customer adoption, and the operational performance of deployed units. See “Cautionary Statement Regarding Forward-Looking Information” at the front of this report.

 

RAD-G: Agentic AI and Platform Partnerships

 

Robotic Assistance Devices Group, Inc. (“RAD-G”) operates the Company’s agentic AI development and platform business. RAD-G holds, develops, and commercializes the SARA platform and related AI assets, and is the operating home of the Company’s partnership and ecosystem strategy. RAD Lanka, the Company’s Sri Lanka subsidiary, operates as a wholly owned subsidiary of RAD-G.

 

25

 

 

SARA™ (Speaking Autonomous Responsive Agent)

 

SARA is the Company’s proprietary agentic AI platform. SARA combines large language model architecture, situational logic, voice interaction, and autonomous action to enable RAD devices—and, increasingly, third-party devices and platforms—to engage with and respond to security situations in real time. SARA is embedded in substantially all of the Company’s deployed devices and is the foundational asset around which RAD-G’s commercial activity is organized.

 

SARA received Judges’ Choice and Best in Threat Detection and Response Solutions honors in the Security Industry Association New Product Showcase at ISC West 2025. In 2026, SARA was again recognized at ISC West in connection with the Company’s integration partnership with Immix, the leading central station monitoring software platform.

 

Platform Partnership Strategy

 

The Company’s long-term view is that the value of an agentic AI platform in physical security is determined principally by the breadth of devices, monitoring platforms, dealers, and end users with which it integrates. RAD-G is therefore organized around expanding the SARA ecosystem along five categories of relationship:

 

Monitoring platforms and central stations. The Company’s integration with Immix, announced and recognized during fiscal 2026, is intended as a model for embedding SARA into the platforms that already sit at the center of the remote video monitoring industry. Management views this category as the highest-leverage opportunity for SARA adoption.

 

Third-party hardware manufacturers. SARA’s commercial value increases with every additional camera, sensor, and access control device it can operate. The Company is actively pursuing licensing and integration arrangements with hardware vendors across the security industry.

 

Dealers and integrators. As of the date of this report, the Company’s authorized dealer network has grown to over one hundred dealers across the United States, Canada, and the European Union. The dealer channel is one of the Company’s primary growth engines, and RAD-G supports the channel with SARA-enabled product positioning and joint sales materials.

 

Enterprise and Fortune 500 end users. The Company’s existing enterprise customer base serves as both a revenue base and a credibility base for SARA adoption. Deepening relationships within existing accounts and converting reference deployments into category-defining case studies is a continuing priority.

 

Insurance, regulatory, and policy stakeholders. As AI-orchestrated security response becomes a more substantial component of the physical security industry, insurance carriers, municipal regulators, and standards bodies will increasingly shape the operating environment. The Company participates in industry policy efforts, including through Mr. Reinharz’s role on the Board of the Security Industry Association and his chairmanship of its Autonomous Working Group.

 

RAD-G Sales Funnel and Expectations

 

RAD-G, based on it’s developing ‘SARA’ solution, has generated substantial industry interest and a relatively substantial sales funnel. The solution has won two Security Industry Association (SIA) awards and Steve Reinharz has been asked several times to speak to various groups and industries about it. This, combined with various partner relationships, incoming interest, outbound prospect generation and other sales activities have created a substantial RAD G sales funnel in management’s view for an early-stage AI platform business. Management has high expectations for substantial revenue generation in this subsidiary. This is a forward-looking statement and actual results may differ materially.

 

26

 

 

RAD-R: Residential Solutions

 

Robotic Assistance Devices Residential, Inc. (“RAD-R”) operates the Company’s residential security product business, principally through the RADCam™ product line. RADCam is an AI-powered, voice-enabled security camera designed for homeowners, property managers, and small businesses, and is differentiated from typical residential security cameras by its real-time conversational engagement capability, supported by SARA in an “SOS” configuration.

 

RAD-R’s financial performance during fiscal 2026 was substantially below Company’s expectations. The principal cause was the structural difference between business-to-business (“B2B”) and business-to-consumer (“B2C”) go-to-market economics. The Company’s core operating expertise, sales channel, and customer acquisition model are built around B2B sale cycles. The B2C residential market requires a substantially higher level of consumer marketing spend than the Company was prepared to commit during fiscal 2026, given competing capital priorities. The business generated an immaterial amount to consolidated revenue.

 

Notwithstanding the financial result, management continues to view RADCam as a superior product to comparable solutions available in the residential security camera market. The Company has no immediate plans to discontinue service to existing RADCam subscribers or to remove the product from sale. RADCam continues to be available for purchase through radcam.ai, Amazon, and other retail outlets.

 

The Company has modified the Residential software so that it can be deployed through RAD-I into the small-and-medium business and enterprise markets and be compatible with RAD’s primary solution RADSoC™.

 

Sales, Channels, and Customers

 

The Company sells through three principal channels: direct enterprise sales, an authorized dealer network, and online retail (in the case of RADCam). The direct enterprise sales team is led by a Senior Vice President of Sales with multiple direct reports and is supplemented by the President of RAD and the Company’s Chief Executive Officer in larger and more strategic accounts. The dealer network, which has grown to over one hundred authorized dealers across the United States, Canada, and the European Union, addresses small and middle-market accounts and provides geographic reach that direct enterprise sales cannot economically cover.

 

The Company’s end-user base spans a broad cross-section of industries. Sales pipeline and deployment activity during fiscal 2026 was concentrated in logistics and distribution, healthcare, commercial real estate, manufacturing, retail, education, government, and residential community markets.

 

Management has identified that the conversion rate of qualified sales opportunities to deployed clients—which historically lagged behind expectations—improved during fiscal 2026, principally as a result of (i) the maturity of the Gen 4 hardware platform, (ii) the broader integration of SARA across the portfolio, (iii) a growing set of reference deployments and case studies, and (iv) targeted investment in dealer enablement. The Company continues to focus on this conversion rate as a primary operational metric.

 

27

 

 

Manufacturing and Supply Chain

 

The Company performs final assembly, system integration, software loading, and quality assurance for its hardware products at its facility in Ferndale, Michigan. Sub-component manufacturing, including machined metal and plastic components, printed circuit boards, and selected sub-assemblies, is sourced from a network of domestic and international suppliers. The Company works to, when reasonable, maintain redundant suppliers for substantially all critical components and has structured its supply chain to mitigate concentration risk.

 

Hardware gross margins to date have been produced under small-batch production conditions. Management expects margin expansion over time as production volumes increase and as the Company captures economies of scale, particularly in connection with the ROAMEO production ramp and additional stationary product introductions.

 

Intellectual Property

 

All hardware designs, software, firmware, AI models, and supporting platforms used in the Company’s products are designed, developed, and owned by the Company and its subsidiaries. RAD-I owns the principal intellectual property associated with the Company’s stationary product platform, including the RAD Service Organization Control (SoC) command and control software, the RAD Mobile SoC , the RADGuard application, and the related operating architecture. RAD-G owns the SARA platform and the underlying agentic AI assets. RAD-M owns the autonomous navigation, fleet management, and ROAMEO-specific platform technology.

 

The Company relies on a combination of trade secret protection, confidentiality and invention-assignment agreements with employees and contractors, copyright, and trademark protection to protect its intellectual property. The Company holds registered trademarks on its principal product names. The Company does not currently rely materially on patent protection.

 

Competition

 

The Company competes across three distinct but related markets: traditional guard services and manned monitoring; legacy passive security hardware (cameras, access control devices, alarm systems); and an emerging set of AI-driven security technology companies. Traditional guard and monitoring service providers compete on price and incumbency but are structurally disadvantaged by labor cost inflation and labor availability constraints. Legacy hardware vendors compete on installed base and channel breadth but typically lack agentic AI capability and recurring software economics. AI-native security technology companies, including a small number of autonomous robotics competitors, compete on technology positioning, but most lack the integrated hardware-plus-software-plus-AI delivery model that the Company has developed.

 

Management believes the Company’s principal competitive advantages are: (i) the integration of proprietary hardware, software, and the SARA agentic AI platform under common ownership and development; (ii) a broad deployed installed base and the operational learning derived from it; (iii) a recurring-revenue business model that aligns the Company with customer success; (iv) a growing dealer and integration partner ecosystem; and (v) the demonstrated ability to bring complex hardware products from concept to commercial deployment, as evidenced by the ROAMEO program.

 

28

 

 

Human Capital and Culture

 

As of the date of this report, the Company has approximately 135 team members across the United States, Canada, the United Kingdom, and Asia, including Sri Lanka. The Company’s Sri Lanka operations are conducted through RAD Lanka, which holds Port City Colombo special economic zone status, providing tax efficiency and access to a cost-effective, educated technical workforce. None of the Company’s employees are represented by a union, and management considers employee relations to be excellent.

 

The Company has built its culture around the principles of emotional intelligence, accountability, and ownership. Self-awareness, composure, internal motivation, empathy, and social skill are deliberately weighted in the hiring process. Team members are expected to operate with multidisciplinary capability and to adjust scope and focus as the business requires. This culture is, in management’s view, a meaningful operational asset: it allows the Company to move faster than competitors of comparable size, to absorb the inevitable setbacks of a hardware-and-AI development business, and to retain experienced team members through periods of capital constraint.

 

The Company’s leadership team includes deep experience in security operations, robotics engineering, software development, artificial intelligence, sales, and capital markets. Mr. Reinharz serves on the Board of the Security Industry Association and chairs its Autonomous Working Group, and is a frequent speaker and panelist at industry conferences including ISC West and GSX.

 

Cybersecurity and Compliance

 

The Company achieved SOC 2 Type 2 status in February 2025 and has maintained SOC 2 Type 2 through annual audits. The Company has also achieved additional cybersecurity certifications appropriate to its enterprise and government customer base. SOC 2 Type 2 status is a benchmark standard, and in many cases a procurement requirement, for enterprise and government software and security purchases, and the Company’s achievement and maintenance of this status reflects management’s ongoing commitment to data protection and operational integrity. Additional disclosure regarding the Company’s cybersecurity program is provided under Item 1C of this report.

 

Available Information

 

The Company’s principal corporate website is www.aitx.ai. Information regarding the Company’s subsidiaries and products is also available at www.radsecurity.com (RAD-I), www.radm.ai (RAD-M), www.radgroup.ai (RAD-G), www.radresidential.ai (RAD-R), and www.radcam.ai (RADCam consumer information). The Company makes available, free of charge through its website and through the SEC’s EDGAR system at www.sec.gov, its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports, as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission.

 

References to the Company’s websites in this report are provided for convenience and information only; the content of those websites is not incorporated by reference into this report.

 

Press Announcements

 

During the fiscal year, the Company issued over 100 press releases, the vast majority of them being sales announcements and new authorized dealers being signed. Public events, conferences, awards and new product announcements were also publicized via press releases. All Company press releases can be found here: AITX News - AITX - Artificial Intelligence Technology Solutions

 

Legal Proceedings

 

See Item 3 - Legal Proceedings.

 

29

 

 

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table sets forth the names, positions and ages of our directors and executive officers as of the date of this report. Our directors serve for one year and until their successors are elected and qualified. Our officers are elected by the board of directors to a term of one year and serve until their successor is duly elected and qualified, or until they are removed from office. The board of directors has no nominating, auditing or compensation committees.

 

Name   Age   Position
Steven Reinharz (1)   50   Chief Executive Officer, Secretary and Director (2)
Anthony Brenz   64   Chief Financial Officer

 

(1) Director as of March 2, 2021
(2) All directors hold office until the next annual meeting of stockholders and until their successors have been duly elected and qualified.

 

Biographical information concerning our director and executive officers listed above is set forth below.

 

Steven Reinharz. RAD was founded by Mr. Reinharz in July of 2016, and he has been continuously employed by RAD and its affiliated companies since that time. He is the holder of a majority of our capital stock. Mr. Reinharz has served as a member of the Board of Directors since March 2, 2021 and as our Chief Executive Officer, Chief Financial Officer, and Secretary of the Company since March 2, 2021 and resigned as our Chief Financial Officer as of April 26, 2021 upon Anthony Brenz’s appointment as our Chief Financial Officer. As our Chief Executive Officer and President of RAD, Mr. Reinharz leverages his extensive knowledge and interest in robotics and artificial intelligence to design and develop robotic solutions that increase business efficiency and deliver immediate and impressive cost savings. Mr. Reinharz is an active voice in both the security and artificial intelligence industries. He started and ran his own security integration company from the age of 24 to 31, becoming one of California’s leading system integrators. Mr. Reinharz later was part of a team that successfully sold an integrator to a global security firm for $42 million and has held various other security industry roles. Mr. Reinharz speaks and contributes to panels at ISC East and West, and ASIS. Mr. Reinharz is a leading member of several industry association committees, mostly through the Security Industry Association. Mr. Reinharz has called Orange County, California home since 1995, having grown up in Montreal and Toronto. He earned a dual Bachelor of Science degree in Political Science and Commercial Studies.

 

Anthony Brenz was appointed as our Chief Financial Officer on April 26, 2021. He is an accomplished senior financial and operational executive for over 20 years of experience in finance and operations, including corporate strategy, procurement and supply chain, human resources, and customer service. From April 2018 to December 2020, Anthony Brenz was the Vice President/Director Finance of AirBoss Flexible Products Company. From September 2014 to April 2018, he was the Chief Financial Officer/Vice President of Finance of Thomson Aerospace and Defense (a Parker Meggitt Company). From August 2012 to September 2014, he was the Vice President/Director of Finance of M B Aeospace US Holdings, Inc. Anthony Brenz received a Bachelor of Accountancy from Walsh College in Troy Michigan in 1989 and has been licensed as a Certified Public Accountant in Michigan since 1989.

 

There are no family relationships between any of the executive officers and directors.

 

Board Committees and Director Independence

 

Mr. Reinharz serves as director, and we do not have a separately designated audit committee, compensation committee or nominating and corporate governance committee. The functions of those committees are being undertaken by our directors. Since we do not have any independent directors and have only two directors, our directors believes that the establishment of committees of the Board would not provide any benefits to our company and could be considered more form than substance.

 

We currently have an employee director, Mr. Reinharz, but no independent directors, as such term is defined in the listing standards of The NASDAQ Stock Market, and we do not anticipate appointing additional directors in the near future.

 

Our directors are not “audit committee financial experts” within the meaning of Item 401(e) of Regulation S-K. As with most small, early stage companies, until such time that the Company further develops its business, achieves a stronger revenue base and has sufficient working capital to purchase directors and officer’s insurance, the Company does not have any immediate prospects to attract independent directors. When the Company is able to expand our Board of Directors to include one or more independent directors, the Company intends to establish an Audit Committee of our Board of Directors. It is our intention that one or more of these independent directors will also qualify as an audit committee financial expert. Our securities are not quoted on an exchange that has requirements that a majority of our Board members be independent, and the Company is not currently otherwise subject to any law, rule or regulation requiring that all or any portion of our Board of Directors include “independent” directors, nor are we required to establish or maintain an Audit Committee or other committee of our Board of Directors.

 

Procedures for Nominating Directors

 

There have been no material changes to the procedures by which security holders may recommend nominees to the Board since the most recently completed fiscal quarter. We do not have a policy regarding the consideration of any director candidates that may be recommended by our stockholders, including the minimum qualifications for director candidates, nor has our sole director established a process for identifying and evaluating director nominees. We have not adopted a policy regarding the handling of any potential recommendation of director candidates by our stockholders, including the procedures to be followed. Our sole director has not considered or adopted any of these policies, as we have never received a recommendation from any stockholder for any candidate to serve on our Board of Directors. Given our relative size and lack of directors and officers insurance coverage, we do not anticipate that any of our stockholders will make such a recommendation in the near future.

 

30

 

 

While there have been no nominations of additional directors proposed, in the event such a proposal is made, all current members of our Board will participate in the consideration of director nominees.

 

Director Qualifications

 

Mr. Steve Reinharz is our sole director and was appointed on March 2, 2021. He is the founder of our operating company, Robotoc Assistance Devices, Inc. (see bio on page 33).

 

Code of Ethics and Business Conduct

 

We have adopted a code of ethics meeting the requirements of Section 406 of the Sarbanes-Oxley Act of 2002. We believe our code of ethics is reasonably designed to deter wrongdoing and promote honest and ethical conduct; provide full, fair, accurate, timely, and understandable disclosure in public reports; comply with applicable laws; ensure prompt internal reporting of violations; and provide accountability for adherence to the provisions of the code of ethics.

 

Director Compensation

 

We reimburse our directors for all reasonable ordinary and necessary business-related expenses, but we did not pay any other director’s fees or any other cash compensation for services rendered as a director during the years ended February 28, 2026 and February 28, 2025 to any of the individuals serving on our Board during that period.

 

Compliance with Section 16(a) of the Securities Exchange Act of 1934

 

Section 16(a) of the Exchange Act requires our executive officers and directors, and persons who beneficially own more than 10% of a registered class of our equity securities to file with the SEC initial statements of beneficial ownership, reports of changes in ownership and annual reports concerning their ownership of our common shares and other equity securities, on Forms 3, 4 and 5 respectively. Executive officers, directors and greater than 10% stockholders are required by the SEC regulations to furnish us with copies of all Section 16(a) reports they file. Based on our review of the copies of such forms received by us, or written representations that no other reports were required, and to the best of our knowledge, we believe that all of our officers, directors, and owners of 10% or more of our common stock filed all required Forms 3, 4, and 5.

 

EXECUTIVE COMPENSATION

 

The following table summarizes all compensation recorded by us in the past two fiscal years for Mr. Reinharz , our President and Chief Executive Officer , Anthony Brenz, our Chief Financial Officer

 

2026 AND 2025 SUMMARY COMPENSATION TABLE

 

Name and Principal Position 

Fiscal

Year

   Salary
or
Fees
($)
   Bonus
($)
   Stock
Awards(2)
($)
   Option
Awards
($)
   Non-Equity
Incentive Plan
Compensation
($)
   Non-Qualified
Deferred
Compensation
Earnings
($)
   All Other
Compensation
($)
   Total
($)
 
Steven Reinharz   2026    420,000        1,500,000            1,000,000        2,920,000 
Chief Executive Officer, Chief Financial Officer, Secretary (1)   2025    320,000    836,167    1,500,000            1,663,833        4,320,000 
                                              
Anthony Brenz   2026    211,865                        1,200    213,055 
Chief Financial Officer (1)   2025    200,408    1,000        17,975            1,200    208,988 

 

(1) Steven Reinharz was appointed Chief Executive Officer, Chief Financial Officer and Secretary on March 2, 2021.Mr.Reinharz ceased being Chief Financial Officer on June 24, 2021 and on that date appointed Anthony Brenz as Chief Financial Officer
(2) Stock awards are payable in Series G and are included in long term liabilities as they will not be paid out in the current year.

 

Employment Agreements

 

On April 9, 2021 Mr. Reinharz entered into an employment agreement with the Company in connection with his service as Chief Executive Officer. The agreement began on April 9, 2021 and has a three-year term, renewable thereafter on an annual basis if neither party files a notice of termination 90 days prior to the term renewal date. The agreement provides for compensation of $240,000 base salary (to be reviewed annually by the Board of Directors) and bonuses to be granted at the discretion of the Board of Directors. The salary for the fiscal year ended February 28, 2026 was $420,000.

 

31

 

 

Outstanding Equity Awards at 2026 Fiscal Year-End

 

The following table provides information concerning unexercised options, stock that has not vested and equity incentive plan awards for Mr. Brenz, our sole executive officers outstanding as of February 28, 2026:

 

OPTION AWARDS  STOCK AWARDS 
Name  Number of Securities Underlying Unexercised Options (#) Exercisable   Number of Securities Underlying Unexercised Options (#) Unexercisable   Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options
(#)
   Option Exercise Price
($)
   Option Expiration Date  Number of Shares or Units of Stock That Have Not Vested (#)   Market Value of Shares or Units of Stock That Have Not Vested ($)   Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)   Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) 
Anthony Brenz   0    0    45,000   $2.00   Sept. 1, 2027   45,000   $12,825    0    0 
Anthony Brenz   0    0    100,000   $2.00   Sept. 1, 2028   100,000   $28,500    0    0 

 

On April 14, 2021, the Shareholders of Series E Preferred Stock and the Board of Directors of our Company (“Board”) approved and adopted the 2021 Incentive Stock Plan (the “2021 Plan”). On August 11, 2022 the Company amended the 2021 Plan increasing the maximum number of shares applicable to the 2021 Plan from 50,000 to 1,000,000. On August 14,2023 the Company further amended the plan increasing the maximum shares to 2,000,000.

 

The purpose of the 2021 Plan is to promote the success of the Company by authorizing incentive awards to retain Directors, executives, selected Employees and Consultants, and reward participants for making major contributions to the success of the Company. The 2021 Plan authorizes the granting of stock options, restricted stock, restricted stock units, stock appreciation rights and stock awards. A total of two d million (2,000,000) shares of common stock may be issued under the 2021 Plan. All awards under the 2021 Plan, whether vested or unvested, are subject to the terms of any recoupment, clawback or similar policy of the Company in effect from time to time, as well as any similar provisions of applicable law, which could in certain circumstances require repayment or forfeiture of awards or any shares of stock or other cash or property received with respect to the awards, including any value received from a disposition of the shares acquired upon payment of the awards. The 2021 Plan will be administered by the Board or any Committee authorized by the Board, if applicable, which will have the sole authority to, among other things: construe and interpret the 2021 Plan; make rules and regulations relating to the administration of the 2021 Plan; select participants; and establish the terms and conditions of awards, all in accordance with the terms of the 2021 Plan. The 2021 Plan will remain in effect until April 14, 2031, unless sooner terminated by the Board. Termination will not affect awards then outstanding.

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

At July 15, 2026, we had 419,371,776 shares of Common Stock issued and outstanding. The following table sets forth information regarding the beneficial ownership of our Common Stock as of July 14, 2026, and reflects:

 

  each of our executive officers;
     
  each of our directors;
     
  all of our directors and executive officers as a group; and
     
  each stockholder known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock.

 

32

 

 

Information on beneficial ownership of securities is based upon a record list of our stockholders and we have determined beneficial ownership in accordance with the rules of the SEC. We believe, based on the information furnished to us, that the persons and entities named in the table below have sole voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable community property laws, except as otherwise provided below.

 

   Amount and
Nature of
     
Name  Beneficial
Ownership (1)
   Percent of
Common Stock (2)
 
         
Named Executive Officers and Directors:          
Steven Reinharz (3)   1,410,561,057    77.08%
Anthony Brenz   0    0 
           
All executive officers and directors as a group (2 persons)   1,410,561,057    77.08%
           
5% Shareholders:          
Steven Reinharz   1,410,561,057    77.08%

 

(1) Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Beneficial ownership also includes shares of stock subject to options and warrants currently exercisable or exercisable within 60 days of the date of this table. In determining the percent of common stock owned by a person or entity as of the date of this Report, (a) the numerator is the number of shares of the class beneficially owned by such person or entity, including shares which may be acquired within 60 days on exercise of warrants or options and conversion of convertible securities, and (b) the denominator is the sum of (i) the total shares of common stock outstanding on as of July 15, 2026 was 419,371,776 shares, and (ii) the total number of shares that the beneficial owner may acquire upon exercise of the derivative securities. Unless otherwise stated, each beneficial owner has sole power to vote and dispose of its shares.
   
(2) Based on 1,453,137,790 shares of the Company’s common stock issued and outstanding as of July 15, 2026.
   
(3) Steve Reinharz is a director and the Company’s Chief Executive Officer, Chief Financial Officer and Secretary as well as the CEO of RAD and is the holder of (i) 3,350,000 shares of our Series E Preferred Stock and, (ii) 2,450 shares of our Series F Convertible Preferred Stock. If Mr. Reinharz converted the 2,450 shares of the Company’s Series F Convertible Preferred Stock, he would receive 1,410,561,057 shares of the Company’s common stock, which is included in the chart above as if such conversion has occurred. Further, the outstanding shares of Series E preferred stock have the right to take action by written consent or vote based on the number of votes equal to twice the number of votes of all outstanding shares of common stock. As a result, the holders of Series E preferred stock has 2/3rds of the voting power of all shareholders at any time corporate action requires a vote of shareholders.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

 

We do not have a written policy for the review, approval or ratification of transactions with related parties or conflicted transactions. When such transactions arise, they are referred to our board of directors for its consideration.

 

For the years ended February 28, 2026, and February 28, 2025, the Company had net (advances) repayments of ($132,268) and ($71,927), respectively, to its loan payable-related party. At February 28, 2026, the loan payable-related party was $461,633 and $329,365 at February 28, 2025. As of February 28, 2026, included in the balance due to the related party is $285,638 of deferred salary all of which bears interest at 12%. As of February 28, 2025, included in the balance due to the related party is $190,013 of deferred salary all of which bears interest at 12%. The accrued interest included at February 28, 2026, was $79,268 (February 28, 2025- $51,575).

 

During the year ended February 28, 2026, the Company had a net repayment of $390,744 in deferred compensation for the CEO. This would bring his annual bonus for the year ended February 28, 2026, to $1.0 million. For the fiscal year ended February 28, 2025, the Company paid out $1,390,744 to the CEO. During the year ended February 28, 2025, the Company a net accrual of $1,663,833 in deferred compensation for the CEO. This would bring his annual bonus for the year ended February 28, 2025, to $2.5 million. For the fiscal year ended February 28, 2025, the Company paid out $836,167 to the CEO. This was all in accordance with a December 2023 board action allowing for $1 million of discretionary compensation.

 

During the years ended February 28, 2026, and February 28, 2025, the Company accrued 1,500 Series G shares to be issued totaling $1,500,000 and 1,500 Series G preferred shares to be issued totaling $1,500,000, respectively, both per Company resolution. The Series G preferred shares are redeemable at $1,000 per share and will be issued by the Company at the appropriate time. The balance of Incentive Compensation Plan Payable at February 28, 2026, was $5,500,000 and the balance February 28, 2025, was $4,000,000.

 

During the years ended February 28, 2026, and February 28, 2025, the Company was charged $2,576,111 and $2,541,180, respectively in consulting fees for research and development to a company partially owned by a principal shareholder included in research and development expenses. The principal shareholder received no compensation from this partially owned research and development company and the fees were spent on core development projects. As at February 28, 2026, and February 28, 2025, the balance due to this company was $160,557 and $76,532, respectively.

 

33

 

 

DESCRIPTION OF SECURITIES

 

Common Stock

 

Our authorized capital stock consists of 27,500,000,000 shares of common stock, par value $0.0001 per share, and 20,000,000 shares of preferred stock, par value $0.001 per share. As of July 15, 2026, we had 419,371,776 shares of common stock issued and outstanding, and 1,250,000 shares of common stock issuable. Holders of our common stock are entitled to one vote per share and, subject to the rights of any outstanding preferred stock, to receive dividends when and if declared by our Board of Directors and to share ratably in our assets legally available for distribution upon liquidation, dissolution or winding up. Holders of our common stock do not have preemptive, subscription, redemption or conversion rights, and no sinking fund provisions apply to our common stock. The rights, preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we have designated or that we may designate and issue in the future.

 

The number of authorized shares of our common stock has been amended on several occasions. On October 15, 2025, our Board of Directors increased the authorized common stock from 23,000,000,000 shares to 27,500,000,000 shares. On March 19, 2026, the Board of Directors and the holder of a majority of the Company’s voting power approved, by written consent, a decrease in the Company’s authorized common shares from 27,500,000,000 to 12,000,000,000. The Certificate of Amendment effecting this decrease was not filed with, or accepted by, the Nevada Secretary of State until July 15, 2026, on which date the decrease became effective. As of February 28, 2026 and continuing through the filing date of the Company’s original Annual Report on Form 10-K for the fiscal year ended February 28, 2026, the Company’s authorized common shares remained 27,500,000,000.

 

Preferred Stock

 

Under our Articles of Incorporation, as amended, we are authorized to issue up to 20,000,000 shares of preferred stock, par value $0.001 per share. Our Board of Directors is authorized, without further action by our stockholders, to designate and issue preferred stock in one or more series and to fix the designations, powers, preferences and relative, participating, optional and other rights, and the qualifications, limitations and restrictions thereof, including dividend rights, conversion rights, voting rights, redemption terms and liquidation preferences, of each series. As of the date of this prospectus, our Board of Directors has designated five series of preferred stock, as described below, and 15,534,000 authorized shares of preferred stock remain undesignated. The issuance of preferred stock could adversely affect the voting power, dividend rights and other rights of holders of our common stock and could have the effect of delaying, deferring or preventing a change in control of our Company.

 

Series B Convertible, Redeemable Preferred Stock

 

Our Board of Directors has designated 5,000 shares as Series B Convertible, Redeemable Preferred Stock, par value $0.001 per share, with a stated value of $1,200 per share. As of the date of this prospectus, no shares of Series B Convertible, Redeemable Preferred Stock were issued or outstanding. The Series B preferred stock ranks senior to our common stock and common stock equivalents with respect to distributions upon liquidation, votes together with the common stock on an as-converted basis, and accrues cumulative dividends at 8% per annum, payable quarterly in cash or in additional shares of preferred stock at the Company’s discretion. Each holder may convert its shares into common stock at a conversion price equal to the lower of (i) a fixed price based on the closing bid price of the common stock on the trading day immediately preceding acquisition of the shares and (ii) the lowest traded price of the common stock during the ten calendar days immediately preceding the conversion date, subject to downward adjustment upon an event of default. The Company is obligated to redeem the Series B preferred stock in installments on the 30th, 60th and 90th days following issuance at a redemption price equal to the stated value of each share, plus accrued and unpaid dividends and other amounts due to the holder.

 

Series C Convertible, Redeemable Preferred Stock

 

Our Board of Directors has designated 1,000 shares as Series C Convertible, Redeemable Preferred Stock, par value $0.001 per share, with a stated value of $1,200 per share. As of May 31, 2026, 354 shares of Series C Convertible, Redeemable Preferred Stock were issued and outstanding. The Series C preferred stock ranks senior to our common stock upon liquidation, votes together with the common stock on an as-converted basis, and accrues cumulative dividends at 12% per annum, payable quarterly. Beginning 180 days after issuance, each holder may convert its shares into common stock at a conversion price equal to the lower of (i) a fixed price based on the closing bid price of the common stock on the trading day immediately preceding acquisition of the shares and (ii) the lowest traded price of the common stock during the ten calendar days immediately preceding the conversion date, subject to downward adjustment upon an event of default. The shares are redeemable at 109.5% of stated value, plus accrued and unpaid dividends and other amounts due, on the 180th day following issuance, or earlier at the Company’s election upon three trading days’ written notice.

 

34

 

 

Series E Preferred Stock

 

Our Board of Directors has designated 4,350,000 shares as Series E Preferred Stock, par value $0.001 per share. As of the date of this prospectus, 3,350,000 shares of Series E Preferred Stock were issued and outstanding, all of which are held by Steven Reinharz, our Chief Executive Officer, Chief Financial Officer, Secretary and Chairman. The Series E Preferred Stock is not convertible, is not redeemable, is not entitled to dividends, ranks junior to our common stock with respect to distributions upon liquidation, and has no liquidation preference. The Series E Preferred Stock carries super-voting rights. The outstanding shares of Series E Preferred Stock are entitled to take action by written consent, or to vote together with the common stock, in each case with a number of votes equal to twice the number of votes of all outstanding shares of the Company’s equity securities entitled to vote. As a result, the holder of the Series E Preferred Stock controls two-thirds of the total voting power of the Company on any matter submitted to a vote of stockholders and is able to determine the outcome of substantially all such matters, including the election of directors. In addition, by virtue of this voting power, our Chief Executive Officer and Chairman is able, at any time, to unilaterally approve an increase in the number of authorized shares of our common stock under our Articles of Incorporation and bylaws without the need to call a general meeting of the holders of our common stock. See “Risk Factors” and “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”

 

Series F Convertible Preferred Stock

 

Our Board of Directors has designated 10,000 shares as Series F Convertible Preferred Stock, par value $1.00 per share. As of the date of this prospectus, 2,513 shares of Series F Convertible Preferred Stock were issued and outstanding, of which 2,450 shares are held by Steven Reinharz, our Chief Executive Officer and Chairman. The Series F Convertible Preferred Stock is not redeemable, is not entitled to dividends, has no voting rights and has no liquidation preference. Each holder may, at any time, convert all (but not less than all) of its shares of Series F Convertible Preferred Stock into a number of shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the conversion date by 3.45, allocated pro rata among the holders. So long as any shares of Series F Convertible Preferred Stock are outstanding, the Company may not, without the approval of the holders of a majority of the outstanding shares, alter or change the rights, preferences or privileges of the Series F preferred stock in a manner adverse to the holders or create any senior or pari passu securities. Because of the size of the conversion factor, conversion of the outstanding Series F Convertible Preferred Stock would result in the issuance of a very substantial number of shares of common stock and would be materially dilutive to holders of our common stock.

 

Series G Preferred Stock

 

Our Board of Directors has designated 100,000 shares as Series G Preferred Stock, par value $0.001 per share. As of the date of this prospectus, no shares of Series G Preferred Stock were issued or outstanding. The Series G Preferred Stock is redeemable at $1,000 per share, has no voting rights, has no liquidation preference and is not entitled to dividends.

 

Undesignated Preferred Stock

 

The remaining 15,534,000 authorized shares of preferred stock are undesignated and available for future issuance in one or more series having such designations, powers, preferences, rights, qualifications, limitations and restrictions as our Board of Directors may determine, in each case without further action by the holders of our common stock.

 

Transfer Agent

 

The Company’s transfer agent is Transhare Corporation located at, 17755 US Highway 19 N., Suite 140, Clearwater, Florida 33764 and their telephone number is (303) 662-1112

 

35

 

 

LEGAL MATTERS

 

The validity of the shares of common stock offered by this prospectus will be passed upon for us by Frederick M. Lehrer, P. A.

 

EXPERTS

 

Our consolidated financial statements as of and for the fiscal years ended February 28, 2026 and February 28, 2025 included in this prospectus have been audited by L J Soldinger Associates, LLC, our independent registered public accounting firm, as stated in their report appearing herein (which report expresses an unqualified opinion and includes an explanatory paragraph relating to our ability to continue as a going concern), and are included in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We file annual, quarterly, and current reports and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC’s website at www.sec.gov. We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares of common stock offered by this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement and its exhibits. For further information with respect to us and our common stock, we refer you to the registration statement and its exhibits.

 

36

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Report of Independent Registered Public Accounting Firm F-2
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations F-4
   
Consolidated Statements of Stockholders’ Deficit F-5
   
Consolidated Statements of Cash Flows F-7
   
Notes to the Consolidated Financial Statements F-8

 

Table of Contents

 

  PAGE
PART I FINANCIAL INFORMATION  
     
ITEM 1. Financial Statements F-41
     
  Condensed Consolidated Balance Sheets as of May 31, 2026 and February 28, 2026 (Unaudited) F-41
     
  Condensed Consolidated Statements of Operations for the Three Months Ended May 31, 2026 and 2025 (Unaudited) F-42
     
  Condensed Consolidated Statements of Stockholders’ Deficit for the Three Months Ended May 31, 2026 and 2025 (Unaudited) F-43
     
  Condensed Consolidated Statements of Cash Flows for the Three Months Ended May 31, 2026 and 2025 (Unaudited) F-44
     
  Notes to the Consolidated Financial Statements (Unaudited) F-45

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of Artificial Intelligence Technology Solutions, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Artificial Intelligence Technology Solutions, Inc. and its subsidiaries (the “Company”) as of February 28, 2026 and February 28, 2025, and the related consolidated statements of operations, stockholders’ deficit, and cash flows for each of the years in the two-year period ended February 28, 2026, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of February 28, 2026, and February 28, 2025, and the results of its operations and its cash flows for each of the years in the two-year period ended February 28, 2026, in conformity with accounting principles generally accepted in the United States of America.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company had negative cash flow from operating activities of approximately $9.3 million, an accumulated deficit of approximately $171.1 million and negative working capital of approximately $17.0 million as of and for the year ended February 28, 2026, which raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.

 

/s/ L J Soldinger Associates, LLC
   
We have served as the Company’s auditor since 2019.
   
Deer Park, Illinois
PCAOB ID: 318
June 8, 2026  

 

F-2

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

CONSOLIDATED BALANCE SHEETS

 

  

February 28,

2026

  

February 28,

2025

 
ASSETS          
Current assets:          
Cash  $109,043   $865,975 
Accounts receivable, net   1,004,201    1,367,331 
Share proceeds receivable       418,669 
Device parts inventory, net   1,318,742    1,583,726 
Prepaid expenses and deposits   503,017    792,842 
Total current assets   2,935,003    5,028,543 
Operating lease asset   931,814    1,010,545 
Revenue earning devices, net of accumulated depreciation of $3,257,668 and $2,292,172, respectively   5,097,627    4,539,180 
Fixed assets, net of accumulated depreciation of $540,426 and $491,186, respectively   183,185    258,328 
Trademarks   35,319    33,321 
Investment at cost   100,000    100,000 
Security deposit   19,280    15,880 
Total assets  $9,302,228   $10,985,797 
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable and accrued expenses  $3,007,270   $2,121,871 
Customer deposits   147,326    91,578 
Current operating lease liability   243,690    197,349 
Current portion of deferred variable payment obligation   3,161,727    1,901,258 
Loan payable - related party   461,633    329,365 
Deferred compensation for CEO   1,811,856    2,202,600 
Current portion of loans payable, net of discount of $635,774 and $0   8,848,140    519,105 
Current portion of accrued interest payable   2,271,106    213,555 
Total current liabilities   19,952,748    7,576,681 
Non-current operating lease liability   676,694    810,513 
Loans payable, net of discount of $0 and $360,163, respectively   24,188,380    31,922,078 
Deferred variable payment obligation   2,525,000    2,525,000 
Incentive compensation plan payable   5,500,000    4,000,000 
Accrued interest payable   9,122,552    13,680,453 
Total liabilities   61,965,374    60,514,725 
           
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly,$1,200 stated value, 5,000 shares authorized, no shares issued and outstanding at February 28, 2026 and February 28, 2025, respectively        
Series C Convertible, Redeemable Preferred Stock. $0.001 par value; $1,200 stated value, redeemable at 109.5%, 12% dividend, 1,000 shares authorized, 417 and 306 shares issued and outstanding at February 28, 2026 and February 28, 2025, respectively   547,941    402,084 
           
Commitments and Contingencies   -     -  
Stockholders’ deficit:          
Preferred Stock, undesignated; 15,534,000 shares authorized; no shares issued and outstanding at February 28, 2026 and February 28, 2025, respectively        
Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at February 28, 2026 and February 28, 2025, respectively        
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively   3,350    3,350 
Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,513 shares issued and outstanding, respectively   2,513    2,513 
Common Stock, $0.00001 par value; 27,500,000,000 shares authorized as of February 28, 2026 and February 28, 2025 (subsequently decreased to 12,000,000,000 shares authorized effective July 15, 2026 — see Summary of Common Stock Activity below); 267,872,804 and 144,124,538 shares issued, issuable and outstanding, respectively   2,679    1,441 
Additional paid-in capital   117,803,027    106,459,528 
Preferred stock to be issued   99,086    99,086 
Accumulated deficit   (171,121,742)   (156,496,930)
Total stockholders’ deficit   (53,211,087)   (49,931,012)
Total liabilities and stockholders’ deficit  $9,302,228   $10,985,797 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
         
Revenues  $7,745,336   $6,130,886 
           
Cost of goods sold   159,020    1,334,824 
Depreciation and Amortization   1,981,679    1,051,498 
Loss on disposal of revenue earning devices   70,937    - 
Total Cost of Goods Sold   2,211,636    2,386,322 
           
Gross Profit   5,533,700    3,744,564 
           
Operating expenses:          
Research and development (note 9)   4,128,155    3,462,558 
General and administrative   12,933,696    13,559,009 
Depreciation and amortization   141,051    429,139 
Loss on disposal of fixed assets   22,312     
Operating lease cost and rent   251,883    240,731 
Total operating expenses   17,477,097    17,691,437 
           
Loss from operations   (11,943,397)   (13,946,873)
           
Other income (expense), net:          
Interest expense   (6,001,539)   (5,456,981)
Gain on settlement of debt   3,434,685    468,262 
Total other income (expense), net   (2,566,854)   (4,988,719)
           
Net Loss  $(14,510,251)  $(18,935,592)
           
Net loss per share - basic  $(0.07)  $(0.16)
           
Net loss per share - diluted  $(0.07)  $(0.16)
           
Weighted average common share outstanding – basic and diluted   202,908,578    116,476,733 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED FEBRUARY 28, 2026 AND FEBRUARY 28, 2025

 

                                             
   Temporary Equity   Shareholder’s Deficit 
   Series B & C   Series E   Series F           Additional       Total 
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   Paid-In   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                             
Balance at February 29, 2024           3,350,000   $3,350    2,533   $101,619    92,387,510   $924   $92,656,977   $(132,962,427)  $       (40,199,557)
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024                                       (4,175,535)   (4,175,535)
Issuance of shares, net of $701,565 issuance costs                           49,796,369    498    13,120,181        13,120,679 
Debt exchanged for common stock                           1,940,659    19    561,981        562,000 
Series F Preferred Shares exchanged for debt                   (20)   (20)           (65,793)   (334,187)   (400,000)
Issuance of Series B Preferred Shares   300    360,000                            (82,000)       (82,000)
Series B Preferred Shares issued as commitment fee   20    24,000                            (24,000)       (24,000)
Series B Preferred shares issued as dividend   4    5,188                            (5,188)       (5,188)
Redemption of Series B Preferred shares   (324)   (389,188)                           89,189    (89,189)    
Issuance of Series C Preferred Shares   306    402,084                            (123,504)       (123,504)
Stock based compensation                                   331,685        331,685 
Net loss                                       (18,935,592)   (18,935,592)
Balance at February 28, 2025   306   $402,084    3,350,000   $3,350    2,513   $101,599    144,124,538   $1,441   $106,459,528   $(156,496,930)  $(49,931,012)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ DEFICIT

 

                                             
   Temporary Equity   Shareholder’s Deficit 
   Series B & C   Series E   Series F           Additional       Total 
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   Paid-In   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                             
Balance at February 28, 2025   306    402,084    3,350,000   $3,350    2,513   $101,599    144,124,538   $1,441   $106,459,528   $(156,496,930)  $      (49,931,012)
Issuance of shares, net of $364,161 issuance costs                           50,403,802    504    4,800,680        4,801,184 
Debt exchanged for common stock                           71,350,000    714    6,383,286        6,384,000 
Conversion of Series C Preferred shares   (85)   (111,690)                   1,994,464    20    196,360    (84,690)   111,690 
Cash redemption of Series C shares   (95)   (125,000)                           29,871    (29,871)    
Series C Preferred shares issued as dividend   44    58,100                            (58,100)       (58,100)
Penalty on failure to redeem Series C Preferred shares   114    149,307                            (149,307)       (149,307)
Penalty on failure to convert Series C Preferred shares   133    175,140                            (175,140)       (175,140)
Stock based compensation                                   315,849        315,849 
Net loss                                       (14,510,251)   (14,510,251)
Balance at February 28, 2026   417   $547,941    3,350,000   $3,350    2,513   $101,599    267,872,804   $2,679   $117,803,027   $(171,121,742)  $(53,211,087)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(14,510,251)  $(18,935,592)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   2,122,730    1,480,636 
Inventory provision (recovery)   (290,000)   (494,000)
Bad debts expense   138,405    83,682 
Reduction of right of use asset   141,217    119,151 
Accretion of lease liability   103,956    118,502 
Stock based compensation   1,815,848    1,831,685 
Amortization of debt discounts   536,078    271,234 
Penalty added to face value of the loan   24,510     
Gain on settlement of debt   (3,434,685)   (468,262)
Loss on disposal of revenue earning devices and fixed assets   93,249     
Increase in related party accrued payroll and interest   132,268    71,927 
Changes in operating assets and liabilities:          
Accounts receivable   224,725    (694,929)
Prepaid expenses   294,264    (160,393)
Deposit on right of use asset   (13,187)    
Security deposit on operating lease   (3,400)    
Device parts inventory   (2,133,437)   (2,464,468)
Accounts payable and accrued expenses   879,021    505,068 
Deferred compensation for CEO   (390,744)   1,663,833 
Customer deposits   55,748    17,876 
Operating lease liability payments   (238,792)   (225,413)
Current portion of deferred variable payment obligations for Payments   1,260,469    996,881 
Accrued interest payable   3,847,474    4,086,194 
Net cash used in operating activities   (9,344,534)   (12,196,388)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of fixed assets   (10,863)   (23,724)
Purchase of trademarks   (1,998)   (6,241)
Purchase of investment (convertible note receivable)       (50,000)
Net cash used in investing activities   (12,861)   (79,965)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Share proceeds net of issuance costs   5,219,853    12,702,010 
Proceeds on issuance of Series B Preferred Shares       278,000 
Redemption of Series B or Series C Preferred Shares   (125,000)   (389,188)
Proceeds on issuance of Series C Preferred Shares       278,580 
Proceeds from loans payable   4,808,171    350,000 
Repayment of loans payable   (1,302,561)   (183,000)
Net cash provided by financing activities   8,600,463    13,036,402 
           
Net change in cash   (756,932)   760,049 
           
Cash, beginning of period   865,975    105,926 
           
Cash, end of period  $109,043   $865,975 
           
Supplemental disclosure of cash and non-cash transactions:          
Cash paid for interest  $188,993   $94,517 
Cash paid for income taxes  $   $ 
           
Noncash investing and financing activities:          
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024  $   $4,175,535 
Right of use asset for lease liability  $53,739   $ 
Transfer from device parts inventory to fixed assets  $2,688,421   $3,506,341 
Series C penalty shares issued  $324,447     
           
Discount applied to face value of loans  $811,689   $ 
           
Exchange of Series F Preferred Shares for loans payable  $   $400,000 
Exchange of loans payable and accrued interest for common shares  $6,484,000   $562,000 
Convertible note receivable exchanged for investment at cost  $   $50,000 
Dividend on Series B or Series C Preferred Shares paid in Series B or Series C Preferred Shares  $58,100   $5,188 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1. GENERAL INFORMATION AND GOING CONCERN

 

Artificial Intelligence Technology Solutions Inc. (formerly known as On the Move Systems Corp.) (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

 

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a LLC. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc. through the issuance of 10,000 common shares to its sole shareholder.

 

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and AITX was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, in which AITX purchased all of the outstanding shares of capital stock of RAD. As a result, AITX’s business going forward will consist of one segment activity which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

 

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

 

GOING CONCERN

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

For the year ended February 28, 2026, the Company had negative cash flow from operating activities of $9,344,534. As of February 28, 2026 the Company has an accumulated deficit of $171,121,742 and negative working capital of $17,017,745. Management does not anticipate having positive cash flow from operations in the near future. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

 

The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:

 

Management is committed to raise funds either through convertible debt or equity financing.. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In May 2026, the Company entered into an equity financing agreement whereby an investor will purchase up to $10,000,000 of the Company’s common stock at a discount over a three-year period. There remains approximately $10 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways : growing revenues ,through equity proceeds, and issuing debt.

 

F-8

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

2. ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation

 

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the instructions on Form 10-K of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). The audited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group, Inc, Robotic Assistance Devices Mobile, Inc., Robotic Assistance Devices Residential, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

 

In order to prepare financial statements in conformity with accounting principals generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments used in debt settlements, amendments and extensions.

 

Reclassifications

 

Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.

 

Concentrations of Loans Payable

 

At February 28, 2026 there were $33,672,294 loans payable, $32,178,506 or 96% of these loans to companies controlled by one individual. At February 28, 2025 there were $32,801,345 loans payable, $28,581,506 or 87% of these loans to companies controlled by one individual..

 

Cash

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions which, at times, may exceed federally insured limits, and, to date has not experienced losses on any of its balances.

 

F-9

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Accounts Receivable

 

Accounts receivable are comprised of balances due from customers, net of estimated allowances for credit losses. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $170,000 and $140,000 provided as of February 28, 2026 and February 28, 2025, respectively. For the year ended February 28, 2026, two customer account for 31% of total accounts receivable . For the year ended February 28, 2025, one customer accounts for 52% of total accounts receivable.

 

Device Parts Inventory

 

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. At February 28, 2026 and at February 28, 2025 there was a valuation reserve of $175,000 and $465,000, respectively.

 

Revenue Earning Devices

 

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

 

Fixed Assets

 

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from three to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

 

Computer equipment   3 years
Furniture and fixtures   3 years
Office equipment   4 years
Warehouse equipment   5 years
Demo Devices   4 years
Vehicles   3 years
Leasehold improvements   5 years, the life of the lease

 

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

 

F-10

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Research and Development

 

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At February 28, 2026 and February 28, 2025, the Company had no deferred development costs.

 

Contingencies

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

Sales of Future Revenues

 

The Company has entered into transactions, as more fully described in footnote 10, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

 

  Does the agreement purport, in substance, to be a sale
     
  Does the Company have continuing involvement in the generation of cash flows due the investor
     
  Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets
     
  Is the investors rate of return implicitly limited by the terms of the agreement
     
  Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return
     
  Does the investor have recourse relating to payments due

 

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

 

F-11

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Revenue Recognition

 

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.. For the year ended February 28, 2026, two customers accounted for 55% of total revenue and for the year ended February 28, 2025, one customer accounted for 55% of total revenue (see Note-3).

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2026, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements.

 

Leases

 

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

 

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

 

F-12

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

 

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our CEO and Chairman holds sufficient shares of the Company’s voting stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company without the need to call a general meeting of common shareholders of the Company.

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

F-13

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

  Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
     
  Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
     
  Level 3 – Inputs that are unobservable for the asset or liability.

 

Measured on a Recurring Basis

 

The following table presents information about our assets and liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

 

   Amount at   Fair Value Measurement Using 
   Fair Value   Level 1   Level 2   Level 3 
February 28, 2026                    
Assets                    
Investment at cost  $100,000   $50,000   $   $50,000 
Liabilities                    
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares  $5,500,000   $   $   $5,500,000 
                     
February 28, 2025                    
Liabilities                    
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares  $4,000,000   $   $   $4,000,000 

 

For the incentive compensation plan , the Company recorded stock based compensation of $1,500,000 and $1,500,000 for the years ended February 28, 2026 and February 28, 2025 with corresponding adjustments to incentive compensation plan payable.

 

The method of valuation of the incentive compensation plan payable is based on the redemption value of the Series G Preferred Shares. The method of valuation of the Level 3 investment at cost is an independent third party valuation of the common share value of the investment.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

 

F-14

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

 

Recently Adopted Accounting Pronouncements

 

ASU 2023-07 – Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments require enhanced disclosures about significant segment expenses and other segment items, require disclosure of the title and position of the chief operating decision maker (“CODM”), explain how the CODM uses reported measures of segment profit or loss to assess performance and allocate resources, and expand interim disclosure requirements. The amendments apply to entities with a single reportable segment as well as entities with multiple reportable segments.

 

The Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, during fiscal 2025. The standard requires enhanced disclosures regarding segment expenses and CODM information and applies to entities with a single reportable segment. Adoption of the standard impacted the Company’s segment reporting disclosures only and did not affect its consolidated financial position, results of operations, or cash flows.

 

Recently issued accounting pronouncement not yet effective

 

ASU 2024-04—Debt with Conversion and Other Options (Topic 470-20): Induced Conversions of Convertible Debt Instruments

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments. The amendments clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions or as debt extinguishments. Under the amended guidance, an induced conversion requires that the inducement offer provide the holder, at a minimum, the consideration issuable under the existing conversion privileges of the instrument.

 

The amendments are effective for annual reporting periods beginning after December 15, 2025, including interim reporting periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements and related disclosures.

 

ASU 2025-05—Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets

 

In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments refine the guidance in ASC 326 related to the measurement of expected credit losses for accounts receivable and contract assets arising from revenue transactions accounted for under ASC 606. The update clarifies the application of the current expected credit loss (“CECL”) model to such assets, including the use of practical expedients and considerations in estimating expected credit losses over the contractual term of the asset.

 

The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-05 on its consolidated financial statements and related disclosures.

 

3. REVENUE FROM CONTRACTS WITH CUSTOMERS

 

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, , and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

 

As disclosed in the revenue recognition section of Note 2 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 2 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

 

F-15

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

   Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
Device rental activities  $6,920,336   $5,050,255 
Direct sales of goods and services   825,000    1,080,631 
Revenue  $7,745,336   $6,130,886 

 

The Company operates as one reportable segment The Chief Executive Officer (“CEO”) serves as the Chief Operating Decision Maker (“CODM”). The CODM evaluates the Company’s performance based on consolidated net income. This measure aligns with the Company’s consolidated financial statements and serves as the basis for resource allocation and performance assessment. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM monitors profitability and strategic growth initiatives on a consolidated basis, without disaggregating profit or loss into separate operating segments. The Company determined there are no significant segment expenses that require a separate disclosure. The consolidated net income is used to assess overall company performance, benchmark against industry standards, and identify profitability trends, which guides resource allocation and investment in expansion and program upgrades. The CODM also evaluates company performance using operating income. Operating income provides the CODM with a focused view of the Company’s profitability excluding the effects of financing activities, tax strategies, and other non-operating items. This measure enables the CODM to assess operational efficiency, monitor performance trends, and evaluate the effectiveness of strategies aimed at revenue generation and cost management.

 

4. LEASES

 

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

 

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

 

Below is a summary of our lease assets and liabilities at February 28, 2026 and February 28, 2025.

 

Leases  Classification  February 28,
2026
   February 28,
2025
 
Assets             
Operating  Operating Lease Assets  $931,814   $1,010,545 
Liabilities             
Current             
Operating  Current Operating Lease Liability  $243,690   $197,349 
Noncurrent             
Operating  Noncurrent Operating Lease Liabilities   676,694    810,513 
Total lease liabilities     $920,384   $1,007,862 

 

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

 

F-16

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Operating lease cost and rent was $251,883 and $240,731 for both the twelve months ended February 28, 2026 and February 28, 2025, respectively.

 

5. INVESTMENT

 

On December 23, 2022 the Company entered into a Simple Agreement for Future Equity (SAFE) contract to invest $50,000 to acquire shares of a company’s capital stock at a discount. On June 3, 2024 the Company acquired a $50,000 convertible note receivable from Nightingale Intelligent Systems, Inc., a private Delaware corporation that provides unmanned aerial vehicles (UAV) for commercial applications. On January 3, 2025 the Company exchanged it’s convertible note receivable for : 1,770,840 Series A preferred shares, 15,000 common shares and 165,000 common share warrants. On February 28, 2025, there was a 10 :1 split. The Company now holds 177,084 Series A preferred shares, 1,500 common shares and 16,500 common share warrants (at a strike price of $0.80/share). The Company values the Nightingale Intelligent Systems, Inc.’s shares and warrants at $50,000 bringing total investments at cost to $100,000 at February 28, 2026.

 

6. REVENUE EARNING DEVICES

 

Revenue earning devices (RED) consisted of the following:

  

   February 28,
2026
   February 28,
2025
 
Revenue earning devices  $8,355,295   $6,831,352 
Less: Accumulated depreciation   (3,257,668)   (2,292,172)
Total  $5,097,627   $4,539,180 

 

During the year ended February 28, 2026, the Company made total additions to revenue earning devices of $2,632,720 which were transferred from inventory. For the year ended February 28, 2026, the Company disposed of assets with a value $1,108,776 and related accumulated depreciation $1,037,839 with a net book value of $70,937 for zero net proceeds..

 

During the year ended February 28, 2025, the Company made total additions to revenue earning devices of $3,398,505 which were transferred from inventory. There was no permanent impairment on revenue earning services for the year ended February 28, 2025.

 

Depreciation and amortization for the years ended February 28, 2026, and February 28, 2025, are as follows:

 

Depreciation and Amortization RED  Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
         
Cost of Goods Sold  $1,981,679   $1,051,498 
Operating expenses   91,811    287,830 
Total Depreciation and Amortization RED  $2,073,490   $1,339,328 

 

F-17

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

7. FIXED ASSETS

 

Fixed assets consisted of the following:

  

   February 28,
2026
   February 28,
2025
 
Automobile  $74,237   $74,237 
Demo devices   265,421    302,186 
Tooling   107,020    107,020 
Machinery and equipment   17,246    8,825 
Computer equipment   157,448    157,448 
Office equipment   15,312    15,312 
Furniture and fixtures   21,225    21,225 
Warehouse equipment   38,746    36,305 
Leasehold improvements   26,956    26,956 
Fixed assets gross   723,611    749,514 
Less: Accumulated depreciation   (540,426)   (491,186)
Fixed assets, net of accumulated depreciation  $183,185   $258,328 

 

During the year ended February 28, 2026, the Company made additions to fixed assets of $10,863 and also additions through inventory transfers of $55,701. For the year ended February 28, 2026, the Company disposed of assets with a value $92,466 and related accumulated depreciation $70,154 with a net book value of $22,312 for zero net proceeds.

 

During the year ended February 28, 2025, the Company made additions to fixed assets of $23,724 and also additions through inventory transfers of $107,836.

 

Depreciation and amortization for the years ended February 28, 2026, and February 28, 2025, are as follows:

 

Depreciation and Amortization  Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
         
Fixed assets  $49,240   $141,309 
Revenue earning devices   91,811    287,830 
Total Depreciation and Amortization included in operating expenses  $141,051   $429,139 

 

F-18

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

8. DEFERRED VARIABLE PAYMENT OBLIGATION

 

On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

 

On May 9, 2019 the Company entered into two similar arrangements with two investors:

 

  (1) The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.
     
  (2) The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

 

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

 

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

 

On November 18, 2019 the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020 the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

 

On December 30, 2019 the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020 the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

 

On April 22, 2020 the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020 the investor has fully funded this commitment.

 

On July 1, 2020 the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment

 

F-19

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

On August 27, 2020 the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020 and the Payments are secured by the assets of the Company. This interest may be secured by UCC filing but is subordinated to equipment financing on the products the Company leases to its customers.

 

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%

 

The Payments will first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and will accrue every quarter thereafter. As of February 28, 2026, the Company has accrued approximately $3,161,727 in Payments, of which $1,901,259 is in arrears. As of February 28, 2025, the Company has accrued approximately $1,901,258 in Payments, of which $904,377 is in arrears No notices have been received by the Company.

 

On March 1, 2021 the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

 

  1) The rate payment was reduced from 14.25 % to 9.65 %
  2) The asset disposition % (see below) was reduced from 31 % to 21%

 

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021 the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

 

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of February 28, 2026, and February 28, 2025, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

 

For both the years ended February 28, 2026 and February 28, 2025, the Company has received $0 related to the deferred payment obligation as the balance remains $2,525,000 at both February 28, 2026 and February 28, 2025.

 

F-20

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

9. RELATED PARTY TRANSACTIONS

 

For the years ended February 28, 2026, and February 28, 2025, the Company had net (advances) repayments of ($132,268) and ($71,927), respectively, to its loan payable-related party. At February 28, 2026, the loan payable-related party was $461,633 and $329,365 at February 28, 2025. As of February 28, 2026, included in the balance due to the related party is $285,638 of deferred salary all of which bears interest at 12%. As of February 28, 2025, included in the balance due to the related party is $190,013 of deferred salary all of which bears interest at 12%. The accrued interest included at February 28, 2026, was $79,268 (February 28, 2025- $51,575).

 

During the year ended February 28, 2026, the Company a net repayment of $390,744 in deferred compensation for the CEO. This would bring his annual bonus for the year ended February 28, 2026, to $1.0 million. For the fiscal year ended February 28, 2025, the Company paid out $1,390,744 to the CEO. During the year ended February 28, 2025, the Company a net accrual of $1,663,833 in deferred compensation for the CEO. This would bring his annual bonus for the year ended February 28, 2025, to $2.5 million. For the fiscal year ended February 28, 2025, the Company paid out $836,167 to the CEO. This was all in accordance with a December 2023 board action allowing for $1 million of discretionary compensation.

 

During the years ended February 28, 2026, and February 28, 2025, the Company accrued 1,500 Series G shares to be issued totaling $1,500,000 and 1,500 Series G preferred shares to be issued totaling $1,500,000, respectively, both per Company resolution. The Series G preferred shares are redeemable at $1,000 per share and will be issued by the Company at the appropriate time. The balance of Incentive Compensation Plan Payable at February 28, 2026, was $5,500,000 and the balance February 28, 2025, was $4,000,000.

 

During the years ended February 28, 2026, and February 28, 2025, the Company was charged $2,576,111 and $2,541,180, respectively in consulting fees for research and development to a company partially owned by a principal shareholder included in research and development expenses. The principal shareholder received no compensation from this partially owned research and development company and the fees were spent on core development projects. As at February 28, 2026, and February 28, 2025, the balance due to this company was $160,557 and $76,532, respectively.

 

F-21

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

10. LOANS PAYABLE

 

Loans payable at February 28, 2026 consisted of the following:

 

Date  Maturity  Description    Principal   Interest Rate 
July 18, 2016  July 18, 2017  Promissory note (1)*  $3,500    22%
December 10, 2020  March 1, 2027  Promissory note (2)   3,921,168    12%
December 10, 2020  March 1, 2027  Promissory note (3)   2,754,338    12%
December 10, 2020  December 10, 2024  Promissory note (4)       12%
December 14, 2020  March 1, 2027  Promissory note (5)   310,375    12%
December 30, 2020  March 1, 2027  Promissory note (6)   350,000    12%
January 1, 2021  March 1, 2027  Promissory note (7)   25,000    12%
January 1, 2021  March 1, 2027  Promissory note (8)   145,000    12%
January 14, 2021  March 1, 2027  Promissory note (9)   237,500    12%
February 22, 2021  March 1, 2027  Promissory note (10)   1,650,000    12%
March 1, 2021  March 1, 2027  Promissory note (11)   6,000,000    12%
June 8, 2021  June 8, 2027  Promissory note (12)   2,750,000    12%
July 12, 2021  July 26, 2026  Promissory note (13)       7%
September 14, 2021  September 14, 2027  Promissory note (14)   1,650,000    12%
July 28, 2022  March 1, 2027  Promissory note (15)   170,000    15%
August 30, 2022  August 30,2027  Promissory note (16)   3,000,000    15%
September 7, 2022  March 1, 2027  Promissory note (17)   400,000    15%
September 8, 2022  March 1, 2027  Promissory note (18)   475,000    15%
October 13, 2022  March 1, 2027  Promissory note (19)   350,000    15%
October 28, 2022  October 31, 2026  Promissory note (20)   400,000    15%
November 9, 2022  October 31, 2026  Promissory note (20)   400,000    15%
November 10, 2022  October 31, 2026  Promissory note (20)   400,000    15%
November 15, 2022  October 31, 2026  Promissory note (20)   400,000    15%
January 11, 2023  October 31, 2026  Promissory note (20)   400,000    15%
February 6, 2023  October 31, 2026  Promissory note (20)   400,000    15%
April 5. 2023  October 31, 2026  Promissory note (20)   400,000    15%
April 20, 2023  October 31, 2026  Promissory note (20)   400,000    15%
May 11, 2023  October 31, 2026  Promissory note (20)   400,000    15%
October 27, 2023  October 31, 2026  Promissory note (20)   400,000    15%
November 30, 2023  April 30, 2027  Purchase Agreement (21)   203,000    15%
March 8, 2024  August 8, 2027  Purchase Agreement (22)   350,000    15%
July 26, 2025  July 26, 2026  Promissory note (23)   165,000    15%
August 7,2025  August 7,2026  Promissory note (24)   245,000    15%
August 25, 2025  August 25, 2026  Promissory note (25)   137,500    15%
August 25, 2025  May 6, 2026  Future Receivables Purchase and Sale Agreement (26)   189,951    108%
September 25, 2025  September 25, 2026  Promissory note (27)   550,000    15%
October 30. 2025  October 30. 2026  Promissory note (28)   200,000    15%
November 6, 2025  November 6, 2026  Promissory note (29)   275,000    15%
November 24, 2025  November 24, 2026  Promissory note (30)   450,000    15%
December 9, 2025  December 9, 2026  Promissory note (31)   450,000    15%
December 17, 2025  September 23, 2026  Business loan (32)   329,962    65%
December 22, 2025  December 22, 2026  Convertible note (33)   495,000    12%
December 27, 2025  December 27, 2026  Promissory note (34)   275,000    15%
January 12, 2026  January 12, 2027  Promissory note (35)   330,000    15%
January 27, 2026  January 27, 2027  Promissory note (36)   170,000    15%
February 2, 2026  February 2, 2027  Promissory note (37)   330,000    15%
February 19, 2026  February 19, 2027  Convertible note (38)   165,000    12%
                   
February 24, 2026  February 24, 2027  Promissory note (39)   170,000    15%
           $33,672,294      
                   
Less: current portion of loans payable     (9,483,914)     
Less: discount on non-current loans payable     -      
Non-current loans payable, net of discount    $24,188,380      
                   
Current portion of loans payable    $9,483,914      
Less: discount on current portion of loans payable     (635,774)     
Current portion of loans payable, net of discount    $8,848,140      

 

* In default

 

As of February 28, 2026 , all long term debt matures in the fiscal year ending February 29, 2028.

 

F-22

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.
   
(2) This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(3) This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. On February 8, 2026, the holder exchanged $192,000 in accrued interest for 8,000,000 common shares at fair value of $320,000 with a loss on settlement of $128,000.
   
(4) This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense. The Company was charged a penalty of $24,510 which it added the loan with a corresponding adjustment to interest expense. The Company repaid the loan in full $190,155 with accrued interest of $104,046.
   
(5)

This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. On December 14, 2023, the parties extended the maturity date from December 14. 2023 date to March 1,2027.

   
(6) The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the year ended February 28, 2026, the Company recorded amortization expense of $138, with an unamortized discount of $0 at February 28, 2026.The loan is fully amortized.
   
(7) This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(8) This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

 

F-23

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(9) The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024, to March 1, 2025, with all other terms and Conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the year ended February 28, 2026, the Company recorded amortization expense of $144, with an unamortized discount of $0 at February 28, 2026.The loan is fully amortized. Through an exchange agreement on February 11, 2025, the Company repaid $162,000 in principal st through the issuance of 600,000 common shares. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. On March 5, 2025 the Company repaid $150,500 in loan principal as well as $275,000 in accrued interest (all totaling $425,500) was repaid on March 5, 2025 through the issuance of 1,850,000 common shares at a fair value of $444,000 with a loss on settlement of $18,500.
   
(10) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022, to February 22, 2024, on February 28, 2022, in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the year ended February 28, 2026, the Company recorded amortization expense of $700, with an unamortized discount of $0 at February 28, 2026. The loan is fully amortized. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(11) The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. For the year ended February 28, 2026, the Company has issued 36,500,000 common shares at fair market value of $4,365,500 to repay $3,840,500 in accrued interest with a loss on settlement of debt of $525,000.
   
(12) The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $964, with an unamortized discount of $0 at February 28, 2026. The loan is fully amortized On April 16, 2025, the parties again extended the maturity date from June 8, 2025, to June 8, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of price the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. During the period the holder exchanged $1,416,000 in accrued interest for 25,000,000 common shares at a fair value of $1,680,000 with a loss on settlement of $264,000.

 

F-24

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(13) This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. During the six months ended August 31, 2025 the Company repaid $420,000 as part of a settlement with the estate of the lender. A settlement agreement was entered into on April 25,2025 between the Company and the Estate of the lender whereby the Company will repay a total of $420,000 to fully discharge the outstanding loan balance and accrued interest which totaled $4,790,185. This settlement agreement was approved by the court on June 5, 2025. Upon settlement in August 2025, the Company recorded a gain on settlement of debt of $4,370,185. At February 28, 2026 the outstanding principal and interest was $0.
   
(14) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $8,856, with an unamortized discount of $16,325 at February 28, 2026. On April 16, 2025, the parties again extended the maturity date from September 14, 2025, to September 14, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(15) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(16) A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. On April 16, 2025, the parties again extended the maturity date from August 30, 2025, to August 30, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(17) Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(18) Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

 

F-25

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(19) Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(20) On October 28, 2022, the Company entered into as secured loan agreement with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of this secured loan agreement into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:
   
  October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,483, with an unamortized discount of $14,428 at February 28, 2026.
   
  November 9, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,573, with an unamortized discount of $14,502 at February 28, 2026.

 

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,637, with an unamortized discount of $18,647 at February 28, 2026.

 

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,515, with an unamortized discount of $14,456 at February 28, 2026.

 

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,573, with an unamortized discount of $14,502 at February 28, 2026.

 

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,638, with an unamortized discount of $14,557 at February 28, 2026.

 

F-26

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,683, with an unamortized discount of $14,594 at February 28, 2026.

 

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,824, with an unamortized discount of $14,711 at February 28, 2026.

 

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $19,288, with an unamortized discount of $15,096 at February 28, 2026.

 

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with six a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,761, with an unamortized discount of $14,657 at February 28, 2026.

 

(21)

On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed April through to August 2024 payments in agreement with the lender. The Company have missed the subsequent monthly payments. On April 16, 2025, the parties extended the maturity date from April 30, 2025, to April 30, 2026, with all other terms and conditions remaining the same. On April 30,2026, the parties extended the maturity to April 30, 2027, with the default rate still applicable after April 30, 2025.

 
(22) On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 8, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The August 2024 through to August 2025 payments have not been made and the note was not repaid at original maturity. On August 8, 2025 the parties extended the maturity to August 8, 2027 , with the default rate still applicable after August 8, 2025.
   
(23) Original $165,000 note may be pre-payable at any time. The note balance includes an original issue discount of $15,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(24) Original $245,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(25) Original $137,500 note may be pre-payable at any time. The note balance includes an original issue discount of $12,500. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(26) On August 25, 2025, the Company entered into Future Receivables Purchase and Sale Agreement secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $555,671 after fees of $29,329 and a financing fee of $222,300 for total fees of $251,629. The Company must repay $807,300, in weekly payments of 7% of estimated receipts from accounts receivables. The estimated monthly payments will be approximately $99,725. For the year ended February 28, 2026, the Company recorded amortization expense of $192,422, with an unamortized discount of $59,207 at February 28, 2026. For the year ended February 28, 2026, the Company has repaid $617,348.
   
(27) Original $550,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $19,988, with an unamortized discount of $30,012 at February 28, 2026.
   
(28) Original $200,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $7,665, with an unamortized discount of $17,335 at February 28, 2026.
   
(29) Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $7,229, with an unamortized discount of $17,771 at February 28, 2026.
   
(30) Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $10,704, with an unamortized discount of $39,296 at February 28, 2026.

 

F-27

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(31)

 

Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $10,410, with an unamortized discount of $39,590 at February 28, 2026.

   
(32)

On December 17, 2025, the Company entered into a business loan secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $300,000 after fees of $14,000 and a financing fee of $91,060 for total fees of $105,060. The Company must repay $405,060, in 4 weekly payments of $2,276.50 and 36 weekly payments of $10,998.72. The loan is personally guaranteed by the CEO. For the year ended February 28, 2026, the Company recorded amortization expense of $19,478 with an unamortized discount of $85,582 at February 28, 2026. For the year ended February 28, 2026, the Company has repaid $75,098.

   

(33)

$495,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $440,000, with fees of $10,000 and an original issue discount of $45,000. Principal and interest due at maturity. For the year ended February 28, 2026, the Company recorded amortization expense of $9,705, with an unamortized discount of $45,295 at February 28, 2026. After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.
   
(34) Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $4,122, with an unamortized discount of $20,878 at February 28, 2026.

 

(35)

Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $3,864, with an unamortized discount of $26,136 at February 28, 2026.

 

(36) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $1,769, with an unamortized discount of $18,231 at February 28, 2026.

 

(37)

Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $1,863, with an unamortized discount of $28,137 at February 28, 2026.

 

(38)

$165,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $142,500, with fees of $7,500 and an original issue discount of $15,000. Principal and interest due at maturity. For the year ended February 28, 2026, the Company recorded amortization expense of $484, with an unamortized discount of $22,016 at February 28, 2026. After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.

 

(39)

Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the nine months ended February 28, 2026, the Company recorded amortization expense of $188, with an unamortized discount of $19,812 at February 28, 2026.

 

 

F-28

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

11. STOCKHOLDERS’ DEFICIT

 

Preferred Stock: The Company is authorized to issue up to 20,000,000 shares of $0.001 par value preferred stock. The board of directors is authorized to designate any series of preferred stock up to the total authorized number of shares.

 

Series B Convertible, Redeemable Preferred Stock

 

The board of directors has designated 5,000 shares of Series B Convertible, Redeemable Preferred Stock with a par value of $0.001 per share. As of February 28, 2026 , there are no shares of Series B Preferred Stock outstanding. The Series B Convertible Preferred Stock are redeemable at $1,200 per share, rank in priority to common stock and common stock equivalents upon liquidation of the Company, have voting rights on a converted basis and receives quarterly dividends of 8%. Each holder may, at any time and from time to time convert all, but not less than all, of their shares of Series B Convertible, Redeemable Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by dividing the redemption value by the Conversion Price. The Conversion price is equal to the lower of (1) a fixed price equaling the closing bid price of the Common Stock on the trading day immediately preceding the date of the acquisition of the shares and (2) the lowest traded price of the Common Stock during the ten (10) calendar days immediately preceding, but not including, the Conversion Date. Following an event of default,” as defined in the Purchase Agreement, the Conversion price shall equal the lower of: (a) the then applicable Conversion Price; or (b) a price per share equaling eighty five percent (85%) of the lowest traded price for the Company’s common stock during the fifteen (15) Trading Days immediately preceding, but not including, the Conversion Date. Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of eight percent (8%) per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Preferred Share has been converted or redeemed. Dividends may be paid in cash or in shares of Preferred Stock at the discretion of the Company. Any dividends that are not paid a shall continue to accrue and shall entail a late fee, which must be paid in cash, at the rate of 14% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the dividend payment date through and including the date of actual payment in full. On the thirtieth day following the issue date of this Preferred Stock the Company shall have the obligation to redeem one-third of the Preferred Stock outstanding for a redemption price equal to the redemption value of each such share of Preferred Stock, plus any accrued but unpaid dividends, plus all other amounts due to the Holder including, but not limited to Late Fees, liquidated damages and the legal fees and expenses of the Holder’s counsel. On the sixtieth (60th) calendar day following the date Preferred Stock is issued, the Corporation shall have the obligation to redeem one-half of the Preferred Stock then outstanding for the redemption price. On the ninetieth (90th) calendar day following the date Preferred Stock is issued, the Corporation shall have the obligation to redeem all of the Preferred Stock then outstanding for the redemption price. From the date of issuance until the date no shares of Series B Preferred Stock are issued and outstanding, unless Holders of at least 75% in Stated Value of the then outstanding shares of Preferred Stock shall have otherwise given prior written consent, the Corporation shall not, and shall not permit any of the Subsidiaries to, directly or indirectly: (a) other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; (b) other than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; (c) amend its charter documents, including, without limitation, its articles of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Holder; (d) repay, repurchase or offer to repay, repurchase or otherwise acquire of any shares of its Common Stock, Common Stock Equivalents or Junior Securities, other than as to the Conversion Shares as permitted or required under the Transaction Documents: (e) pay cash dividends or distributions on Junior Securities of the Corporation; f) enter into any transaction with any Affiliate of the Corporation which would be required to be disclosed in any public filing with the Commission, unless such transaction is made on an arm’s-length basis and expressly approved by a majority of the disinterested directors of the Corporation (even if less than a quorum otherwise required for board approval); or(g) enter into any agreement with respect to any of the foregoing.

 

F-29

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Series C Convertible, Redeemable Preferred Stock

 

The board of directors has designated 1,000 shares of Series C Convertible, Redeemable Preferred Stock with a par value of $0.001 per share. As of the February 28, 2026, there are 417 shares of Series C Preferred Stock outstanding. The Series C Convertible Preferred Stock are redeemable at $1,200 per share, rank in priority to common stock and common stock equivalents upon liquidation of the Company, have voting rights on a converted basis and receives quarterly dividends of 12%. Each holder may, after 180 days after issuance, at any time and from time to time convert all, but not less than all, of their shares of Series C Convertible, Redeemable Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by dividing the redemption value by the Conversion Price. The Conversion price is equal to the lower of (1) a fixed price equaling the closing bid price of the Common Stock on the trading day immediately preceding the date of the acquisition of the shares and (2) the lowest traded price of the Common Stock during the ten (10) calendar days immediately preceding, but not including, the Conversion Date. Following an event of default,” as defined in the Purchase Agreement, the Conversion price shall equal the lower of: (a) the then applicable Conversion Price; or (b) a price per share equaling ninety percent (90%) of the lowest traded price for the Company’s common stock during the ten (10) Trading Days immediately preceding, but not including, the Conversion Date. Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of twelve percent (12%) per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Preferred Share has been converted or redeemed. Dividends may be paid in cash or in shares of Preferred Stock at the discretion of the Company. Any dividends that are not paid a shall continue to accrue and shall entail a late fee, which must be paid in cash, at the rate of 14% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the dividend payment date through and including the date of actual payment in full. On the one hundred eightieth day following the issue date of this Preferred Stock the Company shall have the obligation to redeem all outstanding Series Preferred Shares for one hundred nine and one half percent (109.5%) of the stated value, plus any accrued but unpaid dividends, plus all other amounts due to the Holder pursuant to the Certificate of Designation and/or any Transaction Documents (“Redemption Date”). Prior to the Redemption Date, the Company at its discretion and on three (3) Trading Days’ written notice, may redeem all outstanding Preferred Shares for one hundred nine and one half percent (109.5%) of the stated value, plus any accrued but unpaid dividends, plus all other amounts due to the Holder pursuant to the Certificate of Designation and/or any Transaction Documents.

 

From the date of issuance until the date no shares of Series C Preferred Stock are issued and outstanding, unless Holders of at least 75% in Stated Value of the then outstanding shares of Preferred Stock shall have otherwise given prior written consent, the Corporation shall not, and shall not permit any of the Subsidiaries to, directly or indirectly: (a) other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; (b) other than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; (c) amend its charter documents, including, without limitation, its articles of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Holder; (d) repay, repurchase or offer to repay, repurchase or otherwise acquire of any shares of its Common Stock, Common Stock Equivalents or Junior Securities, other than as to the Conversion Shares as permitted or required under the Transaction Documents: (e) pay cash dividends or distributions on Junior Securities of the Corporation; f) enter into any transaction with any Affiliate of the Corporation which would be required to be disclosed in any public filing with the Commission, unless such transaction is made on an arm’s-length basis and expressly approved by a majority of the disinterested directors of the Corporation (even if less than a quorum otherwise required for board approval); or(g) enter into any agreement with respect to any of the foregoing.

 

F-30

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Series E Preferred Stock

 

The board of directors has designated 4,350,000 shares of Series E Preferred Stock. As of February 28, 2026, there are 3,350,000 shares of Series E Preferred Stock outstanding. The Series E Preferred Stock ranks subordinate to the Company’s common stock as to distributions of assets upon liquidation, dissolution or winding up of the Corporation. The Series E preferred stock is non-redeemable, does not have rights upon liquidation of the Company and does not receive dividends. The outstanding shares of Series E Preferred Stock have the right to take action by written consent or vote based on the number of votes equal to twice the number of votes of all outstanding shares of equity instruments with voting rights. As a result, the holder of Series E Preferred Stock has 2/3rds of the voting power of all shareholders at any time corporate action requires a vote of shareholders.

 

Series F Convertible Preferred Stock

 

The board of directors has designated 10,000 shares of Series F Convertible Preferred Stock with a par value of $1.00 per share. As of February 28, 2026 , there are 2,513 shares of Series F Convertible Preferred Stock outstanding. The Series F Convertible Preferred Stock is non-redeemable, does not have rights upon liquidation of the Company, does not have voting rights and does not receive dividends. Each holder may, at any time and from time to time convert all, but not less than all, of their shares of Series F Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis. So long as any shares of Series F Convertible Preferred Stock are outstanding, the Company shall not, without first obtaining the approval of the majority of the holders: (a) alter or change the rights, preferences or privileges of any capital stock of the Company so as to affect adversely the Series F convertible preferred stock; (b) create any Senior Securities; (c) create any pari passu Securities; (d) do any act or thing not authorized or contemplated by the Certificate of Designation which would result in any taxation with respect to the Series F Convertible Preferred Stock under Section 305 of the Internal Revenue Code of 1986, as amended, or any comparable provision of the Internal Revenue Code as hereafter from time to time amended, (or otherwise suffer to exist any such taxation as a result thereof).

 

Series G Preferred Stock

 

The board of directors has designated 100,000 shares of Series G Preferred Stock. As of the date of this report, there are no shares of Series G Preferred Stock outstanding. The series G shares are redeemable at $1,000 per share The Series G preferred stock does not have voting rights, does not have rights upon liquidation of the Company and does not receive dividends.

 

Summary of Preferred Stock Activity

 

F-31

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Series C Convertible, Redeemable Preferred Stock (Temporary Equity)

 

On February 10, 2025, in connection with a Share Purchase Agreement the Company created a new class of Series C Convertible Redeemable with 1,000 authorized shares.

 

In exchange for 306 Series C Convertible Redeemable Preferred Shares (“Series C”), the Company received gross proceeds of $306,000 with net proceeds of $278,580 after paying $6,000 in legal fees and $21,420 in broker fees both charged against paid in capital. The Company must redeem the shares at stated capital of 1,200 per share and a 1.095 premium at 180 days after issuance. The Company recorded the 306 outstanding shares at its redemption value of $402,084 at February 28, 2025, with the offsetting adjustment to paid in capital. During the year the Company issued 12% quarterly dividends in 44 Series C shares with a value of $58,100. The Company failed to redeem the Series C shares on the August 9, 2025 redemption date and a penalty of 114 Series C shares with a value of $149,307 was recorded. In August 2025 the Company redeemed 95 Series C shares for $125,000 including a deemed dividend of $29,871. In September 2025 the Company failed to convert a conversion notice of 96 shares. This conversion was withdrawn inI December 2025 and a new conversion for 85 Series C shares with a value of $111,690 including a dividend of $84,690 with a corresponding adjustment to paid in capital .In exchange for the converted Series C shares , the Company issued 1,994,464 common shares. In January 2026, the Company failed to convert a conversion notice of 80 shares. On March 19, 2026 the Company entered into an agreement with the investor whereby the parties agreed to reduce the penalty on the September 2025 and January 2026 failed conversion to 133 Series C shares at a value of $175,140 ( The penalty was reduced from 345 Series C shares to 133 Series C shares) . The parties agreed on the Series C share balance at February 28, 2026 to be 417 series C shares. In addition the parties agreed to issue an additional 222 Series C shares for proceeds of $200,000 and fees of $22,000. These shares have a redemption value of $291.708. Also on March 19, 2026 ,the parties agreed to convert 165 Series C shares at a value of $198,000 for 13,550,625 common shares. At February 28, 2026 and February 28, 2025 there are 417 and 306 outstanding Series C shares.

 

Series F Convertible Preferred Stock

 

Each holder of Series F Convertible Preferred Shares may, at any time and from time to time convert all, but not less than all, of their shares into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis.

 

On April 30, 2024 the Company increased authorized shares to 10,000 Series F Preferred Shares.

 

Series F Preferred Stock Activity:

 

During the year ended February 28, 2026 Series F shareholders there was no activity.

 

During the year ended February 28, 2025 Series F shareholders had the following activity:

 

  A Series F preferred shareholder exchanged 20 Series F preferred shares for a $400,000 note payable. (see Note 11). The Company record an adjustment to the par value of the shares of $20, paid -in capital for the carrying value of the shares of $65,793 with the remaining amount of $334,187 a deemed dividend.

 

At both February 28, 2026 and February 28, 2025 there are 2513 outstanding Series F preferred stock.

 

Unissued Series F Preferred Stock

 

At both February 28, 2026 and February 28, 2025 there remains 46 issuable Series F preferred stock at a value of $99,086.

 

Summary of Preferred Stock Warrant Activity

 

   Number of
Series F
Preferred
Warrants
  

Weighted

Average
Exercise Price

  

Weighted

Average
Remaining
Years

 
Outstanding at March 1, 2025   939   $1.00    8.5 
Issued            
Exercised            
Forfeited and cancelled            
Outstanding at February 28, 2026   939   $1.00    7.5 

 

F-32

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Summary of Common Stock Activity

 

The Company increased authorized common shares from 5,000,000,000 to 6,000,000,000 on July 8, 2022, from 6,000,000,000 to 7,225,000,000 on March 19, 2023 from 7,225,000,000 to 10,000,000,000 on August 30, 2023, from 10,000,000,000 to 12,500,000,000 on March 22, 2024., from 12,500,000,000 to 15,000,000,000 on October 4, 2024 from 15,000,000,000 to 20,000,000,000 on February 21, 2025, from 20,000,000,000 to 23,000,000,000 on July 25, 2025 and from 23,000,000,000 to 27,500,000,000 on October 15, 2025.

 

On March 19, 2026, the Board of Directors and the holder of a majority of the Company’s voting power approved, by written consent, a decrease in the Company’s authorized common shares from 27,500,000,000 to 12,000,000,000. The Certificate of Amendment effecting this decrease was not filed with, or accepted by, the Nevada Secretary of State until July 15, 2026, on which date the decrease became effective. As of February 28, 2026 and continuing through the filing date of the Company’s original Annual Report on Form 10-K for the fiscal year ended February 28, 2026, the Company’s authorized common shares remained 27,500,000,000.

 

On February 5, 2026, the holders of a majority of the voting power of the Company’s outstanding voting securities executed the written consent approving a reverse stock split of the Company’s issued and outstanding Common Stock at a ratio of 1-for-100. The common shares have been adjusted to reflect this reverse stock split.

 

Summary of Common Stock Activity

 

During the year ended, February 28, 2026, common shareholders had the following activity:

 

  the Company issued 50,403,802 common shares with gross proceeds of $5,185,344 and net proceeds of $4,801,184 after paid issuance costs of $274,161. Included in these common shares was a commitment fee of $90,000 on the issuance of 1,354,167 shares bringing total fees to $364,161.
     
  the Company issued 71,350,000 common shares in gross proceeds of $6,384,000 to repay $5,411,000 loans payable and $37,500 in accrued interest with loss on settlement of $935,500 .
     
 

the Company issued 1,994,464 common shares in gross proceeds of $111,690 on the conversion of 85 Series C Preferred Shares. A dividend of $84,690 was recorded with a corresponding adjustment to paid -in capital.

 

During the year ended, February 28, 2025, common shareholders had the following activity:

 

  the Company issued 49,796,369 common shares with gross proceeds of $13,697,245 and net proceeds of $13,120,679 after paid issuance costs of $576,565. Included in the net proceeds are $418,669 in share proceeds receivable received after year end. Included in these common shares was a commitment fee of $125,000 on the issuance of 43,859,650 shares bringing total fees to $701,565.
     
  the Company issued 1,940,659 common shares to repay $562,000 loans payable from two different lenders.

 

Summary of Warrant and Stock Option Activity

 

   Number of
Warrants
   Weighted Average
Exercise Price
   Weighted Average
Remaining Years
 
Outstanding at February 29, 2024   3,005,957   $0.30    1.00 
Issued            
Exercised            
Forfeited and cancelled   (2,533,243)   (0.30)    
Outstanding at February 28, 2025   472,714   $0.30    2.44 
Issued            
Exercised            
Forfeited and cancelled   (2,714)   (0.04)    
Outstanding at February 28, 2026   470,000   $0.04    1.44 

 

During the year ended February 28, 2026 warrant holders had the following activity:

 

  During the year warrants to acquire 2,714 shares expired.

 

During the year ended February 28, 2025 warrant holders had the following activity:

 

  During the year warrants to acquire 2,533,243 shares expired.

 

F-33

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

For the years ended February 28, 2026 and February 29, 2025, the Company recorded a total of $0 and $0, respectively on stock-based payments for warrants with a corresponding adjustment to additional paid-in capital.

 

For the years ended February 28, 2026 and February 28, 2025 the Company recorded a total of $315,848 and $331,685 respectively, to stock-based compensation for options and shares with a corresponding adjustment to additional paid-in capital. In addition for both the years ended February 28, 2026 and February 28, 2025 the Company recorded other stock based compensation of $0 payable in Series G Preferred shares which have not yet been issued.

 

Summary of Common Stock Option Activity

 

On April 14, 2021, the Shareholders of Series E Preferred Stock and the Board of Directors of our Company (“Board”) approved and adopted the 2021 Incentive Stock Plan (the “2021 Plan”). On August 11, 2022 the Company amended the 2021 Plan increasing the maximum number of shares applicable to the 2021 Plan from 50,000 to 1,000,0000 On August 14, 2023 the Company further amended the plan increasing the maximum shares to 2,000,000.

 

The purpose of the 2021 Plan is to promote the success of the Company by authorizing incentive awards to retain Directors, executives, selected Employees and Consultants, and reward participants for making major contributions to the success of the Company. The 2021 Plan authorizes the granting of stock options, restricted stock, restricted stock units, stock appreciation rights and stock awards. A total of two million (2,000,000) shares of common stock may be issued under the 2021 Plan. All awards under the 2021 Plan, whether vested or unvested, are subject to the terms of any recoupment, clawback or similar policy of the Company in effect from time to time, as well as any similar provisions of applicable law, which could in certain circumstances require repayment or forfeiture of awards or any shares of stock or other cash or property received with respect to the awards, including any value received from a disposition of the shares acquired upon payment of the awards. The 2021 Plan will be administered by the Board or any Committee authorized by the Board, if applicable, which will have the sole authority to, among other things: construe and interpret the 2021 Plan; make rules and regulations relating to the administration of the 2021 Plan; select participants; and establish the terms and conditions of awards, all in accordance with the terms of the 2021 Plan. The 2021 Plan will remain in effect until April 14, 2031, unless sooner terminated by the Board. Termination will not affect awards then outstanding.

 

During the year ended February 28, 2026 the Company had the following common stock option activity:

 

On the original 2021 plan, options to purchase 33,000 shares were forfeited due to employee terminations. On the 2023 plan (see below) 57,160 options to purchase shares were forfeited due to employee terminations.

 

During the year ended February 28, 2025 the Company had the following common stock option activity:

 

On the original 2021 plan, options to purchase 24,750 shares were forfeited due to employee terminations. On the 2023 plan (see below) 39,639 options to purchase shares were forfeited due to employee terminations.

 

F-34

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Summary of Common Stock Option Activity

 

   Number of
Options
  

Weighted

Average
Exercise Price

   Weighted Average
Remaining
Years
 
Outstanding at March 1, 2024   1,886,670   $2.00    4.10 
Issued            
Exercised            
Forfeited, extinguished and cancelled   (64,389)  $2.00    (3.50)
Outstanding at February 28, 2025   1,822,281   $2.00    3.10 

 

   Number of
Options
  

Weighted

Average
Exercise Price

   Weighted Average
Remaining
Years
 
Outstanding at March 1, 2025   1,822,281   $2.00    3.10 
Issued            
Exercised            
Forfeited, extinguished and cancelled   (90,160)  $2.00    (2.60)
Outstanding at February 28, 2026   1,732,121   $2.00    2.10 

 

12. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

The related legal costs are expensed as incurred.

 

On September 24, 2024, a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet made on June 7, 2024. The Company and its counsel believe the claim is without merit however the courts have mandated mediation. After consideration of business factors the parties executed a settlement agreement in June 2025 with the Company agreeing to pay $65,000 with no admission of wrongdoing. The Company paid the $65,000 on August 1, 2025.

 

F-35

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Operating Lease

 

On March 10, 2021, the Company entered into a 10 year lease agreement for a manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

 

On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.

 

On March 11, 2025, the Company entered into a 3-year lease agreement for a vehicle commencing March 11, 2025 through to March 11, 2028 with a minimum base rent of $1,286 per month. The Company paid a down payment of $13,188. The Company recorded the right of use asset of $53,739 with a corresponding adjustment to operating lease liability.

 

The Company’s leases are accounted for as operating leases. The weighted average discount rate used was 10% and the weighted average remaining lease term at February 28, 2026 was 4.93 years. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $251,883 and $240,731 for the years ended February 28, 2026 and February 28, 2025, respectively.

 

Maturity of Lease Liabilities  Operating
Leases
 
February 28, 2027  $243,690 
February 28, 2028   227,383 
February 29, 2029   207,558 
February 28, 2030   207,558 
February 28, 2031   207,558 
February 28, 2032 and after   34,593 
Total lease payments   1,128,340 
Less: Interest   (207,956)
Present value of lease liabilities  $920,384 

 

F-36

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

13. LOSS PER SHARE

 

The net loss per common share amounts were determined as follows:

 

   2026   2025 
   For the Year Ended 
   February 28,   February 28, 
   2026   2025 
Numerator:          
Net loss available to common shareholders  $(14,510,251)  $(18,935,592)
           
Effect of common stock equivalents          
Less redemption dividend to Series F and Series B preferred shareholders   (114,561)   (423,476)
Net loss adjusted for common stock equivalents   (14,624,812)   (19,358,968)
           
Denominator:          
Weighted average shares - basic   202,908,578    116,476,733 
           
Net loss per share – basic  $(0.07)  $(0.16)
           
Denominator:          
Weighted average shares – diluted   202,908,578    116,476,733 
           
Net loss per share – diluted  $(0.07)  $(0.16)

 

The anti-dilutive shares of common stock equivalents for the years ended February 28, 2026 and February 28, 2025 were as follows:

 

   2026   2025 
   For the Year Ended 
   February 28,   February 28, 
   2026   2025 
Convertible Series F Preferred Shares   924,161,175    497,229,655 
Convertible Series C Preferred Shares   22,830,847    1,718,308 
Convertible and exchangeable debt   1,095,380,027     
Stock options and warrants   2,202,121    2,294,996 
Total   2,044,574,170    501,242,959 

 

F-37

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

14. INCOME TAXES

 

The Company has adopted ASC 740-10, “Income Taxes”, which requires the use of the liability method in the computation of income tax expense and the current and deferred income taxes payable (deferred tax liability) or benefit (deferred tax asset). Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

The income tax expense (benefit) consisted of the following for the fiscal years ended February 28, 2026 and ended February 28, 2025:

 

    February 28,
2026
    February 28,
2025
 
Total current  $   $ 
Total deferred        
Total  $   $ 

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

The following is a reconciliation of the expected statutory federal income tax provision to the actual income tax benefit for the fiscal years ended February 28, 2026 and February 28, 2025:

 

   February 28,
2026
 
Federal statutory rate  $(2,900,000)
State income tax benefit, net of federal benefit   (660,000)
Non deductible interest   500,000 
Non deductible stock based compensation   334,000 
Change in valuation allowance   2,726,000 
Total  $ 

 

   February 28,
2025
 
Federal statutory rate  $(4,000,000)
State income tax benefit, net of federal benefit   (900,000)
Non deductible interest   500,000 
Non deductible stock based compensation   322,000 
Change in valuation allowance   4,078,000 
Total  $ 

 

For the years ended February 28, 2026 and February 28, 2025, the expected tax benefit, temporary timing differences and long-term timing differences are calculated at the 21% statutory rate.

 

F-38

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Significant components of the Company’s deferred tax assets and liabilities were as follows for the fiscal years February 28, 2026 and February 28, 2025:

 

   February 28,
2026
   February 28,
2025
 
Deferred tax assets:          
Net operating loss carryforwards  $22,726,000   $20,000,000 
           
Deferred tax liabilities:          
Depreciation        
Deferred revenue        
Total deferred tax liabilities        
           
Net deferred tax assets:          
Less valuation allowance   (22,726,000)   (20,000,000)
Net deferred tax assets (liabilities)  $   $ 

 

The Company has incurred losses since inception, therefore, the Company has no federal tax liability. Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes which occurred in the Company on August 28, 2017. The net deferred tax asset generated by the loss carryforward has been fully reserved. The cumulative net operating loss carryforward was approximately $90,000,000 at February 28, 2026 and $76,973,800 at February 28, 2025, that is available for carryforward for federal income tax purposes and begin to expire in 2030.

 

Although the Company has tax loss carry-forwards, there is uncertainty as to utilization prior to their expiration. Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance.

 

The Company has maintained a full valuation allowance against its deferred tax assets at February 28, 2026 and February 28, 2025. A valuation allowance is required to be recorded when it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Since the Company cannot be assured of realizing the net deferred tax asset, a full valuation allowance has been provided.

 

The Company does not have any uncertain tax positions at February 28, 2026 and February 28, 2025 that would affect its effective tax rate. The Company does not anticipate a significant change in the amount of unrecognized tax benefits over the next twelve months. Because the Company is in a loss carryforward position, the Company is generally subject to US federal and state income tax examinations by tax authorities for all years for which a loss carryforward is available. If and when applicable, the Company will recognize interest and penalties as part of income tax expense.

 

The Company’s tax returns for the years ended February 28, 2025 and February 29, 2024, and February 28, 2023 are open for examination under Federal statute of limitations.

 

F-39

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

15. SUBSEQUENT EVENTS

 

Subsequent to February 28, 2026 through to filing date,

 

— the Company issued 36,786,492 common shares pursuant to a share purchase agreement for gross proceeds of $900,871, issuance costs of $77,391 and cash proceeds of $823,480.

 

the Company issued 39,000,000 shares to a lender to settle $745,900, pursuant to exchange agreements with the lender.

 

the Series C Preferred Shareholder converted 298 Series C preferred shares at a value of $391,572 for 24,473,250 common shares

 

on May 4 2026 the Company entered into an Equity Financing Agreement whereby an investor shall invest up to $10,000,000 over the course of thirty-six (36) month at a purchase price of eighty-seven percent (87%) of the average of the three lowest bid trade price in the 10 day preceding period. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement.

 

on March 12, 2026 the Company issued a promissory note to a lender for $170,000 with cash proceeds of $150,000 and an original issue discount of $20,000. The loan bears interest at 15% compounding annually, matures in 1 year and has a general security charging all of the Company’s present and after-acquired property.

 

on March 19, 2026 the Company entered into a memorandum of understanding whereby the outstanding Series C Preferred Shares were adjusted to 417 Series C Preferred Shares. The memorandum reduced penalties that were added after the Company refused conversions . The reduction amounted to 212.16 Series C Preferred Shares or a stated value of $254,492. In exchange, the Company agreed to proceed with the present conversion of 165 Series C Preferred shares for 13,550,625 common shares and issue 222 new Series C shares with a redemption value of $291,708 in exchange for net proceeds of $200,000.

 

on March 25, 2026, the Company issued a convertible, redeemable note to a lender for $110,000 with cash proceeds of $95,000, an original issue discount of $10,000, and $5,000 for fees. The loan bears interest at 12%, the note is redeemable by the Company at any time subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note . The note matures in 1 year and converts after 180 days at 80% of the lowest trading price 15 trading days prior to the conversion date.

 

on March 25, 2026, the Company issued a convertible, redeemable note to a lender for $630,000 with cash proceeds of $595,000, an original issue discount of $30,000, and $5,000 for fees. The loan bears interest at 12%, the note is redeemable by the Company at any time subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note. The note matures in 1 year and converts after 180 days at 20% of the lowest trading price 15 trading days prior to the conversion date. A refundable commitment fee of 14.1 million common shares was issued, but is returnable if the loan plus accrued interest is paid back by May 5, 2026. On May 5, 2026, the Company repaid in full, principal and interest of $638,492 and the 14.1 million commitment fee shares were returned.

 

on April 20, 2026, the Company issued a convertible note to a lender for $277,778 with cash proceeds of $250,000, an original issue discount of $27,778, and $5,000 for fees. The loan bears interest at 12%, and the note matures in 1 year. If the loan is prepaid, one year’s full interest of $ 33,333 is due. The note converts at any time at 75% of the lowest closing trading price 10 trading days prior to the conversion date. Interest is payable in common shares at either the redemption date or maturity. A commitment fee of 5million common shares at a fair value of $164,500 was issued.

 

on April 20, 2026, the Company issued a convertible, redeemable note to a lender for $257,000 with cash proceeds of $250,000 and $7,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The note matures on January 15, 2027, and converts after 180 days at 65% of the lowest trading price 10 trading days prior to the conversion date.

 

on May 1, 2026, the Company issued a convertible, redeemable note to a lender for $157,000 with cash proceeds of $150,000 and $7,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The note matures on January 15, 2027, and converts after 180 days at 65% of the lowest trading price 10 trading days prior to the conversion date.

 

on May 4, 2026, the Company issued a convertible, redeemable note to a lender for $700,000 with cash proceeds of $630,000 and an original issue discount of $70,000. The loan bears interest at 12%, and the note matures in 1 year. The note must be redeemed in monthly instalments of 10% of outstanding principal plus accrued interest commencing 60 days after issuance. The note is convertible after 180 days at 65% of the lowest closing trading price 10 trading days prior to the conversion date. A commitment fee of 1.25 million common shares at a fair value of $28,750 was issued.
   
 on May 29, 2026 the Company issued a promissory note to a lender for $225,000 with cash proceeds of $200,000 and an original issue discount of $25,000. The loan bears interest at 15% compounding annually, matures in 1 year and has a general security charging all of the Company’s present and after-acquired property.

 

on June 3, 2026, the Company issued a convertible, redeemable note to a lender for $230,000 with cash proceeds of $200,000 an original issue discount of $23,000 and $7,000 for fees. The loan bears interest at 6%, the note is redeemable by the Company at any time subject to a premium ranging from 105% to 140% if redeemed within the first 180 days of the note. The note matures on June 3, 2027, and converts after 180 days at 65% of the lowest trading price 20 trading days prior to the conversion date, including the conversion date.

 

F-40

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

  

May 31, 2026

  

February 28, 2026*

 
ASSETS          
Current assets:          
Cash  $94,643   $109,043 
Accounts receivable, net   974,897    1,004,201 
Device parts inventory, net   1,378,950    1,318,742 
Prepaid expenses and deposits   556,737    503,017 
Total current assets   3,005,227    2,935,003 
Operating lease asset   891,922    931,814 
Revenue earning devices, net of accumulated depreciation of $3,781,667 and $3,257,668, respectively   4,850,345    5,097,627 
Fixed assets, net of accumulated depreciation of $562,268 and $540,426, respectively   176,943    183,185 
Trademarks   36,157    35,319 
Investment at cost   100,000    100,000 
Security deposit   19,280    19,280 
Total assets  $9,079,874   $9,302,228 
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable and accrued expenses  $2,675,960   $3,007,270 
Customer deposits   127,520    147,326 
Current operating lease liability   239,242    243,690 
Current portion of deferred variable payment obligation   3,459,840    3,161,727 
Loan payable - related party   331,946    461,633 
Deferred compensation for CEO   1,990,751    1,811,856 
Current portion of loans payable, net of discount of $871,697 and $635,774   26,897,629    8,848,140 
Current portion of accrued interest payable   9,167,495    2,271,106 
Total current liabilities   44,890,383    19,952,748 
Non-current operating lease liability   643,129    676,694 
Loans payable, net   7,953,001    24,188,380 
Deferred variable payment obligation   2,525,000    2,525,000 
Incentive compensation plan payable   5,500,000    5,500,000 
Accrued interest payable   3,207,606    9,122,552 
Total liabilities   64,719,119    61,965,374 
           
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly,$1,200 stated value, 5,000 shares authorized, no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively        
Series C Convertible, Redeemable Preferred Stock. $0.001 par value; $1,200 stated value, redeemable at 109.5%, 12% dividend, 1,000 shares authorized, 354 and 417 shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively   465,465    547,941 
           
Commitments and Contingencies          
Stockholders’ deficit:          
Preferred Stock, undesignated; 15,534,000 shares authorized; no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively        
Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively        
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively   3,350    3,350 
Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,513 shares issued and outstanding, respectively   2,513    2,513 
Common Stock, $0.00001 par value; 27,500,000,000 shares authorized as of May 31, 2026 and February 28, 2026 (subsequently decreased to 12,000,000,000 shares authorized effective July 15, 2026 — see Summary of Common Stock Activity below); 388,482,589 and 267,872,804 shares issued, issuable and outstanding, respectively   3,885    2,679 
Additional paid-in capital   120,717,508    117,803,027 
Preferred stock to be issued   99,086    99,086 
Accumulated deficit   (176,931,052)   (171,121,742)
Total stockholders’ deficit   (56,104,710)   (53,211,087)
Total liabilities and stockholders’ deficit  $9,079,874   $9,302,228 

 

* Derived from audited information

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-41

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   Three Months Ended
May 31, 2026
   Three Months Ended
May 31, 2025
 
         
Revenues  $1,831,202   $1,854,837 
           
Cost of goods sold   134,183    173,381 
Depreciation and amortization   513,195    447,955 
Total Cost of Goods Sold   647,378    621,336 
           
Gross Profit   1,183,824    1,233,501 
           
Operating expenses:          
Research and development (see Note 10)   885,593    1,087,619 
General and administrative   2,907,577    3,232,211 
Depreciation and amortization   32,646    34,121 
Operating lease cost and rent   67,372    58,219 
Total operating expenses   3,893,188    4,412,170 
           
Loss from operations   (2,709,364)   (3,178,669)
           
Other expense, net:          
Interest expense   (2,298,874)   (1,415,349)
Loss on settlement of debt   (707,600)    
Total other expense, net   (3,006,474)   (1,415,349)
           
Net loss  $(5,715,838)  $(4,594,018)
           
Net loss per share - basic  $(0.02)  $(0.03)
           
Net loss per share - diluted  $(0.02)  $(0.03)
           
Weighted average common share outstanding - basic   325,956,059    155,176,712 
           
Weighted average common share outstanding - diluted   325,956,059    155,176,712 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-42

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
   Temporary Equity   Shareholder’s Deficit 
  

Series C

Preferred Stock

  

Series E

Preferred Stock

  

Series F

Preferred Stock

   Common Stock  

Additional

Paid-In

   Accumulated  

Total

Shareholders’

 
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                             
Balance at February 28, 2025   306   $402,084    3,350,000   $3,350    2,513   $101,599    144,124,538   $1,441   $106,459,528   $(156,496,930)  $(49,931,012)
                                                        
Issuance of shares, net of $121,746 issuance costs                           19,000,000    190    2,691,104        2,691,294 
Debt exchanged for common shares                           6,850,000    69    1,250,431        1,250,500 
Series C Preferred shares issued as dividend   9    12,073                            (12,073)       (12,073)
Stock based compensation                                   80,355        80,355 
Net loss                                       (4,594,018)   (4,594,018)
Balance at May 31, 2025   315   $414,157    3,350,000   $3,350    2,513   $101,599    169,974,538   $1,700   $110,469,345   $(161,090,948)  $(50,514,954)

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
   Temporary Equity   Shareholder’s Deficit 
   Series C
Preferred Stock
   Series E
Preferred Stock
   Series F
Preferred Stock
   Common Stock   Additional
Paid-In
   Accumulated   Total
Shareholders’
 
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                             
Balance at February 28, 2026   417    $547,941    3,350,000   $3,350    2,513   $101,599    267,872,804   $2,679   $117,803,027   $(171,121,742)  $(53,211,087)
                                                        
Issuance of shares, net of $77,391 issuance costs                           36,786,492    368    823,112        823,480 
Debt exchanged for common shares                           39,000,000    390    1,453,110        1,453,500 
Commitment fee issuable                           1,250,000    13    28,738        28,751 
Commitment fee issued                           5,000,000    50    173,450        173,500 
Commitment fee returnable                           14,100,000    141    (141)        
Redemption of Series C on conversion to common shares   (298)   (391,572)                   24,473,250    244    484,800    (93,472)   391,572 
Issuance of Series C shares   222    291,708                            (91,708)       (91,708)
Series C Preferred shares issued as dividend   13    17,388                            (17,388)       (17,388)
Stock based compensation                                   60,508        60,508 
Rounding shares                           43                 
Net loss                                       (5,715,838)   (5,715,838)
Balance at May 31, 2026   354   $465,465    3,350,000   $3,350    2,513   $101,599    388,482,589   $3,885   $120,717,508   $(176,931,052)  $(56,104,710)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-43

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   Three Months
Ended
May 31, 2026
   Three Months
Ended
May 31, 2025
 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(5,715,838)  $(4,594,018)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   545,841    482,076 
Bad debts expense   70,000    48,982 
Inventory provision        
Reduction of right of use asset   38,013    33,865 
Accretion of lease liability   23,281    27,428 
Stock based compensation   60,508    80,355 
Amortization of debt discounts   385,493    47,089 
Loss on settlement of debt   707,600     
Increase (decrease) in related party accrued payroll and interest   (129,687)   5,700 
Changes in operating assets and liabilities:          
Accounts receivable   (40,696)   424,655 
Prepaid expenses and deposits on inventory   (51,841)   104,498 
Deposit on right of use asset       (13,187)
Device parts inventory   (336,925)   (480,951)
Accounts payable and accrued expenses   (332,150)   524,109 
Customer deposits   (19,806)   (487)
Operating lease liability payments   (60,449)   (58,962)
Deferred compensation for CFO   178,895    (1,246,687)
Current portion of deferred variable payment obligations for payments   298,112    301,287 
Accrued interest payable   1,620,342    993,063 
Net cash used in operating activities   (2,759,307)   (3,321,185)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of fixed assets   (15,600)   (8,422)
Acquisition of trademarks   (838)   (1,298)
Net cash (used in) investing activities   (16,438)   (9,720)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Share proceeds net of issuance costs   823,480    2,839,777 
Proceeds on issuance of Series C shares   200,000     
Proceeds from loans payable   2,714,028     
Repayment of loans payable   (976,163)   (50,000)
Net cash provided by financing activities   2,761,345    2,789,777 
           
Net change in cash   (14,400)   (541,128)
           
Cash, beginning of period   109,043    865,975 
           
Cash, end of period  $94,643   $324,847 
           
Supplemental disclosure of cash and non-cash transactions:          
Cash paid for interest  $19,257   $8,910 
Cash paid for income taxes  $   $ 
           
Noncash investing and financing activities:          
Transfer from device parts inventory to fixed assets and revenue earning devices  $276,717   $917,294 
Exchange of notes payable and accrued interest for common shares  $745,900   $1,250,500 
Discount applied to face value of loan  $419,167   $ 
Conversion of Series C shares to common shares  $391,572   $ 
Series C preferred shares issued as dividend  $17,388   $12,073 
Commitment fee shares as debt discount  $202,050   $ 
Right of use asset for lease liability  $   $53,739 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-44

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

1. GENERAL INFORMATION

 

Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

 

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.

 

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

 

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

 

2. GOING CONCERN

 

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

For the three months ended May 31, 2026, the Company had negative cash flow from operating activities of $2,759,307. As of May 31, 2026, the Company has an accumulated deficit of $176,931,052, and negative working capital of $41,885,156. Management does not anticipate having positive cash flow from operations in the near future. These factors raise a substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

 

The Company does not have the resources currently to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:

 

Management is committed to raising funds . There is no assurance that management will be able to raise funds nor can we provide assurance that these possible raises may not have dilutive effects. On June 23, 2026, the Company entered into an equity financing agreement whereby an investor will purchase up to $10,000,000 of the Company’s common stock at a discount over a three-year period. There still remains $10 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways: growing revenues, through equity proceeds, and issuing debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.

 

F-45

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

3. ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 9, 2026. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., and Robotic Assistance Devices Residential, Inc., and Robotic Assistance Devices Lanka (Private) Limited. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three months ended May 31, 2026, are not necessarily indicative of the results that may be expected for the entire year.

 

Use of Estimates

 

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments used in debt settlements, amendments and extensions.

 

Reclassifications

 

Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.

 

Concentrations

 

Loans payable

 

At May 31, 2026 there were $35,722,326 of loans payable, $32,466,506 or 91% of these loans to companies controlled by one individual. At February 28, 2026 there were $33,672,294 loans payable, $32,178,506 or 96% of these loans to companies controlled by one individual.

Cash

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

 

Accounts Receivable

 

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $240,000 and $170,000 provided as of May 31, 2026, and February 28, 2026, respectively. For the three months ending May 31, 2026, two customers account for 23% of total accounts receivable. For the three months ending May 31, 2025, three customers account for 53% of total accounts receivable

 

Device Parts Inventory

 

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of May 31, 2026, and February 28, 2026, there was a valuation reserve of $175,000 and $175,000, respectively.

 

F-46

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Revenue Earning Devices

 

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

 

Fixed Assets

 

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

 

Computer equipment and software   2 or 3 years
Office equipment   4 years
Manufacturing equipment   7 years
Warehouse equipment   5 years
Tooling   2 years
Demo Devices   4 years
Vehicles   3 years
Leasehold improvements   5 years, the life of the lease

 

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

 

Research and Development

 

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At May 31, 2026 and February 28, 2026, the Company had no deferred development costs.

 

Contingencies

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

Sales of Future Revenues

 

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

 

F-47

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

  Does the agreement purport, in substance, to be a sale
  Does the Company have continuing involvement in the generation of cash flows due to the investor
  Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets
  Is the investors rate of return is implicitly limited by the terms of the agreement
  Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return
  Does the investor have recourse relating to payments due

 

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

 

Revenue Recognition

 

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the three months ended May 31, 2026, two customers accounted for 36% of total revenue and for the three months ended May 31, 2025, two customers accounted for 65% of total revenue.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2027, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements.

 

Leases

 

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

 

F-48

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

 

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

 

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

F-49

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

  Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
     
  Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
     
  Level 3 – Inputs that are unobservable for the asset or liability.

 

Measured on a Recurring Basis

 

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

 

   Amount at   Fair Value Measurement Using 
   Fair Value   Level 1   Level 2   Level 3 
May 31, 2026                    
Assets                    
Investment at cost  $100,000   $50,000   $   $50,000 
Liabilities                    
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares  $5,500,000   $   $   $5,500,000 
                     
February 28, 2026                    
Assets                    
Investment at cost  $100,000   $50,000   $   $50,000 
Liabilities                    
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares  $5,500,000   $   $   $5,500,000 

 

For the incentive compensation plan referred to above , the Company recorded stock based compensation of $0 and $0 for the three months ended May 31, 2026 and May 31, 2025 with corresponding adjustments to incentive compensation plan payable.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

 

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

 

Recently Adopted Accounting Pronouncements

 

ASU 2023-07 – Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments require enhanced disclosures about significant segment expenses and other segment items, require disclosure of the title and position of the chief operating decision maker (“CODM”), explain how the CODM uses reported measures of segment profit or loss to assess performance and allocate resources, and expand interim disclosure requirements. The amendments apply to entities with a single reportable segment as well as entities with multiple reportable segments.

 

F-50

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

The Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, during fiscal 2025. The standard requires enhanced disclosures regarding segment expenses and CODM information and applies to entities with a single reportable segment. Adoption of the standard impacted the Company’s segment reporting disclosures only and did not affect its consolidated financial position, results of operations, or cash flows.

 

Recently issued accounting pronouncement not yet effective

 

ASU 2024-04—Debt with Conversion and Other Options (Topic 470-20): Induced Conversions of Convertible Debt Instruments

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments. The amendments clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions or as debt extinguishments. Under the amended guidance, an induced conversion requires that the inducement offer provide the holder, at a minimum, the consideration issuable under the existing conversion privileges of the instrument.

 

The amendments are effective for annual reporting periods beginning after December 15, 2025, including interim reporting periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements and related disclosures.

 

ASU 2025-05—Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets

 

In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments refine the guidance in ASC 326 related to the measurement of expected credit losses for accounts receivable and contract assets arising from revenue transactions accounted for under ASC 606. The update clarifies the application of the current expected credit loss (“CECL”) model to such assets, including the use of practical expedients and considerations in estimating expected credit losses over the contractual term of the asset.

 

The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-05 on its consolidated financial statements and related disclosures.

 

4. REVENUE FROM CONTRACTS WITH CUSTOMERS

 

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

 

As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

 

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

   Three Months Ended
May 31, 2026
   Three Months Ended
May 31, 2025
 
Device rental activities  $1,613,095   $1,627,286 
Direct sales of goods and services   218,107    227,551 
Revenue  $1,831,202   $1,854,837 

 

F-51

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

5. LEASES

 

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

 

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

 

Below is a summary of our lease assets and liabilities at May 31, 2026 and February 28, 2026.

 

Leases  Classification 

May 31, 2026

  

February 28, 2026

 
Assets             
Operating  Operating Lease Assets  $891,922   $931,814 
Liabilities             
Current             
Operating  Current Operating Lease Liability  $239,242   $243,690 
Noncurrent             
Operating  Noncurrent Operating Lease Liabilities   643,129    676,694 
Total lease liabilities     $882,371   $920,384 

 

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

 

Operating lease cost and rent was $67,372 and $58,219 for the three months ended May 31, 2026 and May 31, 2025, respectively.

 

6. INVESTMENT

 

On December 23, 2022 the Company entered into a Simple Agreement for Future Equity (SAFE) contract to invest $50,000 to acquire shares of a company’s capital stock at a discount. On June 3, 2024 the Company acquired a $50,000 convertible note receivable from Nightingale Intelligent Systems, Inc., a private Delaware corporation that provides unmanned aerial vehicles (UAV) for commercial applications. On January 3, 2025 the Company exchanged it’s convertible note receivable for : 1,770,840 Series A preferred shares, 15,000 common shares and 165,000 common share warrants. On February 28, 2025, there was a 10 :1 split. The Company now holds 177,084 Series A preferred shares, 1,500 common shares and 16,500 common share warrants (at a strike price of $0.80/share). The Company values the Nightingale Intelligent Systems, Inc.’s shares and warrants at $50,000 bringing total investments at cost to $100,000 at May 31, 2026 and February 28, 2026.

 

7. REVENUE EARNING DEVICES

 

Revenue earning devices consisted of the following:

 

   May 31, 2026   February 28, 2026 
Revenue earning devices  $8,632,012   $8,355,295 
Less: Accumulated depreciation   (3,781,667)   (3,257,668)
Total  $4,850,345   $5,097,627 

 

During the three months ended May 31, 2026, the Company made total additions to revenue earning devices of $276,717 which were transfers from inventory. During the three months ended May 31, 2025, the Company made total additions to revenue earning devices of $895,547 which were transfers from inventory

 

Depreciation and amortization for the years ended May 31, 2026, and May 31, 2025, are as follows:

 

Depreciation and Amortization RED 

Three Months

Ended

May 31 2026

  

Three Months

Ended

May 31, 2025

 
         
Cost of Goods Sold  $513,195   $447,955 
Operating expenses   10,804    4,104 
Total Depreciation and Amortization RED  $523,999   $452,059 

 

F-52

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

8. FIXED ASSETS

 

Fixed assets consisted of the following:

  

   May 31, 2026   February 28, 2026 
Automobile  $74,237   $74,237 
Demo devices   265,421    265,421 
Tooling   122,620    107,020 
Machinery and equipment   17,246    17,246 
Computer equipment   157,448    157,448 
Office equipment   15,312    15,312 
Furniture and fixtures   21,225    21,225 
Warehouse equipment   38,746    38,746 
Leasehold improvements   26,956    26,956 
Fixed assets gross   739,211    723,611 
Less: Accumulated depreciation   (562,268)   (540,426)
Fixed assets, net of accumulated depreciation  $176,943   $183,185 

 

During the three months ending May 31, 2026, the Company made additions of $15,600. During the three months ending May 31, 2025, the Company made additions of $46,071 of which $22,347 were transfers from inventory with remaining additions of $23,724.

 

Depreciation and amortization for the years ended May 31, 2026, and May 31, 2025, are as follows:

Depreciation and Amortization 

Three Months Ended

May 31 2026

   Three Months Ended
May 31, 2025
 
         
Fixed assets  $21,842   $30,017 
Revenue earning devices   10,804    4,104 
Total Depreciation and Amortization included in operating expenses  $32,646   $34,121 

 

9. DEFERRED VARIABLE PAYMENT OBLIGATION

 

On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

 

On May 9, 2019 the Company entered into two similar arrangements with two investors:

 

  (1) The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.
     
  (2) The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

 

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

 

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

 

F-53

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

 

On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

 

On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.

 

On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

 

On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets, but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.

 

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below, this aggregate asset disposition % was reduced from 43.77 % to 33.77%.

 

The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of May 31, 2026, the Company has accrued $3,459,840 in Payments of which $2,202,545 are in arrears. As of February 28, 2026, the Company has accrued approximately $3,161,727 in Payments, of which $1,901,259 is in arrears. No notices have been received by the Company. The Company has recorded cumulative interest of 6% interest totaling $204,427 commencing this quarter, on the balance in arrears, and will continue to adjust quarterly.

 

On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

 

  1) The rate payment was reduced from 14.25 % to 9.65 %
  2) The asset disposition % (see below) was reduced from 31 % to 21%

 

F-54

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

 

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of May 31, 2026, and February 28, 2026, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

 

For both the three months ended May 31, 2026, and year ended February 28, 2026, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both May 31, 2026 and February 28, 2026.

 

10. RELATED PARTY TRANSACTIONS

 

For both the three months ended May 31, 2026, and May 31, 2025, the Company had repayments of net advances of $129,687 and $0, respectively. At May 31, 2026, the loan payable-related party was $331,946 and $461,633 at February 28, 2026. Included in the balance due to the related party at May 31, 2026, is $255,414 of deferred salary and interest, $157,513 of which bears interest at 12%. As of February 28, 2026, included in the balance due to the related party is $285,638 of deferred salary all of which bears interest at 12%. The accrued interest included in the loan at May 31, 2026, and February 28, 2026, was $84,956, and $79,268, respectively.

 

During the three months ended May 31, 2026, the Company paid out gross payments to the CEO of $71,105 offset by a bonus accrual of $250,000, which yields a net change of $178,895 relating to deferred compensation for CEO. This was all in accordance with a December 2023 board action allowing for $1 million of annual discretionary compensation as well as a February 28, 2026, board action which provided an additional $1.5 million in compensation. During the three months ended May 31, 2025, the Company paid out gross payments to the CEO of $1,496,687 offset by a bonus accrual of $250,000, which yielded a net change of $1,246,687 relating to deferred compensation for CEO. The balance of deferred compensation for CEO was $1,990,751 and $1,811,856 at May 31, 2026, and February 28, 2026, respectively

 

For the three months ended May 31, 2026, the Company accrued $0 (three months ended May 31, 2025-$0) of incentive compensation plan payable to the CEO. This will be payable in Series G Preferred Shares, which are redeemable at the Company’s option at $1,000 per share. On May 31, 2026, and February 28, 2026, there was $5,500,000 and $5,500,000 incentive compensation payable.

 

During the three months ended May 31, 2026, and 2025, the Company was charged $390,130 and $736,875, respectively for fees for research and development from a company partially owned by a principal shareholder. The principal shareholder received no compensation from this partially owned research and development company, and the fees were spent on core development projects. As at May 31, 2026, and February 28, 2026, the balance due to this company was $76,532 and $160,557, respectively.

 

F-55

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

11. LOANS PAYABLE

 

Loans payable at May 31, 2026 consisted of the following:

 

Date  Maturity  Description  Principal   Interest Rate 
July 18, 2016  July 18, 2017  Promissory note (1)* $3,500    22%
December 10, 2020  March 1, 2027  Promissory note (2)  3,921,168    A12%
December 10, 2020  March 1, 2027  Promissory note (3)  2,754,338    A12%
December 14, 2020  March 1, 2027  Promissory note (5)  310,375    12%
December 30, 2020  March 1, 2027  Promissory note (6)  350,000    A 12%
January 1, 2021  March 1, 2027  Promissory note (7)  25,000    12%
January 1, 2021  March 1, 2027  Promissory note (8)  145,000    12%
January 14, 2021  March 1, 2027  Promissory note (9)  237,500    A 12%
February 22, 2021  March 1, 2027  Promissory note (10)  1,650,000    12%
March 1, 2021  March 1, 2027  Promissory note (11)  6,000,000    12%
June 8, 2021  June 8, 2027  Promissory note (12)  2,750,000    12%
September 14, 2021  September 14, 2027  Promissory note (14)  1,650,000    A 12%
July 28, 2022  March 1, 2027  Promissory note (15)  170,000    15%
August 30, 2022  August 30,2027  Promissory note (16)  3,000,000    A 15%
September 7, 2022  March 1, 2027  Promissory note (17)  400,000    15%
September 8, 2022  March 1, 2027  Promissory note (18)  475,000    15%
October 13, 2022  March 1, 2027  Promissory note (19)  350,000    15%
October 28, 2022  October 31, 2026  Promissory note (20)  293,000    A 15%
November 9, 2022  October 31, 2026  Promissory note (20)  400,000    A 15%
November 10, 2022  October 31, 2026  Promissory note (20)  400,000    A 15%
November 15, 2022  October 31, 2026  Promissory note (20)  400,000    A 15%
January 11, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
February 6, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
April 5. 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
April 20, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
May 11, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
October 27, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
November 30, 2023  April 30, 2027  Purchase Agreement (21)  203,000    15%
March 8, 2024  August 8, 2027  Purchase Agreement (22)  350,000    15%
July 26, 2025  July 26, 2026  Promissory note (23)  165,000    C 15%
August 7,2025  August 7,2026  Promissory note (24)  245,000    C 15%
August 25, 2025  August 25, 2026  Promissory note (25)  137,500    C 15%
August 25, 2025  May 6, 2026  Future Receivables Purchase and Sale Agreement (26)      108%
September 25, 2025  September 25, 2026  Promissory note (27)  550,000    C 15%
October 30. 2025  October 30. 2026  Promissory note (28)  200,000    C 15%
November 6, 2025  November 6, 2026  Promissory note (29)  275,000    C 15%
November 24, 2025  November 24, 2026  Promissory note (30)  450,000    C 15%
December 9, 2025  December 9, 2026  Promissory note (31)  450,000    C 15%
December 17, 2025  September 23, 2026  Business loan (32)      65%
December 22, 2025  December 22, 2026  Convertible note (33)  495,000    12%
December 27, 2025  December 27, 2026  Promissory note (34)  275,000    C 15%
January 12, 2026  January 12, 2027  Promissory note (35)  330,000    C 15%
January 27, 2026  January 27, 2027  Promissory note (36)  170,000    C15%
February 2, 2026  February 2, 2027  Promissory note (37)  330,000    C15%
February 19, 2026  February 19, 2027  Convertible note (38)  165,000    12%
February 24, 2026  February 24, 2027  Promissory note (39)  170,000    C15%
March 16, 2026  March 16, 2027  Promissory note (13)  170,000    C15 %
March 25, 2026  March 25, 2027  Convertible note (40)  110,000    12%
March 25, 2026  March 25, 2026  Convertible note (41)      12%
April 9, 2026  January 15, 2027  Convertible note (42)  257,000    10%
April 13, 2026  April 13, 2027  Future Receivables Purchase and Sale Agreement (43)  641,279    NA 
April 20, 2026  April 20, 2027  Convertible note (44)  277,778    12%
May 1, 2026  January 15, 2027  Convertible note (45)  157,000    10%
May 4, 2026  May 4, 2027  Convertible Note (46)  700,000    12%
May 28 2026  May 28 2026  Convertible Note (47)  138,889    12%
May 29, 2026  May 29, 2027  Promissory note (4)  225,000    C15%
         $35,722,327      
                 
Less: current portion of loans payable      (27,769,326)     
Less: discount on non-current loans payable   -      
Non-current loans payable, net of discount     $7,953,001      
                 
Current portion of loans payable     $27,769,326      
Less: discount on current portion of loans payable      (871,697)     
Current portion of loans payable, net of discount     $26,897,629     

 

* In default
AOn June 15, 2026 the Company and lender entered into a Loan Amendment Agreement whereby it was agreed that simple interest was to be calculated from the loan issuance date through to February 28, 2026 and commencing March 1, 2026 compounded on the respective principal and interest balance at February 28, 2026.
CCompounding annually
(1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.

 

F-56

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(2) This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On December 10, 2025 an exchange agreement was made whereby principal and interest of this note may be exchanged for common shares at 90% of the 5 days’ lowest bid of shares. For the three months ending May 31, 2026 the company exchanged $336,000 accrued interest for 14,000,000 common shares at a fair value of $910,700 with a loss on settlement of $574,700.
   
(3) This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. On February 8, 2026, the holder exchanged $192,000 in accrued interest for 8,000,000 common shares at fair value of $320,000 with a loss on settlement of $128,000.
   
(4) Original $225,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $115, with an unamortized discount of $24,885 at May 31, 2026.
   
(5) This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. On December 14, 2023, the parties extended the maturity date from December 14, 2023 date to March 1, 2027.
   
(6) The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized.
   
(7) This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(8) This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(9) The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024, to March 1, 2025, with all other terms and Conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized. Through an exchange agreement on February 11, 2025, the Company repaid $162,000 in principal st through the issuance of 600,000 common shares. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. On March 5, 2025 the Company repaid $150,500 in loan principal as well as $275,000 in accrued interest (all totaling $425,500) was repaid on March 5, 2025 through the issuance of 1,850,000 common shares at a fair value of $444,000 with a loss on settlement of $18,500.

 

F-57

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(10) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022, to February 22, 2024, on February 28, 2022, in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. For the three months ending May 31, 2026, the Company exchanged $80,000 of accrued interest for 5,000,000 common at a fair value of $100,000 with a loss on settlement of $20,000.
   
(11) The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. For the year ended February 28, 2026, the Company has issued 36,500,000 common shares at fair market value of $4,365,500 to repay $3,840,500 in accrued interest with a loss on settlement of debt of $525,000.
   
(12) The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. The loan is fully amortized. On April 16, 2025, the parties again extended the maturity date from June 8, 2025, to June 8, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of price the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. For the year ended February 28, 2026 the holder exchanged $1,416,000 in accrued interest for 25,000,000 common shares at a fair value of $1,680,000 with a loss on settlement of $264,000.
   
(13) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $3,680, with an unamortized discount of $16,320 at May 31, 2026.
   
(14) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $2,455, with an unamortized discount of $13,870 at May 31, 2026. On April 16, 2025, the parties again extended the maturity date from September 14, 2025, to September 14, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(15) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(16) A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. On April 16, 2025, the parties again extended the maturity date from August 30, 2025, to August 30, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(17) Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

 

F-58

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(18) Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(19) Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(20) On October 28, 2022, the Company entered into as secured loan agreement with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of this secured loan agreement into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:
   
  October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,243, with an unamortized discount of $9,185 at May 31, 2026.For the three months ending May 31, 2026, the Company exchanged $107,000 of principal and $222,900 of accrued interest totaling $329,900 for 20,000,000 common at a fair value of $442,800 with a loss on settlement of $112,900.
   
  November 9, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,269, with an unamortized discount of 9,233 at May 31, 2026.

 

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,288, with an unamortized discount of $8,957at May 31, 2026.

 

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,528, with an unamortized discount of $8,927 at May 31, 2026.

 

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,269, with an unamortized discount of $9,233 at May 31, 2026.

 

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,288, with an unamortized discount of $9,268 at May 31, 2026.

 

F-59

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,302, with an unamortized discount of $9,293 at May 31, 2026.

 

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,343, with an unamortized discount of $9,368 at May 31, 2026.

 

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained For the three months ended May 31, 2026, the Company recorded amortization expense of $5,480, with an unamortized discount of $9,616 at May 31, 2026.

 

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with six a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,325, with an unamortized discount of $9,333 at May 31, 2026.

 

(21) On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed April through to August 2024 payments in agreement with the lender. The Company have missed the subsequent monthly payments. On April 16, 2025, the parties extended the maturity date from April 30, 2025, to April 30, 2026, with all other terms and conditions remaining the same. On April 30,2026, the parties extended the maturity to April 30, 2027, with the default rate still applicable after April 30, 2025.
   
(22) On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 8, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The August 2024 through to August 2025 payments have not been made and the note was not repaid at original maturity. On August 8, 2025 the parties extended the maturity to August 8, 2027 , with the default rate still applicable after August 8, 2025.
   
(23) Original $165,000 note may be pre-payable at any time. The note balance includes an original issue discount of $15,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(24) Original $245,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(25) Original $137,500 note may be pre-payable at any time. The note balance includes an original issue discount of $12,500. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(26) On August 25, 2025, the Company entered into Future Receivables Purchase and Sale Agreement secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $555,671 after fees of $29,329 and a financing fee of $222,300 for total fees of $251,629. The Company must repay $807,300, in weekly payments of 7% of estimated receipts from accounts receivables. The estimated monthly payments will be approximately $99,725. For the year ended May 31, 2026, the Company recorded amortization expense of $59,207, with an unamortized discount of $0 at May 31, 2026. For the year ended February 28, 2026, the Company has repaid $617,348. During the three months ending May 31, 2026 the remaining balance of $ 189,952 was fully repaid.
   
(27) Original $550,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $12,724, with an unamortized discount of $17,288 at May 31, 2026.
   
(28) Original $200,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $6,158, with an unamortized discount of $11,127 at May 31, 2026.
   
(29) Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $6,189, with an unamortized discount of $11,582 at May 31, 2026.
   
(30) Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $10,760, with an unamortized discount of $28,536 at May 31, 2026.

 

F-60

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(31)

 

Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $11,888, with an unamortized discount of $27,702 at May 31, 2026.
   
(32) On December 17, 2025, the Company entered into a business loan secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $300,000 after fees of $14,000 and a financing fee of $91,060 for total fees of $105,060. The Company must repay $405,060, in 4 weekly payments of $2,276.50 and 36 weekly payments of $10,998.72. The loan is personally guaranteed by the CEO. For the year ended February 28, 2026, the Company recorded amortization expense of $19,478 with an unamortized discount of $85,582 at February 28, 2026. For the three months ended May 31, 2026, the Company has repaid $87,990 with the balance of $241,972 transferred to the April 13, 2026 loan described in footnote (43),thereby fully extinguishing this loan.
   
(33) $495,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $440,000, with fees of $10,000 and an original issue discount of $45,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $13,062, with an unamortized discount of $32,233 at May 31, 2026. . After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.
   
(34) Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,908, with an unamortized discount of $14,970 at May 31, 2026.
   
(35) Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,019, with an unamortized discount of $19,117 at May 31, 2026.
   
(36) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $4,594, with an unamortized discount of $13,637 at May 31, 2026.
   
(37)

Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,059, with an unamortized discount of $21,078 at May 31, 2026.

   
(38) $165,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $142,500, with fees of $7,500 and an original issue discount of $15,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,167, with an unamortized discount of $16,849 at May 31, 2026. After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.
   
(39)

Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $4,555, with an unamortized discount of $15,257 at May 31, 2026.

   
(40) $110,000 convertible note that may be redeemed subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note. The Company received proceeds of $95,000, with fees of $5,000 and an original issue discount of $10,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $2,429, with an unamortized discount of $12,571 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.

 

F-61

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(41) $630,000 convertible note that may be redeemed subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note. The Company received proceeds of $595,000, with fees of $5,000 and an original issue discount of $30,000. Principal and interest due at maturity. A refundable commitment fee of 14.1 million common shares was issued, but is returnable if the loan plus accrued interest is paid back by May 5, 2026. The loan was intended as a short term loan with high redemption premiums commencing after 40 days and high conversion discounts after 180 days whereby the note would convert at 20% of the lowest traded price 15 days prior trading to the conversion date. On May 5, 2026, the Company repaid in full, principal and interest of $638,492 and the 14.1 million commitment fee shares will be returned.. For the three months ended May 31, 2026, the Company recorded amortization expense of $35,000, with an unamortized discount of $0 at May 31, 2026.
   
(42) $257,000 convertible note that may be redeemed subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The Company received proceeds of $250,000, with fees of $7,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,000, with an unamortized discount of $0 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest closing traded price in the 10 prior trading days.
   
(43) On April 13, 2026, the Company entered into a business loan secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $295,028 after fees of $16,500 and a financing fee of $91,060 for total fees of $105,060 and a payback of the $241,972 balance on the December 17, loan described in footnote (32) . The Company must repay $709,500, in 52 weekly payments of $13,644. The loan is personally guaranteed by the CEO. For the three months ended May 31, 2026, the Company recorded amortization expense of $16,587 with an unamortized discount of $155,913 at February 28, 2026. For the three months ended May 31, 2026, the Company has repaid $68,221.
   
(44) $277,778 convertible note that may be redeemed anytime with payment of the first year’s accrued interest of $33,333. The Company received proceeds of $245,000, with fees of $5,000 and an original issue discount of $27,778. In addition a commitment fee of 5,000,000 common shares having a fair value of $173,500 was issued and added as a discount. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $10,072, with an unamortized discount of $196,206 at May 31, 2026. The note and interest is convertible at any time a conversion price of 75% of the lowest closing traded price in the 10 prior trading days.
   
(45) $157,000 convertible note that may be redeemed subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The Company received proceeds of $150,000, with fees of $7,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,000, with an unamortized discount of $0 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest closing traded price in the 10 prior trading days.
   
(46) $700,000 convertible note redeemable 90 days after issuance in monthly installments of 10% of the outstanding principal and interest. The Company received proceeds of $615,000, with fees of $15,000 and an original issue discount of $70,000. In addition a commitment fee of 1,250,000 common shares having a fair value of $28,751 was issued and recorded as a discount. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,185, with an unamortized discount of $105,565 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest traded price in the 10 prior trading days.

 

(47) $138,889 convertible note that may be redeemed subject to a premium ranging from 110% to 135% if redeemed within the first 180 days of the note. The Company received proceeds of $119,000, with fees of $6,000 and an original issue discount of $13,889.. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $762, with an unamortized discount of $19,127 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest traded price in the 10 prior trading days.

 

F-62

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

12. STOCKHOLDERS’ EQUITY (DEFICIT)

 STOCKHOLDERS’ DEFICIT

Summary or Preferred Stock Activity

 

Series C Convertible, Redeemable Preferred Stock (Temporary Equity)

 

On February 10, 2025, in connection with a Share Purchase Agreement the Company created a new class of Series C Convertible Redeemable with 1,000 authorized shares.

 

In exchange for 306 Series C Convertible Redeemable Preferred Shares (“Series C”), the Company received gross proceeds of $306,000 with net proceeds of $278,580 after paying $6,000 in legal fees and $21,420 in broker fees both charged against paid in capital. The Company must redeem the shares at stated capital of 1,200 per share and a 1.095 premium at 180 days after issuance. The Company recorded the 306 outstanding shares at its redemption value of $402,084 at February 28, 2025, with the offsetting adjustment to paid in capital. During the year the Company issued 12% quarterly dividends in 44 Series C shares with a value of $58,100. The Company failed to redeem the Series C shares on the August 9, 2025, redemption date and a penalty of 114 Series C shares with a value of $149,307 was recorded. In August 2025 the Company redeemed 95 Series C shares for $125,000 including a deemed dividend of $29,871. In September 2025 the Company failed to convert a conversion notice of 96 shares. This conversion was withdrawn in December 2025 and a new conversion for 85 Series C shares with a value of $111,690 including a dividend of $84,690 with a corresponding adjustment to paid in capital. In exchange for the converted Series C shares, the Company issued 1,994,464 common shares. In January 2026, the Company failed to convert a conversion notice of 80 shares. On March 19, 2026 the Company entered into an agreement with the investor whereby the parties agreed to reduce the penalty on the September 2025 and January 2026 failed conversion to 133 Series C shares at a value of $175,140 ( The penalty was reduced from 345 Series C shares to 133 Series C shares) . The parties agreed on the Series C share balance at February 28, 2026 to be 417 series C shares. In addition, the parties agreed to issue an additional 222 Series C shares for proceeds of $200,000 and fees of $22,000. These shares have a redemption value of $291,708. Also on March 19, 2026, the parties agreed to convert 165 Series C shares at a value of $216,810 for 13,550,625 common shares. The shareholder also converted 40 shares at a value of $52,560 for 3,285,000 common shares on May 6, 2026, and 93 shares at a value of $122,202 for 7,637,628 common shares on May 12, 2026. During the quarter, a dividend of 13 Series C shares having a value of $ $17,388 were accrued. At May 31, 2026, there were 354 outstanding series C shares with a redemption value of $465,465. Ay February 28, 2026, there were 417 outstanding series C shares with a redemption value of $547,941.

 

Series F Convertible Preferred Stock

 

Each holder of Series F Convertible Preferred Shares may, at any time and from time to time convert all, but not less than all, of their shares into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis.

 

Summary of Preferred Stock Warrant Activity

   Number of Series F Preferred Warrants  

Weighted

Average Exercise Price

  

Weighted

Average Remaining Years

 
Outstanding at February 28, 2026   939   $1.00    7.5 
Issued            
Exercised            
Forfeited and cancelled            
Outstanding at May 31, 2026   939   $1.00    7.25 

 

F-63

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Summary of Common Stock Activity

 

For the three months ended May 31, 2026:

 

- On March 19, 2026, the Board of Directors and the holder of a majority of the Company’s voting power approved, by written consent, a decrease in the Company’s authorized common shares from 27,500,000,000 to 12,000,000,000. The Certificate of Amendment effecting this decrease was not filed with, or accepted by, the Nevada Secretary of State until July 15, 2026, on which date the decrease became effective. As of May 31, 2026 and continuing through the filing date of the Company’s original Quarterly Report on Form 10-Q for the quarter ended May 31, 2026, the Company’s authorized common shares remained 27,500,000,000.

 

- On February 5, 2026, the holders of a majority of the voting power of the Company’s outstanding voting securities executed the written consent approving a reverse stock split of the Company’s issued and outstanding Common Stock at a ratio of 1-for-100. This split was deemed effective on March 12, 2026. The common shares have been adjusted to reflect this reverse stock split.

 

- the Company issued 36,784,492 common shares with gross proceeds of $900,871 and net proceeds of $823,480 after issuance costs of $77,391.

 

- the Company issued 39,000,000 common shares having a fair value of $1,453,500 to repay $107,000 in loans payable and $638,900 in accrued interest totaling $745,900 with a loss on settlement of debt of $707,600.

 

-Along with the $630,000 loan of March 25, 2026, a refundable commitment fee of 14,100,000 shares was issued. These shares are refundable if the loan was fully repaid by May 5, 2026, and it was. The shares were recorded at par value of $141 with a corresponding adjustment to paid in capital.

 

-Along with the $277,778 loan of April 20, 2026, a commitment fee of 5,000,000 common shares having a fair value of $173,500 was issued and recorded as a discount.

 

-Along with the $700,000 loan of May 4, 2026, a commitment fee of 1,250,000 common shares having a fair value of $28,751 is issuable and recorded as a discount. These shares will be issued shortly after filing this 10Q.

 

-During the quarter ended March 31, 2026, the Series C Preferred shareholder converted 298 Series C Preferred Shares having a value of $391,572 for 24,473,250 common shares with a deemed dividend of $93,472.

 

The common shares issued , issuable and outstanding at May 31,2026 and February 28, 2026:

Common shares  May 31, 2026   February 28, 2026 
Issued   387,232,589    267,872,804 
Issuable   1,250,000    - 
           
Issued, issuable and outstanding   388,482,589    267,872,804 

 

Summary of Common Stock Warrant Activity

 

For the three months ending May 31, 2026, and May 31, 2025, the Company recorded a total of $60,508 and $80,355 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.

   Number of
Warrants
   Weighted Average
Exercise Price
   Weighted Average
Remaining Years
 
Outstanding at February 28, 2026   470,000   $0.04    1.44 
Issued            
Exercised            
Forfeited and cancelled            
Outstanding at May 31, 2026   470,000   $0.02    1.19 

 

F-64

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Summary of Common Stock Option Activity -Employee Stock Options

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Years 
Outstanding at March 1, 2026   1,732,121   $2.00    2.10 
Issued            
Exercised            
Forfeited, extinguished and cancelled      $     
Outstanding at May 31, 2026   1,732,121   $2.00    1.85 

 

13. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

The related legal costs are expensed as incurred.

 

Operating Lease

 

On March 10, 2021, the Company entered into a 10 year lease agreement for a manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

 

On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.

 

On March 11, 2025, the Company entered into a 3-year lease agreement for a vehicle commencing March 11, 2025 through to March 11, 2028 with a minimum base rent of $1,286 per month. The Company paid a down payment of $13,188. The Company recorded the right of use asset of $67,372 with a corresponding adjustment to operating lease liability.

 

The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. The weighted average discount rate used was 10% and the weighted average remaining lease term at May 31, 2026 was 4.71 years.

 

Rent expense and operating lease cost was $67,372 and $58,219 for the three months ended May 31, 2026 and May 31, 2025, respectively.

Maturity of Lease Liabilities  Operating
Leases
 
May 31, 2027  $239,243 
May 31, 2028   222,427 
May 31, 2029   207,558 
May 31, 2030   207,558 
May 31, 2031   190,261 
Total lease payments   1,067,047 
Less: Interest   (184,676)
Present value of lease liabilities  $882,371 

 

14. EARNINGS (LOSS) PER SHARE

 

The net income (loss) per common share amounts were determined as follows:

   May 31, 2026   May 31, 2025 
   For the Three Months Ended 
   May 31, 2026   May 31, 2025 
Numerator:          
Net loss available to common shareholders  $(5,715,838)  $(4,594,018)
           
Effect of common stock equivalents          
Less: dividends to C preferred shareholders   (110,860)   (12,073)
Net loss adjusted for common stock equivalents   (5,826,698)   (4,606,091)
           
Denominator:          
Weighted average shares – basic   325,956,059    155,176,712 
           
Net loss per share – basic  $(0.02)  $(0.03)
           
Denominator:          
Weighted average shares – diluted   325,956,059    155,176,712 
           
Net loss per share – diluted  $(0.02)  $(0.03)

 

F-65

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

The anti-dilutive shares of common stock equivalents for the three months ended May 31, 2026 and 2025 were as follows:

   May 31, 2026   May 31, 2025 
   For the Three Months Ended 
   May 31, 2026   May 31, 2025 
Convertible or exchangeable debt   3,173,350,733    - 
Convertible Series F Preferred Shares   1,340,264,933    586,412,155 
Convertible Redeemable Series C Preferred Shares   30,948,471    2,958,264 
Stock options and warrants   2,202,121    2,261,775 
Total   4,546,766,258    591,632,194 

 

15. SUBSEQUENT EVENTS

 

Subsequent to May 31, 2026 through to filing date,

 

  the Company issued 32,797,611 common shares pursuant to a share purchase agreement for gross proceeds of $290,783, issuance costs of $14,397 and net proceeds of $276,386.
     
  The Company issued 12,000,000 shares to a lender to settle $89,700 in principal pursuant to exchange agreements with the lender.
     
  on June 3, 2026, the Company issued a convertible, redeemable note to a lender for $230,000 with cash proceeds of $200,000 an original issue discount of $23,000 and $7,000 for fees. The loan bears interest at 6%, the note is redeemable by the Company at any time subject to a premium ranging from 105% to 140% if redeemed within the first 180 days of the note. The note matures on June 3, 2027, and converts after 180 days at 65% of the lowest trading price 20 trading days prior to the conversion date, including the conversion date.
     
  on June 9, 2026, the Company issued a convertible, redeemable note to a lender for $55,000 with cash proceeds of $47,500, an original issue discount of $5,000, and $2,500 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium of one years interest of $5,500. The note matures on June 9, 2027, and converts any time at 65% of the lowest trading price 10 trading days prior to the conversion date.
     
 

on June 9, 2026, the Company issued a convertible, redeemable note to a lender for $110,000 with cash proceeds of $95,000, an original issue discount of $10,000, and $5,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium of one years interest of $11,000. The note matures on June 9, 2027, and converts any time at 65% of the lowest trading price 10 trading days prior to the conversion date.

     
  on June 15, 2026, the Company issued a convertible, redeemable note to a lender for $165,000 with cash proceeds of $142,800, an original issue discount of $15,000, and $7,200 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 115% to 125% if redeemed within the first 180 days of the note. The note matures on June 15, 2027, and converts any time at 65% of the lowest closing bid price 20 trading days prior to the conversion date. The loan is repayable as follows : on December 15, 2026 a payment of $90,750 with 5 monthly payments of $15,125 commencing Jan 15, 2027 through to May 15, 2027 with the remaining $9,625 balance payable June 15, 2027.
     
  on June 23 , 2026 the Company entered into an Equity Financing Agreement whereby an investor shall invest up to $10,000,000 over the course of thirty-six (36) month at a purchase price of eighty-five percent (85%) of the average of the three lowest bid trade price in the 10 day preceding period. The Company may also issue an accelerated put at a purchase price of 85% of the three closing bid prices 10 days following the put date subject to a floor price equal to the greater of: (A) seventy-five percent (75%) of the Closing Bid Price of the Common Stock on the applicable Put Date; or (B) any higher minimum price per share specified by the Company in the applicable Accelerated Put Notice. A commitment fee of five million common shares of the Company’s Common Stock shall be issued in two equal tranches: (i) first tranche of Two Million and Five Hundred Thousand common shares upon S-1 effectiveness; and the remaining (ii) second tranche of Two Million and Five Hundred Thousand common shares, issued ninety days later. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement as well.
     
  on June 26, 2026, the Company issued a convertible, redeemable note to a lender for $157,000 with cash proceeds of $150,000 and $7,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The note matures on March 30, 2027, and converts after 180 days at 65% of the average of the three lowest trading prices, 10 trading days prior to the conversion date.
     
  on July 9, 2026, the Company issued a promissory note to a lender for $165,000 with cash proceeds of $150,000 and an original issue discount of $15,000 for fees. The note matures in one year and bears interest at 15%, per annum ,compounding annually. The note is secured by the assets of the Company.

 

F-66

 

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 13. Other Expenses of Issuance and Distribution

 

The following table sets forth the costs and expenses payable by us in connection with the registration of the securities being registered hereby. All amounts are estimates other than the SEC registration fee.

 

SEC registration fee  $1,503,22 
Accounting fees and expenses  $10,000.00 
Legal fees and expenses  $5,000 
Printing and EDGAR fees  $2,500.00 
Total  $19,003.22 

 

Item 14. Indemnification of Directors and Officers

 

We are a Nevada corporation. Nevada law and our Articles of Incorporation and Bylaws provide for indemnification of our directors and officers to the fullest extent permitted by law.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

 

Bylaws - Limitation of Liability and Indemnification of Directors and Officers

 

We are incorporated under the laws of the State of Nevada. Our bylaws address the personal liability of our directors and our obligation to indemnify our directors, officers, and employees, in each case to the fullest extent allowed by the Nevada Revised Statutes (the “NRS”).

 

Our bylaws eliminate the personal liability of our directors to us and our stockholders for money damages for breach of their fiduciary duties as directors, to the fullest extent the NRS permits.

 

Our bylaws also require us to indemnify our directors, officers, and employees against expenses, judgments, fines, settlement payments, and other losses (including attorneys’ fees) they reasonably incur in connection with any threatened, pending, or completed legal proceeding — whether civil, criminal, administrative, or investigative — that arises because they serve or served in those roles, or served another entity at our request. This protection continues after a person leaves their position and extends to their heirs and estate.

 

A person is entitled to indemnification only if he or she acted in good faith and in a manner reasonably believed to be in, or not opposed to, our best interests, and, in a criminal matter, had no reasonable cause to believe the conduct was unlawful. We generally will not indemnify a person in a case brought by us, or on our behalf, in which the person is found liable to us, unless a court decides that indemnification is nonetheless fair and reasonable. If a person starts a proceeding themselves, we will indemnify them only if our board authorized or ratified that proceeding.

 

We are also required to advance the expenses a director or officer incurs in defending a proceeding before it is finally resolved. If the NRS requires, we will do so only after the person agrees in writing to repay the advanced amounts if it is ultimately determined that they were not entitled to be indemnified.

 

If we do not pay a valid indemnification claim within 60 days (or an expense-advancement claim within 20 days), the person may sue us to recover the unpaid amount and, if they succeed, to recover the cost of bringing that suit. In such a suit, we bear the burden of proving the person is not entitled to indemnification or advancement.

 

The rights described above are contract rights and are not exclusive of any other rights a person may have under any statute, our articles of incorporation, any agreement, a vote of stockholders, or otherwise. Any future change to these bylaw provisions will apply only going forward and will not reduce the protections tied to events that occurred before the change.

 

We will not indemnify a person for amounts paid to settle a claim without our written consent (which we will not unreasonably withhold), or for a judgment where we were not given a reasonable, timely opportunity to participate in the defense at our own expense. If we make an indemnification payment, we take over the person’s rights to recover from others to the extent of that payment.

 

We are permitted, but not required, to indemnify our other employees and agents on similar terms, as authorized by our board. We may also purchase and maintain directors’ and officers’ liability insurance covering these individuals, whether or not we would have the power to indemnify them under the NRS for the same matters.

 

We believe these provisions and any related insurance are necessary to attract and retain qualified directors and officers.

 

II-1
 

 

Nevada Revised Statutes

 

Section 78.7502 of the NRS permits a Nevada corporation to indemnify any person who is or was a party, or is threatened to be made a party, to any threatened, pending or completed action, suit or proceeding — whether civil, criminal, administrative or investigative, other than an action by or in the right of the corporation — by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the corporation’s request in such a capacity for another corporation, partnership, joint venture, trust or other enterprise. Indemnification may extend to expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with the action, suit or proceeding, if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. The termination of a proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent does not, of itself, create a presumption that the person failed to meet the applicable standard of conduct.

 

In the case of an action or suit brought by or in the right of the corporation to procure a judgment in its favor, Section 78.7502 permits indemnification for expenses, including amounts paid in settlement and attorneys’ fees actually and reasonably incurred in connection with the defense or settlement of the action or suit, under the same good-faith standard. Indemnification may not be made, however, for any claim, issue or matter as to which the person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought, or another court of competent jurisdiction, determines that in view of all the circumstances the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

 

Any discretionary indemnification under Section 78.7502, unless ordered by a court or advanced as described below, may be made by the corporation only as authorized in the specific case upon a determination that indemnification is proper under the circumstances because the person has met the applicable standard of conduct. That determination must be made by our stockholders; by our board of directors, by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding; or, if such a quorum so orders or a quorum of such directors cannot be obtained, by independent legal counsel in a written opinion.

 

Section 78.751 of the NRS requires a corporation to indemnify a director, officer, employee or agent, against expenses actually and reasonably incurred (including attorneys’ fees), to the extent that the person has been successful on the merits or otherwise in defense of any action, suit or proceeding described above — including, without limitation, an action by or in the right of the corporation — or in defense of any claim, issue or matter in the proceeding.

 

Section 78.751 further provides that, unless otherwise restricted by the articles of incorporation, the bylaws or an agreement made by the corporation, the corporation may pay the expenses of officers and directors incurred in defending a civil or criminal action, suit or proceeding as those expenses are incurred and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that the person is not entitled to be indemnified by the corporation. The articles of incorporation, the bylaws or such an agreement may require the corporation to advance those expenses upon receipt of such an undertaking.

 

Indemnification and advancement of expenses under Section 78.751 and Section 78.7502 do not exclude any other rights to which a person seeking indemnification or advancement of expenses may be entitled under the articles of incorporation, any bylaw, an agreement, a vote of stockholders or disinterested directors, or otherwise. Indemnification — unless ordered by a court or made as an advancement of expenses — may not, however, be made to or on behalf of any director or officer who is finally adjudged by a court of competent jurisdiction, after exhaustion of any appeals, to be liable for intentional misconduct, fraud or a knowing violation of law where that misconduct, fraud or violation was material to the cause of action. In addition, a right to indemnification or to advancement of expenses arising under a provision of the articles of incorporation or the bylaws is not eliminated or impaired by an amendment to that provision after the occurrence of the act or omission that is the subject of the proceeding for which indemnification or advancement is sought, unless the provision in effect at the time of the act or omission expressly authorized such elimination or impairment.

 

Section 78.752 of the NRS permits a corporation to purchase and maintain insurance or make other financial arrangements on behalf of any person who is or was a director, officer, employee or agent of the corporation, or who is or was serving at the corporation’s request in such a capacity for another entity, for any liability asserted against the person and any liability and expenses incurred by the person in that capacity or arising out of the person’s status as such, whether or not the corporation would have the authority to indemnify the person against such liability and expenses under the NRS. The other financial arrangements permitted by Section 78.752 include the creation of a trust fund, the establishment of a program of self-insurance, the securing of the corporation’s obligation of indemnification by granting a security interest or other lien on any of its assets, and the establishment of a letter of credit, guaranty or surety. In the absence of fraud, the decision of the board of directors as to the propriety of such an arrangement and the terms and conditions of the insurance or other financial arrangement is conclusive, and the arrangement is not void or voidable and does not subject any approving director to personal liability, even if the director is a beneficiary of the arrangement.

 

Our Articles of Incorporation and Bylaws provide for the indemnification of, and the advancement of expenses to, our directors and officers to the fullest extent permitted by the NRS, consistent with the statutory provisions summarized above.

 

II-2
 

 

Item 15. Recent Sales of Unregistered Securities

 

The Commitment Shares and the Put Shares to be issued to Trillium under the Purchase Agreement are or will be issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D thereunder, based on Trillium’s representations that it is an accredited investor and is acquiring the securities for its own account, and the absence of any general solicitation.

 

The unregistered sales of equity securities during the past three years consist of the following:

 

Date  Transaction  Consideration  Shares Issued 
February 28, 2023(1)  Number of shares outstanding February 28, 2023      58,366,416 
June 2, 2023  Common stock issued for services*  $200,000 in debt exchanged for common shares   21,000 
July 24, 2023  Common stock issued for services*  $200,000 in debt exchanged for common shares   100,000 
July 24, 2023  Common stock issued for services*  $162,000 in debt exchanged for common shares   65,000 
March 1, 2023-February 29, 2024  Other registered sales  Various prices   33,835,094 
   Number of shares outstanding February 29, 2024      92,387,510 

 

Date  Transaction  Consideration  Shares Issued 
April 29,2024  Series B share issuance*  Issuance of 320 Series B Convertible Preferred including 20 Series B share commitment fee for cash proceeds of $278,000   

_

 
August 8, 2024  Debt exchange*  $200,000 in debt exchanged for common shares   571,429 
December 16, 2024  Debt exchange*  $200,000 in debt exchanged for common shares   769,230 
February 11, 2025  Series C share issuance*  Issuance of 306 Series C Convertible Preferred for cash proceeds of $278,580     
February 11, 2025  Debt exchange*  $162,000 in debt exchanged for common shares   600,000 
March 1, 2024-February 28, 2025  Other registered sales  Various prices   49,796,369 
   Number of shares outstanding February 28, 2025      144,124,538 

 

II-1

 

 

Date  Transaction  Consideration  Shares Issued 
March 5, 2025  Debt exchange*  $150,500 in debt and $275,000 in accrued interest for a total Of $425,500 exchanged for common shares at a fair value of $444,000 for a loss on settlement of debt of $18,500   1,850,000 
April 21, 2025  Debt exchange*  $475,000 in accrued interest exchanged for common shares at a fair value of $450,000 for a gain on settlement of debt of $25,000   2,500,000 
May 15, 2025  Debt exchange*  $350,000 in accrued interest exchanged for common shares at a fair value of $350,000   2,500,000 
June 9, 2025  Debt exchange*  $300,000 in accrued interest exchanged for common shares at a fair value of $350,000 for a loss on settlement of debt of $50,000   2,500,000 
June 25, 2025  Debt exchange*  $275,000 in accrued interest exchanged for common shares at a fair value of $300,000 for a loss on settlement of debt of $25,000   2,500,000 
July 24, 2025  Debt exchange*  $315,000 in accrued interest exchanged for common shares at a fair value of $350,000 for a loss on settlement of debt of $35,000   3,500,000 
August 7, 2025  Debt exchange*  $360,000 in accrued interest exchanged for common shares at a fair value of $400,000 for a loss on settlement of debt of $40,000   4,000,000 
August 7, 2025  Series C shares issuance *  114 Penalty shares having a redemption value of $149,307 for failure to redeem Series C shares    
September 17, 2025  Debt exchange*  $280,000 in accrued interest exchanged for common shares at a fair value of $480,000 for a loss on settlement of debt of $200,000   4,000,000 
October 1, 2025  Debt exchange*  $280,000 in accrued interest exchanged for common shares at a fair value of $360,000 for a loss on settlement of debt of $80,000   4,000,000 
October 21, 2025  Debt exchange*  $140,000 in accrued interest exchanged for common shares at a fair value of $180,000 for a loss on settlement of debt of $40,000   2,000,000 
November 3, 2025  Debt exchange*  $280,000 in accrued interest exchanged for common shares at a fair value of $320,000 for a loss on settlement of debt of $40,000   4,000,000 
November 14, 2025  Debt exchange*  $350,000 in accrued interest exchanged for common shares at a fair value of $400,000 for a loss on settlement of debt of $50,000   5,000,000 
December 2, 2025  Conversion of Series C Preferred Shares*  Conversion of 85 Series C shares for fair value of $111,690   1,994,464 
December 2, 2025  Debt exchange*  $378,000 in accrued interest exchanged for common shares at a fair value of $480,000 for a loss on settlement of debt of $102,000   6,000,000 
December 4, 2025  Series C shares issuance *  133 Series C s adjusted penalty shares having a redemption value of $175,140 for failure to convert    
December 12, 2025  Debt exchange*   $378,000 in accrued interest exchanged for common shares at a fair value of $420,000 for a loss on settlement of debt of $42,000   6,000,000 
December 22, 2025  Convertible debt issuance*  $495,000 Convertible note that converts after 180 days  at 80% of the lowest traded price 15 prior trading days    
5-Jan-26  Debt exchange*  $324,000 in accrued interest exchanged for common shares at a fair value of $360,000 for a loss on settlement of debt of $36,000   6,000,000 
18-Jan-26  Debt exchange*  $336,000 in accrued interest exchanged for common shares at a fair value of $420,000 for a loss on settlement of debt of $84,000   7,000,000 
8-Feb-26  Debt exchange*  $192,000 in accrued interest exchanged for common shares at a fair value of $320,000 for a loss on settlement of debt of $128,000   8,000,000 
19-Feb-26  Convertible debt issuance*  $165,000 Convertible note that converts after 180 days at 80% of the lowest traded price 15 prior trading days    
March 1, 2025-February 28, 2026  Other registered sales  Various prices   50,403,802 
   Number of shares outstanding February 28, 2026      267,872,804 

 

II-2

 

 

Date  Transaction  Consideration  Shares Issued 
March 9, 2026  Debt exchange*  $224,000 in accrued interest exchanged for common shares at a fair value of $280,000 for a loss on settlement of debt of $56,000   7,000,000 
March 12, 2026  Common share issuance  Rounding shares on reverse split   43 
            
March 19,2026  Series C share issuance*  Issuance of 222 Series C Convertible Preferred including 22 Series C share
Commitment fee for proceeds of $200,000
    
March 19,2026  Conversion of Series C Preferred Shares*  Conversion of 165 Series C shares for fair value of $216,810   13,550,625 
March 20,2026  Debt exchange*  $112,000 in accrued interest exchanged for common shares at a fair value of $630,700 for a loss on settlement of debt of $518,700   7,000,000 
March 25,2026  Convertible debt issuance*  $110,000 Convertible note that converts after 180 days at 80% of the lowest traded price 15 prior trading days    
March 25, 2026  Convertible debt issuance*  $630,000 Convertible note that converts after 180 days with penalty at 20% of the lowest traded price 15 prior trading days. This loan was repaid May 5, 2026.    
March 25, 2026  Common share issuance*  Commitment fee returnable to the Company as $630,00 debt was repaid on May 5, 2025   14,100,000 
April 9, 2026  Convertible debt issuance*  $257,000 Convertible note that converts after 180 days at 65% of the average of the three lowest traded prices 10 prior trading days    
April 20, 2026  Convertible debt issuance*  $277,778 Convertible note that converts at 75% of the lowest traded prices 10 prior trading days    
April 20, 2026  Common share issuance*  Commitment fee on April 20 ,2026 convertible note   5,000,000 
May 1, 2026  Convertible debt issuance*  $257,000 Convertible note that converts after 180 days at 65% of the average of the three  lowest traded prices 10 prior trading days    
February 11, 2025  Series C share issuance*  Issuance of 306 Series C Convertible Preferred for cash proceeds of $278,580     
April 27, 2026  Debt exchange*  $185,600 in accrued interest exchanged for common shares at a fair value of $220,800 for a loss on settlement of debt of $35,200   8,000,000 
May 4, 2026  Convertible debt issuance*  $700,000 Convertible note that converts at 65% of the lowest closing bid prices 10 prior trading days    
May 4, 2026  Common share issuance*  Commitment fee issuable on May 4 ,2026 convertible note(2)   1,250,000 
May 5, 2026  Debt exchange*  $80,000 in accrued interest exchanged for common shares at a fair value of $100,000 for a loss on settlement of debt of $20,000   5,000,000 
May 6, 2026  Conversion of Series C Preferred Shares*  Conversion of 40 Series C shares for fair value of $52,560   3,285,000 
May 12, 2026  Conversion of Series C Preferred Shares*  Conversion of 93 Series C shares for fair value of $122,202   7,637,625 
May 27, 2026  Debt exchange*  $144,300 in principal and accrued interest exchanged for common shares at a fair value of $222,000 for a loss on settlement of debt of $77,700   12,000,000 
May 29, 2026  Convertible debt issuance*  $138,889 Convertible note that converts at 65% of the lowest traded prices 10 prior trading days    
March 1, 2026-May 31, 2026  Other registered sales  Various prices   36,786,492 
   Number of shares outstanding May 31, 2026 2026(2)      388,482,589 

 

II-3

 

 

Date  Transaction  Consideration  Shares Issued 
June 3, 2026  Convertible debt issuance*  $230,000 Convertible note that converts after 180 days at 65% of the lowest traded prices 20 prior trading days    
June 9, 2026  Convertible debt issuance*  $55,000 Convertible note that converts at 65% of the lowest traded prices 10 prior trading days    
June 9, 2026     $110,000 Convertible note that converts at 65% of the lowest traded prices 10 prior trading days    
June 12, 2026  Debt exchange*  $89,700 in principal exchanged for common shares at a fair value of $138,000 for a loss on settlement of debt of $48,300   12,000,000 
June 15, 2026  Convertible debt issuance*  $165,000 Convertible note that converts at 65% of the lowest traded prices 20 prior trading days    
June 26, 2026  Convertible debt issuance*  $230,000 Convertible note that converts after 180 days at 65% of the lowest traded prices 10 prior trading days    
July 8, 206  Conversion of convertible note and interest  Conversion of $10,000 in principal and $600 in interest   1,441,576 
July 13,2026  Cancellation  Cancellation of march 25, 2026 issuance due to repayment of loan   (14,100,000)
May 1-July 8, 2026  Other registered sales  Various prices   32,797,611 
   Number of shares outstanding July 15, 2026(2)      420,621,776 

 

* Sold under rule 144

(1) At February 28, 2023 there were 12,100,000 issuable shares

(2) At May 31, 2026 and July 14, 2026 there were 1,250,000 issuable shares.

 

II-4

 

 

Item 16. Exhibits

 

Exhibit No.   Description
3.1   Articles of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on March 12, 2018)
3.2   Bylaws, as amended (incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on September 2, 2021)
3.3   Certificate of Designation of Series B Convertible, Redeemable Preferred Stock, filed with the Nevada Secretary of State on or about April 27, 2024 in connection with the Company’s Securities Purchase Agreement with GHS Investments, LLC (filed herewith).*
3.4   Certificate of Designation of Series C Convertible, Redeemable Preferred Stock, filed with the Nevada Secretary of State on or about February 10, 2025 (filed herewith).*
4.1   Form of Common Stock Certificate*
4.3   Amendment to Certificate of Designation of Series E Convertible Preferred Stock (previously filed as Exhibit 3.5 to Registrant’s Transition Report on Form-KT filed on 3/12/18 and incorporated by reference)
4.4   Certificate of Designation of Series F Convertible Preferred Stock (previously filed as Exhibit 3.4 to the Registrant’s Transition Report on Form 10-KT filed on 3/12/2018 and incorporated by reference)
4.5   Amendment Number 2 to Certificate of Series F Convertible Preferred Stock (previously filed as Exhibit 10.1 of Registrant’s Form 8-K filed on 8/24/2021 and incorporated by reference
4.6   Certificate of Designation of Series G Preferred Stock (previously filed as Exhibit 3.4 to the Registrant’s Transition report on Form 10-KT on 3/12/2018 and incorporated by reference
5.1   Opinion of Frederick M. Lehrer, P. A. as to the legality of the securities*
10.1   Equity Purchase Agreement, dated June 23, 2026, between the Company and Trillium Partners LP*
10.2   Registration Rights Agreement, dated June 23, 2026, between the Company and Trillium Partners LP*
10.3  

Lease Agreement, dated March 10, 2021, between the Company and the landlord of 10800 Galaxie Avenue, Ferndale, Michigan (filed herewith).*

21.1   Subsidiaries of the Registrant (incorporated by reference to Exhibit 21 filed on January 20, 2023 with the SEC on Form 10-Q for the period ending November 30, 2025,
23.1   Consent of Independent Registered Public Accounting Firm*
23.2   Consent of Frederick M. Lehrer, P. A. (included in Exhibit 5.1)*
24.1   Power of Attorney (included on the signature page of this Registration Statement)
101   Inline XBRL Instance Document and related taxonomy extension files (Instance, Schema, Calculation, Definition, Label and Presentation Linkbases)*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*
107   Filing Fee Table*

 

* Filed herewith.

† Management contract or compensatory plan or arrangement.

 

Item 17. Undertakings

 

The undersigned registrant hereby undertakes the undertakings required by Item 512 of Regulation S-K applicable to a registration statement on Form S-1, including the Rule 415 undertakings and the undertaking regarding indemnification of directors and officers.

 

Item 17. Undertakings

 

The undersigned registrant hereby undertakes as follows:

 

(a) Rule 415 Offeringinclude only if securities are registered pursuant to Rule 415.

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

 

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective registration statement;

 

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

 

II-5

 

 

Provided, however, That paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the registration statement is on Form S-1 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.

 

(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

[Add (a)(4) only if the registrant is a foreign private issuer; add (a)(5) and (a)(6) if relying on Rule 430B or Rule 430C for undertakings regarding the timing/liability of filed prospectuses and primary-offering seller status. These are omitted here as situational — pull the verbatim text of (a)(4)–(a)(7) from 17 CFR 229.512 if your structure triggers them.]

 

(b) Filings incorporating subsequent Exchange Act documents by referenceinclude if the registration statement forward-incorporates Exchange Act filings by reference (available to certain S-1 filers).

 

The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(h) Request for acceleration of effective dateinclude if acceleration of effectiveness is requested under Rule 461 (virtually always the case for a Form S-1). This is the indemnification undertaking you referenced.

 

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

II-6

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ferndale, State of Michigan, on July 16, 2026.

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.    
         
By:/s/ Steve Reinharz     
Steve Reinharz      July 16, 2026
Chief Executive Officer (Principal Executive Officer)       
         
 /s/ Anthony Brenz  Chief Financial Officer   July 16, 2026
 Anthony Brenz       

 

II-7

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-3.3

EX-3.4

EX-4.1

EX-5.1

EX-10.1

EX-10.2

EX-10.3

EX-23.1

EX-FILING FEES

XBRL SCHEMA FILE

XBRL CALCULATION FILE

XBRL DEFINITION FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: R48.htm

IDEA: R49.htm

IDEA: R50.htm

IDEA: R51.htm

IDEA: R52.htm

IDEA: R53.htm

IDEA: R54.htm

IDEA: R55.htm

IDEA: R56.htm

IDEA: R57.htm

IDEA: R58.htm

IDEA: R59.htm

IDEA: R60.htm

IDEA: R61.htm

IDEA: R62.htm

IDEA: R63.htm

IDEA: R64.htm

IDEA: R65.htm

IDEA: R66.htm

IDEA: R67.htm

IDEA: R68.htm

IDEA: R69.htm

IDEA: R70.htm

IDEA: R71.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: forms-1_htm.xml

IDEA: ex107_htm.xml